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All RNAs transcribed by RNA polymerase II (RNAP II) are characterised by a monomethyl 
guanosine cap. RNA cap formation occurs co-transcriptionally and is facilitated by the recruitment of 
the capping enzyme to the phosphorylated carboxyl-terminal domain (CTD) of the largest subunit of 
RNAP II. The cap is functionally important in various aspects of RNA metabolism including RNA 
stability, pre-mRNA splicing, 3'-end formation, RNA transport and cap-dependent translation. The 
effects of the cap in pre-mRNA splicing, 3'-end formation and U snRNA export are mediated by the 
nuclear cap-binding complex (CBC). CBC is a heterodirner comprised of cap-binding proteins CBP20 
and CBP80. Homologues have been identified in a variety of eukaryotes and CBC function appears to 
be evolutionarily conserved in metazoans. Although CBC mediates the cap's effects in three diverse 
nuclear processes, little is known about the proteins that CBC interacts with or the mechanisms 
involved. This thesis aims to characterise CBC in Drosophila melanogaster and uses genetic 
approaches to further understand the mechanisms by which the cap facilitates multiple aspects of 
RNA metabolism through CBC. 
Firstly, P-element induced mutagenesis was used to create mutants in the CBC heterodimer. A P-
element residing in DmCBP20 was mobilised to generate DmCBP20 excision alleles. This showed 
DmCBP20 is an essential gene that functions in both somatogenesis and gametogenesis. Intriguingly, 
the P-hop generated a surprisingly high number of DmCBP20 male steriles compared to DmCBP20 
female steriles. Analysis of male steriles showed the early stages of spermatogenesis that correlate to 
active transcription and RNA processing are normal. Instead, defects might arise in late spermatid 
differentiation. These findings suggest novel function(s) for DmCBP20 in spermatogenesis outwith 
RNA processing. 
A second divergent CBP80 homologue named DmCBP80 Related (DmCBP80R) is identified in fruit-
flies. In contrast to DmCBP80, DmCBP80R appears to be predominantly expressed in adult testes. 
These results suggest DmCBP80R, together with DmCBP20, might have acquired novel functions in 
spermatogenesis as part of a male-specific CBC. 
Finally, to identify CBC-interacting genes, the GAL4-UAS system was used to over-express full-
length and truncated CBP20 and CBP80 in non-essential adult fly tissues. The shortest truncations in 
both cap-binding proteins generated dominant phenotypes. DnzCBP80 dominant phenotype was used 
in genetic modifier screens to identify CBC-interacting genes. This showed the dominant phenotype 
was suppressed by an allele of the largest subunit of RNAP II that has a truncated CTD. These 
findings suggest CBC might interact with the CTD of RNAP II to facilitate the coupling of 
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CHAPTER 1 
Introduction 
Protein-encoding genes and major spliceosomal U snRNAs with the exception of U6 
snRNA, are specifically transcribed by RNA polymerase II (RNAP II). RNAP Ii 
transcripts are characterised by a 5'-end modification termed the monomethyl 
guanosine cap. The cap structure consists of an inverted 7-methyl guanosine, which 
is linked to the first transcribed nucleotide of RNA through a 5' to 5' triphosphate 
bridge (Figure 1.1 and Shatkin, 1976; Salditt-Georgieff et al., 1980). The cap was 
initially characterised as a blocked structure that protects the 5-end of primary 
transcripts against 5' to 3' exoribonucleases and as a result promotes RNA stability 
(Furuichi et al., 1977; Shimotohno et al., 1977; Schwer et at., 1998). Subsequent 
studies have shown that the cap is functionally important in eukaryotic gene 
expression where it plays a central role in RNAP II transcript metabolism. In the 
nucleus, the cap is involved in RNA stability, pre-mRNA splicing (Konarska et al., 
1984; Kramer et al., 1984; Ohno et al., 1987), RNA 3'-end formation (Cooke and 
Aiwine, 1996; Gilmartin et at., 1988; Hart et at., 1985), RNA export and nucleolar 
localisation of U3 and U8 small nucleolar RNAs (Hamm and Mattaj, 1990; 
Jarmolowski et al., 1994; Jacobson and Pederson, 1998). Whilst in the cytoplasm, the 
cap is required for cap-dependent translation of mRNAs (Shatkin, 1985; Sachs et al., 
1997). 
A key observation in the field of gene expression is that transcription, RNA 
processing and translation appear to be mechanistically linked in vivo. This would 
make biological sense, as it would ensure the most efficient passage for gene 
expression. However, the molecular mechanisms by which these events are 
integrated remains to be elucidated. In the last few years, it has become increasingly 
apparent that RNAP II also contributes to various RNA processing reactions required 
to synthesis a mature rnRNA. 
1 
Figure 1.1 Cap Structure 
triphosphate bridge 
N  (H5 	











Figure 1.1 Structure of the cap. RNAP II transcripts are characterised by a 
5' modification termed the monomethyl guanosine cap. The cap consists of an 
inverted 7-methyl guanosine linked to the first transcribed nucleotide of RNA 
through a 5' to 5' tnphosphate linkage. Figure is taken from Shatkin, 1976. 
Charter 1 Introduction 
In particular, the carboxyl-terminal domain (CTD) of the largest subunit of RNAP II 
is found to integrate nuclear RNA processing with transcription. The CTD appears to 
not only recruit RNA processing factors to sites of transcription but also directly 
functions in RNA cap formation, pre-mRNA splicing and RNA 3'-end formation. 
The cap acts as a molecular tag to define RNAP II transcripts. As a result, the cap 
mediates the recognition of RNAP II transcripts by various components of nuclear 
RNA processing machinery. This suggests that the cap might also interact with the 
CTD to facilitate the coupling of transcription with nuclear RNA processing. 
1.1 The capping reaction 
The capping reaction is catalysed by a series of three enzymatic activities; RNA 5'-
triphosphatase, RNA guanylyl transferase and RNA (guanine-7)-methyl transferase 
respectively. Firstly, RNA 5'-triphosphatase hydrolyses the y-phosphate from the 5'-
triphosphate end of the nascent transcript to a 5'-diphosphate. Next, RNA guanylyl 
transferase transfers GMP derived from GTP to the newly formed 5'-diphosphate end 
forming a blocked guanosine cap (GpppN). Lastly, RNA (guanine-7)-methyl 
transferase adds a methyl group to the N7 position of the cap guanosine to generate 
the m7 0 (5')ppp(5') N cap structure (Figure 1.1 and Shuman, 1995). The capping 
enzyme in S. pombe and S. cerevisiae has been characterised and is found to consist 
of a heterodimer comprised of separate triphosphatase (Ceti) and guanylyl 
transferase (Cegi) subunits (Shibagaki, 1992). In contrast, the capping enzyme in 
metazoans is encoded in a single protein that consists of an amino-terminal 
triphosphatase domain linked to a carboxyl-terminal guanylyl transferase domain 
(Yue et al., 1997; Saha et al., 1999). 
Evidence from several laboratories has demonstrated in yeast that capping is 
essential for cell viability. Mutations of the triphosphatase, guanylyl transferase or 
methyl transferase components of the capping apparatus are lethal in vivo (Schwer 
and Schuman, 1994; Shuman et al. 1994; Fresco and Buratowski, 1996; Mao 1996; 
Wang 1997; Ho et al. 1998). This is not unexpected considering the cap plays an 
important role in RNAP 11 metabolism events such as splicing, RNA 3'-end 
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formation, U snRNA export and cap-dependent translation initiation (Konarska et al., 
1984; Shatkin, 1985; Jarmolowski et al., 1994; Cooke and Aiwine, 1996). In 
addition, failure to cap pre-mRNAs results in their accelerated decay through the 
activities of 5' to 3' exoribonucleases (Furuichi et al., 1977; Shimotohno et al., 1977; 
Schwer et al., 1998). 
1.2 The transcription cycle 
Cap formation is the first detectable RNAP II processing event that occurs co-
transcriptionally. Synthesis of RNAP II transcripts involves a complete round of 
transcription that consists of pre-initiation complex (PlC) formation, transcription 
initiation, transition to RNAP II elongation complex and transcription termination 
(Reines ci' al., 1999; Buratowski, 2000). The transcription PlC is formed when 
RNAP II and multiple general transcription factors are recruited to the core promoter. 
Firstly, the TATA-binding protein (TBP) subunit of TFIID directly binds to the 
TATA element within the promoter. Next, TFIIB in collaboration with TFIIF bridges 
TBP and recruits the RNAP II holoenzyme. TFIIE and the ATP-dependent helicase 
component of TFIIH then unwind the promoter DNA, which allows transcription to 
be initiated (Berk, 1999; Green, 2000). During transcription initiation, RNAP II 
synthesises 20-40 nucleotides of the nascent transcript and then pauses. It is within 
this initiation phase that the capping reaction occurs (Coppola et al., 1983; Jove and 
Manley, 1984). RNAP II makes the transition to the elongation complex and the 
holoenzyme then escapes from the promoter and transcribes the remainder of the 
gene. Finally, transcription is terminated and both RNAP II and the nascent transcript 
are released from the DNA template. 
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1.3 Coupling capping with transcription 
The capping reaction occurs co-transcriptionally on nascent transcripts that are 
approximately 20-40 nucleotides in length. At this length, RNAs are sufficiently 
extruded from the RNA-binding pocket of RNAP II to become accessible to the 
capping enzymes (Coppola et al., 1983; Hagler and Shuman, 1992; Rasmussen and 
Lis, 1993). Evidence from several laboratories has shown that RNA cap formation is 
coupled to transcription. This appears to be facilitated by either the phosphorylated 
CTD or the DSIF subunit, SptS both of which physically interact with the capping 
enzyme and stimulate its guanylyl transferase activity. 
Capping is specifically targeted to RNAP II transcripts through the physical 
interaction of one or more of the components of the capping apparatus with the 
phosphorylated CTD. In S. cerevisiae, Cegi and Abdi bind directly to the phospho-
serine-5 residues of the CTD in vitro (Cho et al., 1997; McCracken et al., 1997a). 
Whilst in mammals, both RNA triphosphatase and guanylyl transferase activities 
bind to the phosphorylated CTD (McCracken et at., 1997a; Yue et al., 1997; Ho et 
al., 1998; Ho and Shuman, 1999). 
The CTD consists of a heptad repeat with the consensus sequence Tyr-Ser-Pro-Thr-
Ser-Pro-Ser, which is remarkably conserved in sequence but not copy number. For 
example, in S. cerevisiae the CTD has 26 repeats, Drosophila melanogaster CTD has 
42 repeats, whilst the mammalian CTD has 52 repeats (Allison et al., 1985; Corden 
et aL,1985; Allison et at., 1988). The CTD is rich in potential phospho-acceptor 
amino acid residues and is subject to reversible phosphorylation during the 
transcription cycle (Dahmus, 1996). The phosphorylation status of the CTD is 
important since it not only plays an important role in transcription initiation but also 
recruits factors involved in RNA cap formation, pre-mRNA splicing and RNA 3'-
end formation (Carlson, 1997; Rodriguez et al., 2000; Schroeder et at., 2000). Figure 
1.2 summarises the dynamic association of RNA capping and processing factors with 
the differentially phosphorylated forms of RNAP II throughout the transcription 
cycle. 
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Figure 1.2 Transcription is coupled with mRNA processing. A round of 
transcription consists of pre-initiation complex formation (PlC), transcription 
initiation (I), transition to RNAP II elongation complex (E) and transcription 
termination (T). A. Phosphorylation status of CTD affects recruitment of RNA 
processing factors. 1. NELF is recruited to RNAP hA where it represses 
elongation in association with DSIF. 2. Capping enzyme (CE) binds serine-5 
phosphorylated CTD during initiation. 3. Splicing factors (SF) associate with 
elongating RNAP 110. 4. 3'-end processing factors (PF) recruited to RNAP 110 
during elongation and termination. B. RNA processing factors recruited to 
RNAP hA at promoter and remain associated with RNAP 110 for entire length 
of gene. These include transcription regulator DSIF, cap methyl transferase 
Abdi and 3' processing factor CPSF. C. Phosphorylation status of RNAP II 
during transcription. 1. CTD is hypophosphorylated during PlC assembly. 2. 
CTD undergoes hyperphosphorylation during transcription initiation when 
serine-5 is primarily phosphorylated at the promoter region. 3. Serine-2 
phosphorylation is prevalent around transcription start site and throughout 
transcription elongation and 4. termination. 
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Phosphorylation of the RNAP II CTD serves two functions. Firstly, it leads to the 
release of the PlC from the promoter and secondly, it recruits the capping enzyme 
and subsequent RNA processing factors to the transcription elongation complex. At 
the start of transcription, the PlC assembles on the promoter and contains RNAP IT 
with a hypophosphorylated CTD (RNAP hA) (O'Brien et al., 1994; Weeks et al., 
1993). During transcription initiation, the CTD undergoes hyperphosphorylation 
(RNAP ITO) and consequently activates transition from the initiation complex to a 
stable elongation complex (Lu et al., 1991; Dahmus, 1994). Phosphorylation of the 
CTD primarily occurs at serine-2 and serine-5 residues of the heptapeptide consensus 
sequence (Dahrnus, 1996). However, the phosphorylation of these residues is not 
equivalent but varies along the length of the transcribed gene. The CTD undergoes a 
cycle of extensive phosphorylation and dephosphorylation of serine-2 and serine-5, 
which is co-ordinated with the transcription cycle. Serine-5 is predominantly 
phosphorylated at the promoter region, whereas serine-2 phosphorylation is prevalent 
around the transcription start site and throughout transcription elongation and 
termination (Figure 1.2, Panel C 1-4 and Kormarnitsky et al., 2000). This distribution 
in phospho-serines is thought to result from the activities of different CTD-specific 
kinases and phosphatases throughout the transcription cycle. Although the 
identification and timing of such modulators is unclear, in S. cerevisiae, serine-5 
phosphorylation at the promoter region has been shown to be dependent on the 
kinase Kin28 (Rodriguez et al., 2000). Whilst in metazoans, serine-2 
phosphorylation in the coding region is mediated by the kinase Cdk9, which is a 
subunit of the positive transcription elongation factor b (P-TEFb) (Zhou et al., 2000). 
Genetic studies in S. cerevisiae have shown that Kin28 is responsible for 
phosphorylating serine-5 residues near the gene promoter and recruiting the capping 
enzyme to the CTD (Figure 1.2, Panel C 2-3 and Rodriguez et al., 2000). Kin28 is a 
component of the general transcription initiation factor TFIIH that is present in the 
promoter bound PlC. Phosphorylation of the CTD at serine-5 by Kin28 activates the 
transition of RNAP hA to RNAP 110, thereby positively regulating transcription 
(Feaver et al., 1994; Svejstrup et al., 1996; Hengartner et al., 1998). In addition, 
Kin28 mediated phosphorylation directly recruits the capping apparatus to the RNAP 
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II holoenzyme co-transcriptionally (Rodriguez et al., 2000). As a result, Kin28 
appears to be responsible for coupling RNA cap formation with the switch from 
transcription initiation to elongation. After cap formation, the phosphatase Fcpl is 
thought to dephosphorylate phospho-serine-5, which subsequently triggers the 
dissociation of the capping enzyme from the elongation complex (compare Panels A 
and C, 2-3 and Chambers and Dahmus, 1994; Cho et al., 1999; Kobor et al., 1999; 
Schroeder et al., 2000). Although the capping enzyme is released early in elongation, 
Abdi, the cap methyl transferase appears to remain associated with RNAP 110 until 
the 3'-end of the gene (compare Panels B and C, 1-4 and Schroeder et al., 2000). 
Current evidence only supports a role for Abdi during the capping reaction, 
however, the association of Abdi with the elongating polymerase suggests that it 
might also function in downstream transcription or mRNA processing events. 
It is not clear which CTD-specific kinases are responsible for serine-2 
phosphorylation at the later stages of transcription. However, in metazoans, a strong 
candidate is the cyclin-dependent kinase Cdk9, which is a component of the 
elongation factor P-TEFb (Mancebo et al., 1997; Price, 2000). P-TEFb consists of 
Cdk9 and several alternative regulatory subunits that include cyclin Ti, T2a or T2b, 
which once associated with Cdk9, increase its kinase activity (Zhu et al., 1997; Peng 
et al., 1998; Wei et al., 1998). P-TEFb hyperphosphorylates the CTD and stimulates 
RNAP It transcript elongation in vivo (Marshall and Price, 1995; Marshall et al., 
1996; Mancebo et al., 1997). In general, RNAP 110 elongation is regulated by a 
number of positive and negative transcription factors that counteract each others 
activity. The interplay between these factors shortly after transcription initiation 
appears to cause a kinetic delay that allows the replacement of initiation factors with 
elongation and processing factors. As a result, this allows transcription to be coupled 
with RNA processing (Price, 2000). 
Recent data has suggested that in higher eukaryotes, the capping enzymes may be 
recruited to the PlC independently of the CTD. In vitro, the main mechanism that 
controls P-TEFb stimulated elongation involves DRB inducing sensitivity factor 
(DSIF) and negative elongation factor (NELF) (Wada et al., 1998a). In mammals, 
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NELF has five subunits including one called RD, which has a putative RNA-binding 
domain (Yamaguchi et al., 1999a). Whilst DSIF is a heterodimer comprised of Spt4 
and Spt5 subunits, the latter of which interacts with RNAP II (Hartzog et al., 1998; 
Wada et al., 1998b). Both DSIF and NELF are found in the transcription PlC where 
they repress the switch from transcription initiation to elongation (Figure 1.2, Panels 
A and B 1). Hyperphosphorylation of the CTD by P-TEFb disrupts the DSIF-NELF 
interaction and reverses the negative effect on transcription elongation (Wada et al., 
1998a; Yamaguchi et al., 1999a and 1999b). As a result, NELF dissociates from the 
RNAP 110 elongation complex. In contrast, DSIF remains associated with RNAP 110 
to additionally function in targeting cap formation to RNAP II nascent transcripts 
and facilitating transcription elongation (compare Panels A, B and C 1-4 and Wu-
Baer et al., 1998; Wen and Shatkin, 1999; Andrulis et al., 2000; Kaplan et al., 2000; 
Chiu et al., 2001). 
In addition to the phosphorylated CTD, the selective capping of RNAP II transcripts 
is linked to transcription through the interaction of the capping enzyme with Spt5 
(Wen and Shatkin, 1999). Like the phosphorylated CTD, human Spt5 physically 
interacts with the mammalian capping enzyme and stimulates its guanylyl transferase 
activity to promote RNA cap formation (Wen and Shatkin, 1999; Chiu et al., 2001). 
However, it is currently unknown whether Spt5 targets the capping enzyme to RNAP 
II transcripts prior to, or independent of, the phosphorylated CTD. 
Similar to RNA cap formation, pre-mRNA splicing and RNA 3'-end formation are 
also coupled to transcription through the CTD of RNAP II. Both biochemical and in 
vivo studies have shown that the CTD specifically binds components of the splicing 
and 3'-end processing machinery to enhance the efficiency of these processes 
(Hirose and Manley, 2000). The CTD not only recruits processing factors to 
transcription sites but also appears to function directly with the splicing and 3'-end 
processing machinery. For example, some members of the SR protein family, that are 
required for splicing, have been shown to specifically interact with the 
phosphorylated CTD but not the unphosphorylated CTD (Figure 1.2, Panels A and C 
2-3 and Hirose et al., 1999). In contrast binding of 3'-end processing factors occurs 
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independently of the CTD phosphorylation status (McCracken et al., 1997b; Hirose 
and Manley, 1998). For example, factors such as cleavage and polyadenylation 
specificity factor (CPSF) and yeast cleavage factor TB (CFIB/ Hrpl), which is also 
implicated in mRNA turnover, associate early with RNAP II at the promoter and 
remain stably associated with the transcribing polymerase for the entire length of the 
gene (Panels A, B and C 1-4 and Dantonel et al., 1997; Kornarnitsky et al., 2000). 
1.4 Cap-binding proteins 
Many of the effects of the cap in RNAP II transcript metabolism are mediated by 
proteins that specifically recognise and bind the cap structure. Although several cap-
binding proteins (CBPs) have been reported, only two activities are well 
characterised in eukaryotes, namely the translation initiation factor eIF4E and 
nuclear cap binding complex (CBC) (Sonenberg, 1978 and 1979; Patzelt et al., 1983; 
Rozen and Sonenberg, 1987; Izaurralde et al., 1992). 
CBC is a heterodimer comprised of CBP20 and CBP80 subunits, both of which are 
evolutionarily conserved (Ohno et al., 1990; Izaurralde et al., 1994). CBC binds 
nascent RNAP II transcripts and facilitates the positive effects of the cap in nuclear 
RNA processing events that include pre-mRNA splicing, RNA 3'-end formation and 
U snRNA export (Izaurralde et al., 1995; Lewis et al., 1996; Flaherty et al., 1997; 
Lewis and Izaurralde, 1997). As a result, CBC accompanies pre-mRNA from the site 
of synthesis until it is processed and exported to the cytoplasm for translation 
(Gorlich et al., 1996; Visa et al., 1996). 
Upon export to the cytoplasm, protein synthesis is initiated by the association of the 
cap-dependent translation machinery with mRNA. In most cases, ribosomes do not 
directly bind mRNA but are recruited by a number of eukaryotic initiation factors 
(eIFs) that position a translationally competent ribosome at the initiation codon. 
During cap-dependent translation the most important cis-acting sequences are the cap 
and the poly(A) tail that effectively recruit the translation initiation complex eIF4F. 
eIF4F is a heterotrimer comprised of eIF4A, eIF4G and eIF4E subunits and serves to 
direct the translational machinery to the 5'-end of mRNA (Sachs et al., 1997). The 
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cap-binding component of eIF4F is eIF4E. Whilst eIF4G acts as a molecular bridge 
between the components of the translational machinery and mRNA. eIF4A is an 
ATP-dependent RNA helicase, which in conjunction with the associated co-factor 
eIF4B, unwinds the secondary structures present in the cap-proximal 5' UTR. This 
promotes the binding of the 40S small ribosomal subunit and associated proteins that 
scan the mRNA sequence for the initiation codon. After the initiation codon has been 
recognised, the eIFs dissociate allowing the 60S ribosomal subunit to bind and 
protein synthesis to be initiated (Kozak, 1989; Pestova et al.,2001). 
In addition to its function in cap recognition, eIF4F appears to mediate the 
synergistic effect of the 5' cap and 3' poly(A) tail on cap-dependent translation 
initiation. eIF4G directly interacts with poly(A) binding protein, which is bound to 
the poly(A) tail and consequently brings the 5' and 3'-ends into close proximity 
(Gallie, 1991; Tarun et al., 1997; Wells et al., 1998). This cap-poly(A) synergy is 
proposed to either facilitate the recycling of ribosomes from the 3'-end back to the 5' 
cap or enhance the formation of eIF-mRNA complexes (Preiss and Hentze, 1998; 
Borman et al., 2000). 
In order to allow eIF4F to bind the cap, the nuclear CBC must exchange with eIF4E 
in the cytoplasm. Recent data has shown that in S. cerevisiae, eIF4G physically 
interacts with CBP80 and this association is antagonised by eIF4E (Fortes et al., 
2000). In addition, the CBP80-eIF4G interaction appears to be evolutionarily 
conserved. Mammalian immunoprecipitation experiments have demonstrated a 
significant nuclear pool of eIF4G in vivo that is predominantly associated with CBC 
(McKendrick et al., 2001). This suggests that in the nucleus, CBC interacts with 
eIF4G at the 5'-end of mRNA. In the nucleus, eIF4G also interacts directly with 
poly(A) binding protein, which is bound to the 3' poly(A) tail. As a result, the 
mRNA is circularized in a manner analogous to that described for mRNA in the 
cytoplasm. After the mRNP is exported to the cytoplasm, CBC must exchange with 
eIF4E to initiate cap-dependent translation. The molecular mechanism by which this 
occurs remains to be elucidated. However, it is thought that the exchange of cap-
binding proteins is mediated through eIF4G (McKendrick et al., 2001). 
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1.5 nuclear Cap-Binding Complex 
CBC was initially identified in HeLa cell nuclear extracts as an activity that 
specifically bound to capped RNAs synthesised in vitro (Ohno et al., 1990; 
Izaurralde et al., 1992). Purification of this cap-binding activity showed that CBC 
exists as a heterodirner comprising cap-binding proteins of 20 kDa and 80 kDa 
(Ohno et at., 1990; Izaurralde et at., 1994). Subsequent immunofluorescence studies 
in HeLa cells have demonstrated that the steady state levels of CBC are 
predominantly nuclear. In the nucleus, CBC is localised ubiquitously but is excluded 
from the nucleolus (Kataoka et at., 1994; Izaurralde et at., 1994 and 1995). 
Both subunits of the human (Hs) CBC have been cloned and sequenced. The 
predicted amino acid sequence of HsCBP80 shows that it contains a bipartite nuclear 
localisation signal (NLS) at the amino-terminus (Mattaj, 1993; Izaurralde et at., 
1994). The NLS has been shown to be functional since mutation of this sequence 
inhibits the nuclear import of HsCBP80. In the absence of HsCBP80, HsCBP20 is 
not actively transported into the nucleus. This suggests that HsCBP20 is only 
actively imported into the nucleus in the form of a heterodimer with HsCBP80 
(Izaurralde et at., 1995). Recently a multiple position—specific iterated (PSI)-Blast 
search of the national centre for biotechnology information (NCBI) protein database 
revealed significant sequence similarities between the middle portion of eIF4G 
(MIF4G) and domains in NMD2/Upf2 and CBP80 homologues (Ponting, 2000). 
NMD2/Upf2 is a key component of the surveillance complex that detects premature 
stop codons as part of the nonsense-mediated decay (NMD) pathway (Czaplinski et 
at., 1999; Hentze and Kulozik, 1999). Interestingly, recent work in mammalian cells 
has suggested that both nuclear and cytoplasmic NMD take place in association with 
CBP80 (Ishigaki et at., 2001). Although the functional significance of the MIF4G 
domain in RNA degradation is currently unknown, it is thought to mediate protein-
protein interactions. 
In contrast to HsCBP80, the predicted structure of HsCBP20 essentially consists of a 
RNA-binding domain (RBD) comprised of two RNP motifs, followed by a carboxyl-
tail rich in arginine and glycine (RGG) residues (Izaurralde et at., 1995; Makkerh et 
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al., 1996). Evidence from the X-ray crystal structure of HsCBC together with site-
directed mutagenesis has shown that the RBD of HsCBP20 subunit binds capped 
RNA (Mazza et al., 2001). Despite possessing a RBD, HsCBP20 on its own does not 
exhibit detectable cap-binding or RNA-binding activity unless complexed with 
HsCBP80 (Izaurralde et al., 1995). This suggests that the requirement for CBC 
heterodirnerization results from the poor stability of folded CBP20 in the absence of 
CBP80 (Mazza et al., 2001). The exact role of the carboxyl-terminal auxiliary RGG 
domain in CBP20 is currently unknown. The RGG domain is predicted to stabilise 
the interaction between CBC and capped RNA (Birney et al., 1993; Burd and 
Dreyfuss, 1994). However, there is no direct evidence and the crystal structure of 
CBC-cap complex will be required to analyse this further. 
CBP20 and CBP80 homologues have been identified in a variety of eukaryotes. 
Comparison of the predicted amino acid sequences has demonstrated that both 
subunits show a high degree of similarity in human, Xenopus laevis and S. 
cerevisiae. This suggests that the function of CBC might also be highly conserved 
between these species. 
1.6 pre-mRNA splicing 
After RNAP II nascent transcripts receive a cap to the 5'-end, the pre-mRNAs 
undergo a number of other processing steps before they are exported to the 
cytoplasm. These include the generation of a new 3'-end by endonucleolytic 
cleavage and polyadenylation and the removal of internal non-coding sequences by 
splicing. For most RNAP II transcribed genes, intron sequences must be removed 
from the primary transcript before mRNA can be exported for translation. In general, 
specific mechanisms exist in the nucleus that prevent the export of unspliced RNAs 
unless they are complexed with proteins that bypass the normal mRNA transport 
machinery (Nakielny and Dreyfuss, 1997). Consequently, any inappropriately spliced 
pre-mRNA5 are retained in the nucleus and subject to degradation. Recently, a 
nuclear pathway has been identified in S. cerevisiae that rapidly degrades unspliced 
pre-mRNA5 in a 5' to 3' direction by the exonuclease Rati and 3' to 5' direction by 
the exosome complex (Bousquet-Antonelli et al., 2000). Interestingly, CBC has also 
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been implicated in this pathway, which suggests an additional role for CBC in 
nuclear RNA degradation (Das et al., 2000). 
Introns are recognised and defined by four cis-acting sequences: the 5' splice site, 
branch point, polypyrimidine tract and 3' splice site. The removal of introns and re-
ligation of exons to form mature mRNA occurs within a large dedicated 
ribonucleoprotein complex termed the spliceosome. The spliceosome consists of five 
uracil-rich small nuclear ribonucleoprotein particles (U snRNPs) U!, U2, U416, U5 
that are complexed with 50-100 non-snRNP splicing factors (Graveley, 2001). 
Spliceosome assembly is a dynamic, ordered process where several stable 
intermediates have been identified in vivo and in vitro (Staley and Guthrie, 1998; 
Reed, 2000). Although the order of spliceosomal assembly is strongly conserved in 
both human and S. cerevisiae systems, the characterised components of these 
intermediates only show some similarity. 
Pre-mRNA splicing can be conceptually divided into three distinct stages. The initial 
stage encompasses the recognition of conserved intronic sequences located near the 
5' splice site and branchpoint region by a subset of splicing factors. This is followed 
by the assembly of multiple additional splicing factors that form the mature 
spliceosome. Rearrangements then occur within the spliceosome that activate the two 
chemical steps of intron removal. Finally, spliced mRNA is released for export to the 
cytoplasm whilst the intronic RNA is degraded and the splicing factors are recycled 
(Moore et al., 1993). 
Figure 1.3 describes the splicing cycle in more detail. The first defined step in 
splicing consists of pre-spliceosomal E complex formation in mammals or 
commitment complex formation in S. cerevisiae. The E complex assembles on the 
hnRNP in an ATP-independent manner and serves to commit pre-mRNA to the 
splicing pathway. In E complex, Ui snRNP is bound to the 5' splice site and U2AF 
(U2 snRNP auxiliary factor) is associated with the polypyrimidine tract. 
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Figure 1.3 Spliceosomal assembly pathway. Simplified description of the 
splicing cycle. H complex. pre-mRNA is associated with RNA-binding 
proteins including CBC bound to 5' cap. E complex. CBC facilitates 
association of Ui snRNP with 5' splice site (5' ss) and U2 auxiliary factor 
(1.12AF) binds to polypyrimidine tract (black circle) at 3' splice site (3' ss). A 
complex. U2 snRNP binds to the branch point sequence. This step is ATP-
dependent as are all of the subsequent steps in the cycle. B complex. 
Addition of U4/U6.U5 tri-snRNP particle forms the active spliceosome. Two 
sequential transesterification reactions occur within the spliceosome that 
produce spliced mRNA and intron lariat. mRNA is exported to the 
cytoplasm for translation and intron lariat is degraded in the nucleus. The 
spliceosome disassembles and the components are recycled onto another 
pre-mRNA for subsequent rounds of the splicing cycle. 
er 1 Introduction 
This promotes the binding of U2 snRNP to the branch point sequence to form the A 
pre-spliceosomal complex. U2 snRNP addition is ATP-dependent as are all of the 
subsequent steps in the splicing pathway. The addition of the pre-formed U4/U6.U5 
tri-snRNP particle leads to the formation of the active spliceosome or B complex. 
Within the spliceosome, numerous ATP-dependent rearrangements occur during the 
course of two sequential transesterification reactions. After the completion of the 
splicing reaction, spliced mRNA is released and processed further in the nucleus, 
whilst the intron lariat is debranched and degraded. The spliceosome disassembles 
and the U snRNPs and non-snRNP proteins are recycled onto another pre-mRNA 
molecule for subsequent rounds of the splicing cycle. 
1.7 Role of CBC in pre-mRNA splicing 
A role for the cap in stimulating pre-mRNA splicing was originally shown by in vitro 
studies in mammalian extracts and in vivo experiments in Xenopus oocytes 
(Konarska et al., 1984; Kramer et al., 1984). Evidence from several laboratories 
demonstrated that splicing of a pre-mRNA containing a single intron can be inhibited 
in vitro by cap analogues or in vivo by short capped competitor RNAs. Furthermore, 
this stimulatory effect of the cap in pre-mRNA splicing is restricted to the cap-
proximal intron (Konarska et al., 1984; Edery and Sonenberg, 1985; Ohno et al., 
1987; Patzelt et al., 1987; Inoue et al., 1989). Subsequent work has shown that CBC 
is responsible for mediating the positive effects of the cap on splicing. HeLa cell 
nuclear splicing extracts immunodepleted of CBC exhibit a strong reduction in 
splicing activity and this can be reversed by the addition of recombinant CBC 
(Izaurralde et al., 1994). Neither HsCBP20 or HsCBP80 on its own is able to restore 
splicing to the depleted extract, which demonstrates that only the two subunits in the 
form of a heterodimer constitute the active complex (Izaurralde et al., 1994; Lewis et 
al., 1996). Characterisation of the splicing defect showed that in the absence of CBC, 
Ui snRNP fails to associate efficiently with the cap-proximal 5'splice site to form 
the E complex (Lewis et al., 1996). Since spliceosome assembly is an ordered 
stepwise process, inhibition of the earliest step inhibits the formation of the mature 
spliceosome and subsequent splicing. 
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Interestingly, CBC is also found stably associated with pre-mRNA in the H and B 
complexes, suggesting that CBC associates with pre-mRNA before entering the 
splicing pathway and remains bound to the cap when mRNA leaves the spliceosome 
(Figure 1.3 and Lewis et al., 1996). Despite remaining bound to capped pre-mRNA 
throughout spliceosome assembly, current evidence only supports a role for CBC 
during E complex. However, it is important to note that CBC might also function at 
later stages in the splicing cycle (O'Mullane and Eperon, 1998). 
Collectively these data show that CBC increases the efficiency of U  snRNP binding 
to the cap-proximal 5' splice site. This enhances E complex formation and the rate of 
cap-proximal intron splicing. In vertebrates, the molecular mechanism by which 
CBC functions during E complex formation is currently unknown. However, in S. 
cerevisiae CBC has been shown to interact directly with components of U  snRNP. 
1.8 CBC's function in splicing is conserved from yeast to 
humans 
As mentioned earlier, the components of the spliceosomal assembly pathway show a 
high degree of similarity within the S. cerevisiae and mammalian systems suggesting 
that the mechanism of splicing is also conserved (Colot et al., 1996; Lewis et al., 
1996; Lewis and Izaurralde, 1997). The yeast equivalent to E complex is called the 
commitment complex since its formation commits pre-mRNA to the splicing 
pathway. Like E complex, the commitment complex forms in the absence of ATP 
after the association of Ui snRNP with the 5' splice site and Mud2p, the yeast 
homologue of U2AF, with the polypyrimidine tract (Lewis and Izaurralde, 1997). 
In S. cerevisiae (Sc), MUD13 and GCR3 encode CBP20 and CBP80 respectively 
(Uemura and Jigami, 1992; Colot et al., 1996; Gorlich et al., 1996; Lewis et al., 
1996b). ScCBP20 and ScCBP80 are not essential genes, which suggests that CBC is 
not required for vegetative growth. ScCBP20 was originally identified in a synthetic 
lethal screen designed to identify genes involved in commitment complex assembly 
(Colet et al., 1996). Similar to the experiments in the HeLa system, S. cerevisiae 
splicing extracts immunodepleted of endogenous CBC exhibit a strong reduction in 
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splicing activity that is partially restored by the addition of purified ScCBC (Lewis et 
at., 1996b). Characterisation of the splicing defect showed that in CBC-depleted 
extracts the formation of commitment complex is deficient (Lewis et al., 1996b). 
Although the molecular mechanism by which CBC functions during El commitment 
complex assembly has not been elucidated, recent work in S. cerevisiae has shown 
that CBC interacts directly with components of Ui snRNP and Mud2 (Fortes et al., 
1999a; Fortes et al., 1999b). This is thought to promote the formation of a molecular 
bridge between the 5' cap and 3' splice site and consequently bring both ends of the 
intron into close proximity for splicing (Figure 1.4). Both yeast and vertebrate U  
snRNPs consist of a core of three Sm proteins and three Ui-specific proteins (Ui 
70K! Snpl, U1AI Mudi, U1CI yUI-C). In addition, yeast Ui snRNP contains at least 
six specific proteins that currently have no characterised vertebrate homologues. In S. 
cerevisiae, synthetic lethal interactions have been found between CBC and 
components of the Sm core, Ui-specific and yeast-specific Ui snRNP proteins 
(Figure 1.4). Moreover, genetic and biochemical analysis has shown that CBC 
physically interacts with Snu56, a yeast-specific component of UI snRNP, which 
currently has no identified vertebrate homologue (Fortes et al., 1999a; Fortes et al., 
1999b). As a result, this demonstrates that in S. cerevisiae, CBC facilitates Ui 
snRNP recruitment to the 5' splice site through direct contacts with the components 
of U  snRNP. 
A genetic and physical interaction has also been identified between CBC and Mud2, 
which is the yeast homologue of U2AF 65 (Fortes et al., 1999a; Fortes et al., 1999b). 
Mud2 functions in commitment complex assembly where it binds to the 
polypyrimidine tract and subsequently promotes the binding of U2 snRNP. 
Interestingly, Mud2 is not required for facilitating the interaction between Ui snRNP 
and thepre-mRNA 5' splice site. This suggests that the role of CBC in splicing 
might extend beyond the Ui snRNP function and CBC might also participate at later 
stages of the splicing cycle (O'Mullane and Eperon, 1998). 
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Figure 1.4 Model of yeast commitment complex. A molecular bridge 
between 5' cap and 3' splice site (3'ss) brings both ends of the intron into 
close proximity for splicing. CBC-cap facilitate the association of Ui snRNP 
with 5' splice site (5' ss). Mud2 associates with polypyrimidine tract (PPT) and 
SF1 binds the branch point sequence (BP). SF1 also physically interacts with 
Mud2 along with Prp4O component of Ui snRNP. Synthetic lethal interactions 
have been found between CBC and components of Ui snRNP core Sm 
proteins, Ui-specific proteins and L11-yeast specific proteins (highlighted in 
white). Direct interactions have been found between CBC and Snu56 and 
Mud2 (black arrows). 
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Collectively, these data demonstrate that in splicing, CBC is found to play an 
analogous role in both human and S. cerevisiae systems. Both yeast and mammalian 
CBC function during the earliest stage of spliceosomal assembly where they increase 
the efficiency of cap-proximal intron recognition by Ui snRNP. However in S. 
cerevisiae, CBC appears to mediate its effect through a direct interaction with Ui 
snRNP. This contrasts with the mammalian system, where there is no evidence of a 
direct interaction and the adaptor molecules that facilitate the effects of CBC in 
splicing are yet to be elucidated (Lewis et al., 1996). 
1.9 Exon definition model: CBC is required for efficient 
splicing of the cap-proximal intron 
The exon definition model states that efficient pre-mRNA splicing relies on the 
definition of exons as opposed to introns. Exons are defined through co-operative 
interactions between splicing factors localised on the 3' -end of introns and the 
downstream 5' splice site across the exon (Robberson et al., 1990). This model is 
favoured by the small size of mammalian exons, around 137 nucleotides, in addition 
to the increasing evidence that supports the existence of co-operative interactions 
across exons (Hoffman and Grabowski, 1992; Zeng and Berget, 2000). However, a 
problem with the exon definition model is that it fails to explain how the terminal 
exons are recognised by the components of the spliceosome. An alternative 
mechanism of intron recognition must exist since the 5' terminal exon has a cap 
instead of 3' splice site and the 3' terminal exon has a polyadenylation signal instead 
of 5' splice site. 
As mentioned earlier, evidence from mammalian extracts 	in vitro and Xenopus 
oocytes in vivo have shown that the cap is only required for efficient splicing of the 
cap-proximal intron (Ohno et al., 1987; Inoue et al., 1989). This suggests that the 
first exon might be defined by interactions between the cap and the 5' splice site. 
However, it does not address why the cap-distal intron exhibits cap-independent 
splicing. Subsequent experiments that mutated splice site consensus sequences 
showed that the presence of an upstream polypyrimidine tract is equivalent in 
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function to the cap for efficient recognition of an internal exon (Lewis et al., 1996). 
As a result, the cap together with CBC facilitate the association of Ui snRNP with 
the first functional cap-proximal 5' splice site. Whilst the polypyrimidine tract 
substitutes for CBC-cap function to define the internal exons. Similarly, the 
polyadenylation signal in combination with the terminal 3' splice site participates in 
the definition of the terminal exon. 
1.10 Coupling splicing and transcription 
Early cytological studies first demonstrated a possible link between splicing and 
RNAP II transcription. Several laboratories showed that splicing factors are 
specifically localised to sites of active transcript synthesis (Beyer and Osheim, 1988; 
Bauren and Wieslander, 1994; Zhang et al., 1994). Subsequent biochemical and in 
vivo studies provided further support for the existence of functional interactions 
between RNAP II and the splicing apparatus. These included data where the 
phosphorylated form of RNAP II is found associated with active spliceosomes as 
well as splicing factors (Chabot et at., 1995; Mortillaro et at., 1996 Yuryev et al., 
1996; Kim et at., 1997). Similar to RNA cap formation, experiments using 
transiently transfected mammalian cells showed that splicing of RNAs transcribed by 
CTD-truncated RNAP II is inefficient (McCracken et at., 1997b). In addition, over-
expression of phosphorylated CTD peptides also inhibits splicing in cultured 
mammalian cells (Du and Warren, 1997). Collectively, these observations suggest 
that the hyperphosphorylated CTD is required for targeting splicing factors to 
transcription sites to ensure efficient splicing. 
Recent experiments, in the absence of transcription, have shown that RNAP II also 
plays a direct and active role in splicing in vitro. Purified RNAP 110 strongly 
activates splicing of several different pre-mRNAs in reconstituted splicing assays 
(Hirose et at., 1999). RNAP ITO appears to increase the formation of early 
spliceosomal complexes, most notably A complex. This suggests that RNAP ITO 
might stimulate splicing by accelerating the rate of the first steps of spliceosome 
assembly. Taken together, these data indicate that RNAP II not only couples splicing 
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with transcription by targeting splicing factors to transcription sites but also directly 
functions with splicing factors to enhance splicing efficiency. 
Although it is well established that transcription and splicing are coupled, the 
molecular mechanisms by which these processes are integrated remains to be 
elucidated. However, recent work has proposed that SR and SR-like CTD associated 
factors (SCAFs) might be candidate adaptor molecules that mediate the stimulatory 
effects of the CTD in splicing. Immunoprecipitates of RNAP ITO are found to 
contain nuclear matrix components that include members of the serine-arginine (SR) 
and Sm families of splicing factors (Kim et al., 1997; Mortillaro et al., 1996; Vincent 
et al., 1996). Although these data support interactions between the phosphorylated 
CTD and SR proteins, it is unclear whether these interactions occur directly or 
indirectly. 
Direct contacts have been documented between the CTD and the SCAF family of 
nuclear matrix proteins (Patturajan et al., 1998). SCAFs were initially identified in a 
yeast two-hybrid screen for CTD-interacting proteins and interact with the CTD via a 
distinct CTD-interaction domain (Yuryev et al., 1996). Moreover, a subsequent study 
showed that one SCAF, SCAF8 only interacts with the phosphorylated CTD and is 
localised to foci that overlap with sites of transcription and processing (Patturajan et 
al., 1998). Although these results support a role for SCAFs in coupling RNAP II 
transcription to processing, there is no direct evidence for this and SCAFs do not 
currently have documented functions in RNA processing events. 
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111 RNA 3'-end formation 
Many mRNA precursors are processed at the 3'-end by endonucleolytic cleavage and 
polyadenylation to form the poly(A) tail. The only known exceptions in metazoan 
organisms are the major histone mRNAs. Although the histone pre-mRNAs are 
cleaved, they are not polyadenylated and the factors responsible for the cleavage 
reaction differ from those acting on all other pre-mRNAs (Dominski and Marzluff, 
1999). The poly(A) tail is comprised of a homopolyrner of adenosine residues, which 
after synthesis in the nucleus, is typically 250 nucleotides in length (Minvielle-
Sebastia and Keller, 1999). Unlike the 5' cap modification, the polyadenosine tail is a 
highly dynamic structure that is subject to length alterations during Xenopus, 
Drosophila and mouse development. Changes in poly(A) tail length occur in the 
cytoplasm and serves to regulate translation (Wickens ci' al., 1997; Gray and Wicken, 
1998). 
The poly(A) tail has been proposed to play a role in nearly every aspect of mRNA 
metabolism. As mentioned earlier, the poly(A) tail and the cap have a synergistic 
effect on cap-dependent translation initiation. This cap-poly(A) synergy is thought to 
either facilitate the recycling of ribosomes from the 3'-end back to the 5' cap or 
enhance the formation of eIF-mRNA complexes (Preiss and Hentze, 1998; Borman 
et al., 2000). In addition, the poly(A) tail plays a role in maintaining mRNA stability 
as deadenylation is frequently the first and rate-limiting step of mRNA decay 
(Beelman and Parker, 1995). Finally, the poly(A) tail is thought to be involved in the 
export of mRNAs from the nucleus to the cytoplasm for translation (Eckner ci' al., 
1991; Huang and Carmichael, 1996). 
New 3'-ends are generated in a two step reaction that is tightly coupled in vivo. The 
pre-mRNA is first cleaved endonucleolytically followed by poly(A) addition to the 
upstream cleavage fragment (Colgan and Manley, 1997). In higher eukaryotes, RNA 
3'-end formation requires two cis-acting sequence elements present in the 3' UTR, 
which together define the cleavage/ polyadenylation site. The AAUAAA 
polyadenylation signal is a hexanucleotide repeat that is found 10-30 nucleotides 
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upstream of the cleavage site. AAUAAA is found in 90% of all sequenced 
polyadenylation elements and is one of the most highly conserved elements known 
(Proudfoot, 1991; Wahle and Kuhn, 1997). The second sequence element is the GU-
rich motif located 20-40 nucleotides downstream of the cleavage site. In contrast to 
AAUAAA, the GU-rich element is found in 70% of mammalian pre-mRNA5 and is 
considerably more variable in sequence composition (Wahle and Ruegsegger, 1999). 
Together, AAUAAA and GU-rich elements and their distance from each other 
specify the cleavage/ polyadenylation site and determine the strength of the poly(A) 
signal (MacDonald et al., 1994; Chen et al., 1995). 
To date, at least seven trans-acting factors are found to be required for the in vitro 
reconstitution of mammalian RNA 3'-end cleavage and polyadenylation (Wahle and 
Ruegsegger, 1999; Zhao et al., 1999). The cleavage reaction requires a yet 
unidentified endonuclease as well as cleavage stimulation factor (CstF), cleavage 
factors 1 and 2 and the CTD of RNAP II. Poly(A) polymerase (PAP) and the 
cleavage and polyadenylation specificity factor (CPSF) are required in both cleavage 
and polyadenylation steps. Whilst, poly(A)-binding protein 2 (PABP2) only 
functions during polyadenylation. 
Although the cis and trans-acting factors required for RNA 3'-end formation are well 
characterised, the molecular mechanisms involved remain unclear. Figure 1.5 
illustrates a current model for the formation of the mammalian RNA 3'-end cleavage 
complex. Together, the components of the cleavage complex are thought to establish 
a network of weak co-operative interactions that define the cleavage/ 
polyadenylation site. CPSF binds directly to the cleavage and polyadenylation signal, 
AAUAAA and CstF associates with the GU-rich sequence downstream of the 
cleavage site. The resultant protein-RNA complex then recruits other 3-end 
processing factors that include cleavage factors I, II and PAP (Barabino and Keller, 
1999). 
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Figure 1.5 Model of mammalian RNA 3'-end cleavage complex. 
Components of cleavage complex establish a network of weak co-operative 
interactions that define the cleavage/ polyadenylation site (Cl P site). 
Cleavage and polyadenylation specificity factor (CPSF) is comprised of four 
subunits and binds the cleavage and polyadenylation signal, AAUAAA. The 
heteroirimeric cleavage stimulation factor (CstF) binds the GU-rich signal- This 
recruits other cleavage factors that include: cleavage factor I (CFIAm + CFI Bm ) 
and 2 (CF2m) along with poly(A) polymerase (PAP). The CTD of RNAP II also 
participates as a cleavage factor and physically interacts with CPSF and CstF. 
Both the 5' and 3' ends of RNA contribute to the 3' cleavage reaction. 
However, the adaptor molecules that mediate the positive effects of CBC-cap 
are currently unknown. 
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Recently, the CTD of RNAP II has also been shown to actively participate in RNA 
cleavage and this role of RNAP II in 3'-end processing will be reviewed separately 
(Hirose and Manley, 1998). After the cleavage/ polyadenylation site has been 
defined, the RNA phosphodiester backbone is cleaved by an unknown endonuclease 
and the polyadenylation complex is recruited. How the cleavage complex makes the 
transition into the polyadenylation complex is currently not known. However, during 
polyadenylation CPSF remains associated with the AAUAAA sequence and PAP 
catalyses the addition of the poly(A) tail. PABP2 subsequently binds the poly(A) and 
is thought to increase the efficiency of polyadenylation as well as specify the correct 
length of poly(A) tail (Wahle, 1991; Wahie et al., 1993; Colgan and Manley, 1997) 
After approximately 250 nucleotides have been synthesised, processive poly(A) 
elongation is terminated and the mRNA is exported to the cytoplasm for translation. 
1.12 Role of CBC in RNA 3'-end formation 
The requirement of the cap for efficient 3'-end processing was first demonstrated by 
in vitro studies in HeLa extracts using non-intron containing RNA precursors. The 
addition of cap analogue to HeLa cell nuclear extracts was found to reduce poly(A) 
site cleavage (Hart et al., 1985; Cooke and Alwine, 1996). Furthermore, uncapped 
pre-mRNAs had poorly processed 3'-ends and competed less efficiently for 3'-end 
processing factors than capped pre-RNAs (Gilmartin et al., 1988; Cooke and Alwine, 
1996). The requirement of the cap for efficient 3'-end formation is restricted to non-
intron containing genes. This stimulatory effect is abrogated by introducing an intron 
upstream of the polyadenylation signal (Cooke and Alwine, 1996). Subsequent 
immunodepletion studies showed directly that the positive effect of the cap in RNA 
3'-end formation is mediated by CBC. CBC is required for the cleavage of pre-
mRNA but not for the polyadenylation reaction per se. (Flaherty et al., 1997). 
Taken together, these results suggest that the primary role of CBC in RNA 3'-end 
processing is to facilitate the cleavage reaction. However, the mechanism by which 
CBC mediates this function of the cap remains to be determined. Since most of the 
factors required to reconstitute pre-mRNA 3'-end cleavage in vitro have been 
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identified, a model of the constituents of the cleavage complex can be proposed. 
Figure 1,5 highlights how both the 5' and 3'-ends of eukaryotic RNAs contribute to 
RNA 3'-end formation. In order for the 5' and 3'-ends of eukaryotic RNAs to 
communicate, a network of protein-protein interactions must exist to define the 
cleavage/ polyadenylation site. Although CBC and the cap have been shown to 
directly participate in the cleavage reaction, the adaptor molecules that mediate CBC 
function are yet to be elucidated. 
1.13 Coupling RNA 3'-end formation with transcription 
Similar to capping and splicing, RNA 3'-end formation is also coupled to RNAP II 
transcription. Together, biochemical and in vivo studies support the existence of 
functional interactions between the CTD and 3'-end processing machinery. RNAs 
transcribed by CTD-truncated RNAP II are not efficiently polyadenylated in 
transiently transfected HeLa cells (McCracken et al., 1997b). In addition, in vitro 
binding experiments show that CPSF and the 50 K subunit of the heterotrimeric CstF 
physically interact with the CTD. However, unlike capping and splicing, the 
phosphorylation status of the CTD does not appear to affect the binding of 3'-end 
processing factors (McCracken et at., 1997b). Interestingly, three of the four subunits 
of CPSF are also associated with the general transcription factor TFIID that 
specifically recognises the TATA box of promoter DNA. Furthermore, reconstituted 
transcription assays show that CPSF is transferred from TFIID to RNAP II 
concomitantly with transcription initiation (Dantonel et at., 1997). This suggests that 
in contrast to capping and splicing, 3'-end processing factors can associate early with 
the transcription PlC. Such factors appear to remain stably associated with the 
elongating polymerase for the entire length of the gene until they dissociate at the 
polyadenylation signal to define the cleavage site (Dantonel et at., 1997; McCracken 
et al., 1997b). 
Finally as with capping and splicing, the RNAP II CTD not only recruits processing 
factors to sites of transcription but also appears to have a direct role in RNA 3'-end 
formation. In the absence of transcription, the CTD directly activates in vitro 
cleavage reactions. HeLa nuclear extracts immunodepleted of RNAP II exhibit a 
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reduction in RNA cleavage and this inhibition is restored by the addition of purified 
enzyme (Hirose and Manley, 1998). Collectively, these results support the hypothesis 
that the CTD is a component of the RNA 3'-end processing apparatus where it 
participates in the formation and function of the cleavage complex through direct 
interactions with other 3'-end processing factors (Figure 1.5). 
1.14 RNA nucleocytoplasmic transport 
After pre-mRNAs have been capped, spliced and polyadenylated they are exported to 
the cytoplasm for translation into proteins. Transport in and out of the nucleus occurs 
through aqueous channels called nuclear pore complexes (NPCs) that penetrate the 
nuclear envelope. NPCs are approximately 9 nm in diameter and allow the passive 
diffusion of small molecules and globular proteins less than 60 kDa (Stoffler et al., 
1999; Ryan and Wente, 2000). In contrast, the nucleocytoplasmic transport of larger 
macromolecules such as proteins and RNPs is an active, receptor-mediated process. 
During active transport, the diameter of the NPC can open to approximately 25 nm 
indicating that the NPC recognises and reacts to specific transport substrates by 
undergoing a considerable change in conformation. The transport of molecules 
across the nuclear envelope requires soluble transport factors. In recent years many 
of the key receptor and adaptor proteins that control nucleocytoplasmic transport 
have been identified. As a result, this has lead to a greater understanding of the 
general mechanisms involved in the nuclear import and export of different classes of 
RNA. 
In order to undergo nucleocytoplasmic transport, different classes of cargo must 
contain a transport signal that is recognised by a specific receptor protein. In the 
simplest cases, the cargo is bound by a transport receptor, translocated through the 
NPC via receptor-mediated interactions and released on the other side. The cargo is 
released and the empty receptor is recycled to the original compartment to participate 
in new transport events. Alternatively, the cargo-receptor interaction is not direct but 
mediated by one or more adaptor proteins. Consequently, both receptor and adaptor 
proteins have to be recycled after cargo transport and such proteins are found to 
shuttle continuously between the nuclear and cytoplasmic compartments. 
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A critical characteristic of nucleocytoplasmic transport is directionality. This ensures 
cargoes that have completed translocation do not bind receptors and risk being 
transported to their original compartment. Directionality of all the transport processes 
studied so far is thought to come from the small GTPase Ran. Although Ran is found 
in both the nucleus and cytoplasm, regulation of its nucleotide exchange and 
hydrolysis activity ensures that Ran is asymmetrically distributed within the cell. Ran 
GTPase activating protein (Ran GAP) is localised to the cytoplasm and Ran GTP 
exchange factor (Ran GEF) is localised to the nucleus, where it is stably bound to 
chromatin (Koepp and Silver, 1996; Gorlich, 1997). As a result, nuclear Ran is in the 
GTP-bound state whereas cytoplasmic Ran is GDP-bound. Import receptors that bind 
Ran GTP release their cargo. In contrast, export receptors can only bind cargo in the 
presence of Ran GTP (Azuma and Dasso, 2000). Consequently, Ran GTP releases 
import cargoes into the nucleus whilst the hydrolysis of GTP promoted by Ran GAP 
releases export cargoes in the cytoplasm. This Ran GTP gradient across the nuclear 
envelope provides the directionality necessary for nuclear transport. 
The major classes of cellular RNAs that are synthesised in the nucleus must be 
exported to the cytoplasm to either function in translation (mRNA, rRNA and tRNA) 
or undergo maturation prior to being re-imported to the nucleus (major spliceosomal 
U snRNAs). Microinjection studies using Xenopus oocytes have shown that the 
export pathway of each RNA species is uniquely saturable and mediated by class-
specific receptors and/ or adaptors (Jarmolowski et al., 1994). Interestingly, the only 
export receptor known to bind directly to RNA is exportin-t, which is responsible for 
the export of mature tRNA to the cytoplasm (Arts et al., 1998; Heilmuth et al., 1998; 
Kutay et al., 1998). In comparison, nuclear export of other classes of RNA appear to 
be mediated by factors other than export receptors and adaptors. 
Key players in rnRNA export include TAP and hnRNPs (Reed and Hurt, 2002). TAP 
is the cellular cofactor required for the nuclear export of unspliced retroviral RNA 
containing a constitutive transport element. TAP is thought to heterodimerize with 
p15 to stimulate the export of cellular mRNAs (Wilkie et al., 2001). Nuclear export 
signals have also been identified in the shuttling hnRNP proteins. One of the best 
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characterised is the M9 sequence in hnRNPA1. Aithought there is no direct evidence, 
current work strongly suggests the M9 sequence plays a role in mRNA export (Reed 
and Hurt, 2002). 
In addition to trans-acting factors, the cis-acting sequences of RNAs also stimulate 
RNA export. Important cis-acting sequences include the cap and poly(A) tail that 
after recognition ensure efficient nuclear export. The following sections describe the 
contribution of the cap and CBC to the nucleocytoplasmic transport of U snRNAs, 
snoRNAs and mRNAs. 
1.15 U snRNA biogenesis 
In order to understand the role of CBC and the cap in U snRNA nuclear export, it is 
important to describe the export in context of U snRNA biogenesis. The biogenesis 
of U snRNP complexes requires multiple transport events between the nucleus and 
cytoplasm. After RNAP II transcription, all the major spliceosomal U snRNAs with 
the exception of U6 snRNA are capped. The pre-U snRNAs are then exported to the 
cytoplasm where they interact in an ordered, stepwise manner with seven Sm 
proteins to form the snRNP Sm core structure. The cap is subsequently 
hypermethylated and the 3'-ends of U snRNPs are processed (Mattaj, 1986; 
Chanfreau et al., 1997). After the completion of cytoplasmic processing, newly 
assembled core U snRNPs are re-imported to the nucleus where they function in 
splicing. Nuclear import is mediated by a bipartite signal comprised of the U snRNP 
hypermethylated cap and a yet unidentified Sm core NLS receptor, which is 
recognised by the snurportini-importin import receptor complex. In the nucleus, U 
snRNAs are internally modified at several positions and biogenesis is completed by 
the association of U snRNP-specific proteins (Fischer et al., 1993; Palacios et al., 
1997; Huber et al., 1998). Mature U snRNPs are then available to participate in the 
spliceosomal assembly pathway where they function in pre-mRNA splicing. 
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1.16 Role of CBC in U snRNA nuclear export 
Early Xen opus oocyte studies demonstrated a stimulatory role for the cap in the 
nuclear export of the major RNAP II transcribed spliceosomal U snRNAs. Nuclear 
export of capped U snRNAs either microinjected into the oocyte nucleus or 
transcribed in vivo could be efficiently inhibited by an excess of cap analogue 
(Hamm and Mattaj, 1990; Jarrnolowski et al., 1994). Subsequent experiments 
directly showed that U snRNA nuclear export is inhibited by antibodies directed 
against CBP20. This inhibition could be specifically reversed by pre-incubating anti-
CBP20 antibody with excess recombinant CBP20 (Izaurralde et al., 1995). Although 
inimuno-localisation experiments have demonstrated that the steady state levels of 
CBC are mainly nuclear, recent evidence has shown that CBC does indeed shuttle 
between the nuclear and cytoplasmic compartments (Izaurralde ci' al., 1995; Gorlich 
et al., 1996; Ohno et al., 2000; Shen et al., 2000). Taken together, these data suggest 
that the positive effect of the cap in U snRNA export is mediated by CBC. 
In addition to the cap, other factors implicated in U snRNA export are Ran GTP, 
CRM1 or exportini (Xopl) and phosphorylated adaptor for RNA export (PHAX). 
The nuclear export of capped U snRNAs can be inhibited by reducing the nuclear 
concentration of Ran GTP (Izaurralde et al., 1997). This is expected since Ran GTP 
has been shown to provide directionality to all transport processes studied so far. 
Likewise, U snRNA export is also inhibited by inactivating the export receptor Xpol 
with leptomycin B (Fischer et al., 1995; Fornerod et al., 1997). Since Xpol 
specifically binds cargo carrying leucine-rich nuclear export signal (NES), this 
suggests an adaptor bridges the interaction between Xpol and CBC-capped U 
snRNAs. Recent work has demonstrated the NES-containing adaptor molecule is 
PHAX (Fornerod 1997; Ohno 2000). Figure 1.6 describes the current model of CBC-
dependent U snRNA export as mediated by Xpol and PHAX. 
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Figure 1.6 Model of U snRNA nuclear export. After RNAP II transcription, 
CBC associates with capped U snRNA precursors. In the presence of Ran 
GTP, phosphorylaled PHAX mediates the interaction between CBC-capped U 
snRNA and export receptor Xpol-Ran GTP This functional export complex is 
then translocated through the NPC by receptor-mediated processes. After 
nuclear export, PHAX is dephosphorylated and Ran-GTP is hydrolysed, which 
leads to U snRNP export complex disassembly. In the cytoplasm, U snRNA 
precursors undergo cap hypermethylation and RNA 3'-end processing before 
nuclear re-import to form functional U snRNPs that participate in splicing. 
PHAX and CBC are recycled to the nucleus for further rounds of export. 
Fioure taken from Ohno of aL 2000. 
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After RNAP II transcription, CBC associates with capped U snRNA precursors in the 
nucleus. In the presence of Ran GTP, the phosphorylated form of PHAX mediates 
the interaction between CBC-capped U snRNA and Xpol-Ran GTP (Figure 1.6). 
This forms a functional export complex that is translocated through the NPC by 
receptor-mediated processes. After nuclear export, PHAX is dephosphorylated and 
Ran-GTP is hydrolysed, which leads to the dissociation of the U snRNP export 
complex. During U snRNP nuclear export, directionality appears to be conferred by 
both the asymmetric distribution of Ran GTP and the differential phosphorylation 
status of PHAX. In the cytoplasm, U snRNA precursors undergo cap 
hypermethylation and 3'-end processing. Mature U snRNAs are then re-imported to 
the nucleus to form functional U snRNPs that participate in pre-mRNA splicing 
(Ohno et al., 2000). 
1.17 Nuclear transport of snoRNA 
Similar to the major spliceosomal U snRNAs, U3 and U8 small nucleolar (sno) 
RNAs are also transcribed by RNAP II and their initial cap structure subsequently 
becomes hypermethylated. U3 and U8 snoRNAs are members of a RNA family that 
is defined by their nucleolar localisation and association with the nucleolar protein 
fibrillarin. Both U3 and U8 snoRNAs participate in ribosomal RNA biogenesis 
where they are essential for pre-rRNA processing (Kass et al., 1990; Peculis and 
Steitz, 1993; Peculis, 1997). However, unlike the spliceosomal U snRNAs, which are 
exported to the cytoplasm for cap hypermethylation, U3 and U8 snoRNAs undergo 
cap hypermethylation within the nucleus. Current evidence suggests that similar to U 
snRNA export, the cap also contributes to the nucleolar localisation of U3 and U8 
snoRNAs. 
Microinjection studies using rat kidney epithelial cells have shown that nucleolar 
localisation of human U3 and U8 snoRNAs is facilitated by the cap. U3 and U8 
snoRNAs that contain alternative cap analogues localise less efficiently compared to 
capped snoRNAs. Furthermore, U3 snoRNA nucleolar localisation is inhibited by an 
excess of cap analogue. This suggests the stimulatory effects of the cap are facilitated 
by a cap-binding activity (Jacobson and Pederson, 1998). However, there is no 
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evidence available to suggest that CBC mediates the positive effect of the cap in U3 
and U8 nucleolar localisation. 
1.18 Role of CBC in mRNA nuclear export 
In comparison to U snRNA and snoRNA export, the role of the cap in the nuclear 
export of mRNAs remains unclear. Kinetic experiments using Xenopus oocytes 
showed that the cap only increases mRNA export by a factor of two compared to 
various cap analogues (Izaurralde et al., 1992). In addition, no evidence currently 
exists to suggest this small stimulatory effect is mediated by CBC. However, 
immuno-electron microscopy (EM) studies on Balbiani Ring (BR) mRNAs of the 
insect Chironomus tentans have shown that CBC appears to accompany mRNAs 
from the site of transcription to the cytoplasmic face of the NPC. This suggests that 
in addition to splicing and RNA 3'-end formation, CBC might function in the nuclear 
export of mRNAs. 
BR mRNAs encode large secretory proteins that are made in larval salivary gland 
cells. BR transcripts are 30-40 Kb in length and after processing are packaged into 50 
nm particles for nuclear export. As a result, BR RNPs are large enough to allow 
associated RNA-binding proteins to be easily visualised during the successive stages 
of RNA synthesis, maturation and nuclear export (Daneholt, 1997). 
Immuno-EM experiments have shown that CBC binds nascent BR pre-mRNA after 
transcription initiation, which is consistent with a role in splicing and accompanies 
the BR mRNP from the site of synthesis to the nuclear envelope. CBC then appears 
to remain associated with the 5'-end of mRNP during nucleocytoplasmic 
translocation (Visa et al., 1996). Interestingly, mRNP particles are always 
translocated with the 5 -end leading, which suggests that the mRNP orientation is 
significant during transport (Mehlin et al., 1992 and 1995). Since CBC appears to 
remain bound to the cap during translocation, CBC might also play a role in the early 
recognition of mRNP particles at the NPC. Alternatively, CBC might participate in 
the translocation procedure itself. However, there is no current evidence to support 
this and a role for CBC in mRNA export is purely descriptive. 
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1.19 Regulation of CBC activity 
The available evidence has shown that CBC mediates the positive effects of the cap 
in three diverse nuclear processes: pre-mRNA splicing, RNA 3'-end formation and U 
snRNA export. Interestingly, recent work has suggested that the cap-binding activity 
of CBC is subject to regulation by extracellular stimuli. This raises the question of 
whether CBC might be the nuclear end-point for certain multiple signalling pathways 
required to regulate RNAP II transcript metabolism and ultimately cell growth. 
Experiments using photoaffinity labelling assays correlated the incorporation of [(X-
"P] GTP by CBP20 with the ability of CBC to bind capped RNA. As a result, this 
assay was used in subsequent experiments to show that the cap-binding activity of 
CBC is stimulated by a broad range of stimuli, which include growth factors and cell 
stress conditions (Wilson et al., 1999). The cap-binding activity of CBC also 
appeared to be activated by the expression of a constitutively active form of the 
GTP-binding protein Ras and Cdc42 (Wilson ci' al., 1999). This suggests that 
conditions requiring increased cell growth might promote the activity of CBC 
through the Ras and Cdc42 signal transduction pathways. Interestingly, HeLa 
splicing extracts prepared from cells containing the constitutively active form of 
Cdc42 also appeared to promote cap-dependent splicing, independent of cell growth 
(Wilson et al., 2000; Erickson and Cerione, 2001). This data implies that the Cdc42 
signal transduction pathway stimulates cap-dependent splicing and this effect might 
be mediated by the activation of CBC. Taken together, these results suggest that in 
order to maintain cell growth control, Ras and Cdc42 signalling pathways are 
possible mechanisms by which the activity of CBC and the cap are regulated during 
RNAP II transcript metabolism. 
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1.20 CBC-interacting proteins 
The current literature has shown that CBC facilitates the stimulatory effects of the 
cap in at least three diverse aspects of nuclear RNA metabolism, which include pre-
mRNA splicing, RNA 3'-end formation and U snRNA export. Despite this, little is 
known about the proteins that CBC interacts with and the molecular mechanisms 
involved. Interestingly, genetic studies in S. cerevisiae have revealed a number of 
CBC-interacting proteins that are splicing factors. This provides a possible 
mechanism by which yeast CBC functions during the splicing of the cap-proximal 
intron (Fortes et at., 1999a; Fortes et at., 1999b). Although, a number of CBC-
interacting proteins have been identified, their roles in the mediating the effects of 
CBC and the cap in RNAP II transcript metabolism are yet to be elucidated. This 
section summarises these CBC-interacting proteins and suggests possible CBC-
dependent functions during mRNA nuclear processing. 
[A] hnRNP F 
The CBC-interacting protein, hnRNP F was identified in a three-hybrid screen using 
HsCBC. This genetic interaction was further supported by in vitro binding 
experiments that showed hnRNP F interacts separately with both HsCBP20 and 
HsCBP80 subunits. Moreover, hnRNP F preferentially binds to CBC-mRNA 
complexes compared to RNA alone, which suggests the association between CBC 
and hnRNP F might have functional consequences (Gamberi et al., 1997). 
HnRNPs are amongst the most abundant proteins found in the nucleus and have been 
proposed to function in nearly every step of mRNA processing (Krecic and Swanson, 
1999). HnRNP F has a previously defined role in splicing where it forms part of a 
complex responsible for activating a splicing event that results in the inclusion of a 
neuron-specific exon in the c-src gene (Black, 1991 and 1992; Min et at., 1995). 
However, recent evidence has also suggested that hnRNP F has a more general effect 
on splicing efficiency in vitro (Gamberi et at., 1997). In splicing, CBC is required for 
efficient removal of the cap-proximal intron by facilitating the interaction between 
U  snRNP and the 5' splice site (Colot et at., 1996; Lewis et at., 1996 and Lewis and 
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Izaurralde, 1997). As mentioned earlier, in S. cerevisiae, the interaction between 
CBC and Ui snRNP is direct. However in higher eukaryotes, this interaction appears 
to be indirect and bridged by adaptor molecules (Lewis et al., 1996b). These results 
suggest that in vertebrates, hnRNP F might be a candidate adaptor protein that 
facilitates the positive effects of CBC and the cap during the earliest stages of pre-
mRNA splicing. 
[B] Np13 
Similar to hnRNP F, genetic studies in S. cerevisiae identified another hnRNP, Npl3 
as a CBC-interacting protein. Mutations in NPL3 show synthetic lethal relationships 
with alleles of both ScCBP20 and ScCBP80. In addition, co-immunoprecipitation 
experiments demonstrate that Np13 specifically interacts with ScCBP80. However, 
this interaction depends on the presence of both ScCBP20 and capped RNA (Shen et 
al., 2000). It is currently not known whether the interaction between Np13 and CBC 
is direct or bridged by adaptor proteins. 
Evidence from several laboratories have shown that Np13 is a shuttling protein that is 
implicated in mRNA nuclear export (Flach et al., 1994; Singleton et at., 1995; Henry 
et al., 1996; Lee et at., 1996). Kinetic experiments in Xenopus oocytes have shown 
that the cap has a small stimulatory effect on mRNA export, however, there is no 
evidence to suggest that this effect is mediated by CBC (Izaurralde et al., 1992). 
Interestingly, ScCBP80 has been shown to shuttle between the nucleus and 
cytoplasmic compartments (Shen et al., 2000). In addition, observations from 
immuno-EM studies show that CBC remains associated with the 5'-end of Balbiani 
ring mRNPs during nucleocytoplasmic translocation (Visa et al., 1996). Although 
there is no direct evidence, these data suggest CBC and the cap might function 
indirectly in mRNA export. A model can be proposed whereby after capping occurs 
co-transcriptionally, CBC binds nascent transcripts to promote the recruitment of 
RNA-binding proteins such as Np13 that are required to function in mRNA nuclear 
export. 
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[C] A novel nuclear CBC-dependent degradation pathway? 
Recent genetic studies in S. cerevisiae have shown that a deletion mutant in 
ScCBP80 suppresses a mutation in the cycl-512 gene. The cycl-512 mutation 
generates mRNAs with aberrantly processed 3'-ends. As a result, these transcripts 
are subsequently degraded and this significantly reduces the level of iso-i-
cytochrome c protein. However, the ScCBP80 mutant increases the levels of iso-i-
cytochrome c protein, which suggests that CBC is involved in mRNA decay (Das et 
at., 2000). In addition, two-hybrid analysis and co-immunoprecipitation experiments 
have shown that the riboexonuclease Rrp6 is also a CBC-interacting protein (Das et 
at., 2000). Rrp6 is a component of the exosome, which is the major nuclear RNA 
degradation pathway in S. cerevisiae. Taken together, these data suggest that CBC 
and Rrp6 might also be implicated in a novel nuclear decay pathway that degrades 
aberrantly processed mRNAs retained in the nucleus. 
Interestingly, the recently described MIF4G domain that represents significant 
sequence similarities between the middle portion of eIF4G and domains in 
NMD2/Upf2 is also conserved in CBP80 homologues (Ponting, 2000). NMD2/Upf2 
is a key component of the surveillance complex that detects premature stop codons as 
part of NMD pathway (Czaplinski et al., 1999; Hentze and Kulozik, 1999). Although 
the functional significance of the MIF4G domain in CBP80 is currently unknown, it 
is thought to mediate protein-protein interactions. Recent work has shown that 
HsCBP80 might also participate in NMD. Both nucleus-associated and cytoplasmic 
NMD appears to take place in association with HsCBP80 (Ishigaki et at., 2001). 
During splicing, factors involved in NMD such as Y14 interact with the spliced 
mRNA around 20 nucleotides upstream of the exon-exon junction to form a stable 
exon junction complex. Prior to the pioneer round of translation, the components of 
the exon junction complex remain stably bound and function NMD (Reed and Hurt, 
2002). CBC is also bound to the translated mRNA that is surveyed for premature 
stop codons. If translation termination is sufficiently premature, mRNAs are subject 
to NMD. However, if the quality of translation is approved, CBC exchanges with 
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eIF4E and this permits the formation of the steady-state eIF4F translation initiation 
complex (Fortes et al., 2000; Ishigaki et al., 2001). 
[D] eIF4G 
A synthetic lethal screen in S. cerevisiae identified eIF4G as a CBC-interacting 
protein. This interaction was further supported by in vitro binding experiments that 
showed CBC physically interacts with eIF4G. Furthermore, the CBC-eIF4G 
association is antagonised by the cytoplasmic cap-binding protein, eIF4E (Fortes et 
al., 2000). Biochemical studies in HeLa nuclear extracts have shown that the 
interaction between CBP80 and eIF4G is evolutionarily conserved. Mammalian 
immunofluorescence and immunoprecipitation studies have demonstrated a 
significant nuclear pool of eIF4G in vivo that is predominantly associated with CBC 
(McKendrick ci' al., 2001). This suggests that in the nucleus, CBC interacts with 
eIF4G at the 5'-end of mRNA. However, it is currently not known whether this 
interaction with CBC is indirect and mediated by adaptor proteins (McKendrick ci' 
al., 2001). 
The function of eIF4G in the nucleus is yet to be elucidated. However, nuclear eIF4G 
appears to exhibit partial localisation with spliceosomal U snRNPs and splicing 
factors in vivo. Furthermore, eIF4G appears to stably associate with spliceosomes in 
vitro. There is no evidence to suggest that eIF4G participates directly in general 
splicing. However, these results implicate eIF4G as a candidate adaptor protein that 
might mediate the positive effects of CBC in cap-dependent splicing. 
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1.21 Drosophila melanogaster as a model system 
Current evidence has shown that CBC is a conserved eukaryotic complex that 
mediates the recognition of capped RNA by various components of the nuclear 
RNAP II processing machinery. Key roles for CBC have been characterised in pre-
mRNA splicing, RNA 3'-end formation and U snRNA export (Lewis and Izaurralde, 
1997). In addition, increasing evidence also supports a role for CBC in RNAP II 
transcript degradation (Das ci' al., 2000; Ponting, 2000; Ishigaki ci' al., 2001). CBC 
function appears to be evolutionarily conserved in metazoans. However, in 
vertebrates, little is currently known about the proteins CBC interacts with or the 
mechanisms involved. The overall aim of this thesis is to use the genetic approaches 
available in Drosophila melanogaster to understand the mechanisms by which the 
cap facilitates multiple aspects of RNAP II transcript metabolism through CBC. 
Drosophila provides an excellent system for studying the biology of CBC in vivo. 
Firstly, with only four chromosomes, the fruit-fly is genetically simple and can 
therefore be easily manipulated in DrnCBP20 and DrnCBP80 gene interaction 
studies. In addition, the recent publication of the Drosophila genome facilitates the 
identification and mapping of putative CBC-interacting genes (Adams et al., 2000). 
Secondly, the amenability of the fruit-fly to cell biological and biochemical 
techniques allows genetic studies to be complimented by molecular and cytological 
studies. Lastly, the well characterised Drosophila developmental biology allows us 
to investigate whether CBC plays novel roles during spermatogenesis or oogenesis. 
As a first step to characterising CBC in Drosophila, partial sequences for DrnCBP20 
and DinCBP80 have been identified in Berkeley Drosophila Genome Project 
(BDGP) database and full-length cDNAs have been cloned (Joe Lewis, unpublished 
data). Overall, both Drosophila subunits show high homology to the corresponding 
human cap-binding proteins. This supports that CBC function might also be 
conserved between fruit-fly and human species. Furthermore, initial biochemical 
experiments have shown that DmCBC behaves in a manner analogous to HsCBC. 
Co-expression of DmCBP20 and DmCBP80 in Sf9 cells forms a stable heterodimeric 
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CBC complex that specifically binds the cap structure. In addition, either subunit on 
its own does not exhibit detectable cap-binding activity unless complexed together to 
form an active CBC (Joe Lewis, unpublished data). This suggests that studying the 
biology of CBC in Drosophila might lead to a greater understanding of its functions 
and molecular mechanisms in higher eukaryotes. 
Previous genetic studies in S. cerevisiae have used synthetic lethal screens and yeast 
two-hybrid systems to identify genes that interact with CBC (Gamberi et al., 1997; 
Fortes et al., 1999b). However, these experiments have had limited success. For 
example, in pre-mRNA splicing, the role of CBC has been shown to be 
evolutionarily conserved. Both yeast and human CBC increase the efficiency of Ui 
snRNP associating with the cap-proximal 5' splice site. Genetic studies in S. 
cerevisiae have shown that CBC interacts directly with components of Ui snRNP 
during commitment complex formation. However, in vertebrates, there is no 
evidence to suggest that a direct interaction exists between CBC and Ui snRNP. 
Instead, the available data supports that in higher eukaryotes CBC function is 
mediated through adaptor molecules (Lewis et al., 1996; Fortes et al., 1999b). This 
strongly suggests that in comparison to yeast, genetic studies in Drosophila might be 
more successful in identifying CBC-interacting proteins and elucidating the 
mechanism of CBC function in pre-mRNA splicing, as well as other RNA processing 
events. 
Genetic studies in Drosophila might also reveal novel functions of CBC during 
development that are not uncovered using conventional biochemical approaches. The 
generation of mutants in either DmCBP20 or DmCBP80 allows the role of CBC to be 
investigated during oogenesis or spermatogenesis. Taken together, these data present 
a strong argument that Drosophila melanogaster is model system by which to dissect 
the biology of CBC in vivo. 
The research in this thesis is broadly divided into two aims. Firstly, to determine 
whether CBC has novel functions during fruit-fly development. And secondly, to 
identify CBC-interacting genes that might elucidate the mechanisms whereby CBC 
and the cap facilitate multiple aspects of RNAP II transcript metabolism. 
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CHAPTER 2 
Materials and Methods 
2.1 MATERIALS 
2.1.1 Buffers and solutions 
C 
10 mM Hepes, pH 7.9; 1.5 mM MgC12; 1 mM KCI; 0.5 mM DTT Buffer A 
Buffer C 20 mM Hepes, pH 7.9; 25% Glycerol; 0.42 M NaCl; 1.5 mM 
MgCl2; 0.2 mM EDTA; 0.5 mM PMSF; 0.5 mM DYF 
Buffer D 20 mM Hepes, pH 7.9; 20% Glycerol; 0.1 M KCI; 0,2 mM EDTA; 
0.5 mM PMSF; 0.5 mM DTIT 
10 x DNA loading buffer 20% (w/v) FicoIl; 1% (w/v) SDS; 0.25% (w/v) Bromophenol blue; 
0.25% (w/v) Xylene cyanol; 100 mM EDTA 
Grinding buffer 10 mM Tris-HCI, pH 7.5; 10 mM EDTA, pH 8; 60 mM NaCl; 
5% (w/v) Sucrose; 5 gg1ml RNase 
Hybridisation solution 50% (v/v) deionized Formamide; 5 x SSC; 0.1% (v/v) Tween-20; 
100 g/ml E. coli tRNA; 50 g/rnl Heparin; pH adjusted to 6.5 with 
HCl 
Immunoprecipitation buffer 150 mM NaCl; 50 mM Tris.Cl, pH 7.8; 0.1% (v/v) Triton-X 100; 
0.1% (w/v) SDS; 0.1 mM PMSF 
Lysis buffer 300 mM Tris, pH 9; 100 mM EDTA, pH 8; 1.25% (w/v) SDS; 
5% (w/v) Sucrose 
50 x MOPS 1 M MOPS (Na salt); 0.25 M NaOAc; 500 mM EDTA 
1 xPBS 137 mM NaOAc; 2.6 mM KCI; 10 mM Na-,HPO4; 1.8 mM 
KH2PO4; pH adjusted to 7.4 with HG! 
PBS-Tw 1 x PBS; 0,1% (v/v) Tween-20 
RNA loading buffer 1.6 x MOPS; 64% (v/v) Formamide; 8% (v/v) Formaldehyde; 
0.03 mg/ ml Ethidium bromide; 0.06% (w/v) Bromophenol blue 
20 x SSC 3M NaCl; 0.3 M Sodium citrate; pH adjusted to 7 with HCl 
10 x TBE 0.9 M Tris base; 0.9 M Boric acid; 25 mM EDTA (Na' salt) 
1 x TE 10mM Tris-HCI, pH 7.5; 1 mM EDTA 
20 x Transfer buffer 0.2 M Tris base; 1.9 M Glycine 
10 x Tris-Tricine 1 M Tris base; 1 M Tricine; 1% (w/v) SDS 
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2.1.2 Suppliers 
Chemicals were purchased from Aldrich, BDH, Boehringer Mannheim, Fisher, 
Fisons, Flowgen, Gibco BRL and Sigma. Enzymes were obtained from Boehringer 
Mannheim, New England Biolabs (NEB), Pharmacia, Promega, and Stratagene. 
Deoxyribonucleotides were supplied by Boehringer Mannheim. Reagents for all 
growth media were obtained from Difco, Biogene and Sigma. Ampicillin was 
purchased from Duchefa. 
2.1.3 Escherichia coil media 
All media were autoclaved prior to use and stored at room temperature. For solid 
media, 2% (w/v) agar was added prior to autoclaving. 
1:Meda Type 
Luria-Bertani broth 1% (w/v) Bacto-tryptone; 0.5% (w/v) Bacto-yeast extract; 0.5% (w/v) 
NaCl; pH adjusted to 7.2 with 5 M NaOH 
Super broth 0.1% (w/v) Bacto-tryptone; 0.3% (w/v) Bacto-yeast extract; 0.004% 
(v!v) Glycerol; 0.1 M Potassium phosphate 
2.1.4 Drosophila melanogaster media 
Modialype Components 	Ilk 	iiISIlJ&kl 
Dundee food 1% (w/v) Bacto-tryptone; 0.5% (w/v) Bacto-yeast extract; 0.5% (w/v) 
NaCl; pH adjusted to 7.2 with 5 M NaOH 
Apple juice plates 0.2% (w/v) Bacto-agar; 0.3% (w/v) Sucrose; 0.02% (w/v) Nipagin; 
0.1% (v/v) Apple juice concentrate 
2.1.5 Escherichia coil strains 
MC1066 /t(lacI POZYA)74 	ga/U 	ga/K 	strA' / e u B 6 	trpC9830 P. Legrain 
pyrF74: : Tn5(Knr) hsdK  
XL1-Blue F 	proAB 1 a c I I 	lacZ/M15 TN10 Tt1 ) r e c 	1 endAl NEB 
gyrA96(Na/r) thil hsdR17(rrnk ) supE44 re/Al lac  
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2.1.6 Drosophila melanogaster strains 
A. General Stocks 
1 Stock Comments Reference! 
Source 
W1118 Mutation of the while gene. Bloomington 
w; P(wt arm:DmCBP20) DmCBP20 ORF over-expressed J. Lewis 
using 	the 	ubiquitous 	armadillo 
promoter.  
Iv; P(wt DmCBP20 genomic) DmCBP20 genomic region over- This work 
expressed.  
ry506 	P/ry 72=PZ)1(3)0569705697/ TM3, Homozygous 	lethal 	P-element Bloomington 
RK 	/ 
5
•cr  / Sb 
insertion 	into the 5' UTR 	of 
,y DrnCBP20exon 1. 
Referred in text as: P(lacZ 	1(3)0569 7 
P/w1 =lacWjbi'35 Homozygous 	viable P-element Bloomington 
insertion into bifid. 
Referred in text as: P(lacW w)bi X35 
wWS;  P(ryz12-3) Sb/TM6, Ubx, bx, ty, e P-element 	transposase 	used 	in Robertson 	et 
DmCBP80 local hop. al., 1988 
Sp/CyO;P{ryt12-3) Sb/TM6, Ubx, bx, ry, e P-element transposase 	used 	in Robertson 	et 
mobilisation 	of 	P(lacZ ry) al., 1988 
1(3)05697.  
w, FM6 Balancer used in DmCBP80 local Bloomington 
hop.  
TM2 Ubx, ry, e/TM6B, Tb, Hu, ty, e Balancer used in mobilisation of Bloomington 
P(lacZ iy) 1(3)05697.  
Df(3R) P14 sr'/ TM6B Deficiency 	with 	breakpoints Bloomington 
90C2-D1; 91Al-2 that uncover 
DrnCBP20.  
Df(1) bi-D31FM7c Deficiency with breakpoints 4C5- Bloomington 
6; 4C7-8 that uncover D,nCBP80.  
Df(3R) e-N]9/TM2 Deficiency with breakpoints 93B; Bloomington 
94 that uncover D,nCBP80R.  
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B. GAL4 Drivers 
GAL4 Stock Expression Reference! 
Source 
C22 Ubiquitous llìroughout ciubryogenosis. NI. ('coning 
w; P/w, C22-GAL4)/Sm6a  
Decapentaplegic Larval wing, ventral midline of leg, eye Staeh!ing- 
w, 	wg5"/ Cyo; P/w, dpp-GAL41/ morphogenetic furrow and antenna! Hampton 	et 
TM6B disc. al., 1994 
Eyeless Larval to late pupal eye disc and subset Eggert et at., 
w, P1 w, ey-GAMJ of CNS. 1998b 
GMR Larval to late pupal eye disc, behind Hay 	et 	al., 
w; P(w, GMR-GAL41 the morphogenetic furrow. 1994 
OK-384 Adult 	leg, 	bristles 	and 	thoracic Connolly 	et 
w; P[w, 0K384-GAL4]/TM3 muscles. at., 1996 
Patched Eye cells in embryo; Larval discs, in Speicher etal., 
w; Pfw, ptc-GAL4J/Sm6a the 	stripes 	between 	the 	anterior- 1994 
posterior boundary.  
S31 PNS of embryo; Larval eye, leg and Jarman et al., 
w; P[w, 109(2)68-GAL.41/GyO wing discs. 1998 
Scabrous PNS of embryo; Larval eye, leg and Hinz 	et 	at., 
w; P/wt sca-GAL4J/ C'yO wing discs. 1994 
Scalloped Pupal wing disc. F. Sprenger 
yw67; P/w, sd-GA M]  
Vestigal Pupal wing disc. F. Sprenger 
yw67; P/w, vg-GAL4)/ CyO; TM2/ 
TM6  
w, 	P(w, 	UAS-importin/3, 	GMR- Dominant phenotype observed in adult 1. Davis 
GAL4)/C'yO eye.  
w, 	P(iv, 	UAS-atonal, 	S31-GAL4)/ Dominant 	phenotype 	observed 	in Jarman et al., 
CyO scute!lar macrochaetae. 1998 
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2.17 Oligonucleotides 
All oligos used in this work were purchased from Bioline. 
A. DmCBP20 Oligos 
Description 	1UI! 
S048 TITCACACAGGAAACAGCTATGAC DmCBP20 forward primcr used to 
generate DrnCBP20 	C-terminal 
deletions (Figure 6.2, p135). 
S078 GGCTCGAGCTAGAGTGCCA'VFCACAAAT DmCBP20AC 	reverse primer with 
incorporated Xho I restriction site, 
used 	to 	amplify 	283 	bp 	of 
DniCBP20C 	9 (Figure 6.2, p135). 
S079 GGCTCGAGCTAGCACCTGTCCGCCGGTT D,nCBP20AC 1,125 	reverse primer 
with incorporated Xho I restriction 
site, 	used 	to amplify 	372 	bp 	of 
DrnCBP20C J.12S  (Figure 6.2, p135). 
S264 GGCTCGAGCTAACGCGTGCCGAAAAT DmCBP20 genom ic forward primer 
with incorporated Xho I restriction 
site, 	used to amplify 	1053 	bp of 
DmCBP20 genomic region (Figure 
1 4.3, p85). 
S265 GGTCTAGAATGTCTAAGGGGTATGCT DmCBP20 genom ic reverse primer 
with incorporated Xba I restriction 
site (Figure 4.3, p85). 
B. DmCBP80 Oligos 
$ 	i é i __ 
S102 GGCTCGAGAAGATGAGTCGCAGGAG DmCBP80 	forward 	primer 	with 
incorporated Xho I restriction site, 
used 	to 	generate 	DmCBP80 	C- 
________  terminal deletions (Figure 6.2, p135). 
S103 GGTCTAGACTAGGAGAGCACAGCAAAG DmCBP80AC 	reverse primer 
A with incorporated Xba I restriction 
site, 	used 	to amplify 	537 	bp 	of 
DinCBP80/.0 1-178  (Figure 6.2, p135). 
S105 GGTCTAGACTACAGATGATAGGAGAACC DrnCBP80LC 	1.424  reverse primer 
with incorporated Xba I restriction 
site, used to amplify 	1275 bp of 
DrnCBP80AC J -424 (Figure 6.2, p135). 
S106 GGTCTAGACTAGCCACCACCAGTTGATG DmCBP80AC 	1510  reverse primer 
with incorporated Xba I restriction 
site, used to amplify 	1532 bp of 
DmCBP80AC 	(Figure 6.2, p135). 
S107 GGTCTAGACTAATCGTCAGATGGAGAAT DmCBP80C reverse primer 
with incorporated Xba I restriction 
site, 	used to 	amplify 	1946 bp of 
DmCBP80CL\ 43 (Figure 6.2, p135). 
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C. DmCBP80R Oligos 
Name$ 11jiMr SequenceS to *&V DescrIption 
S471 GGAAGATGAGTCGCAGGAGG RT-PCR intron 	1 forward primer, 
used to amplify 609 bp across intron 1 
of D,nCBP8OR (Figure 5.4, p121  and 
Figure 5.5, p123). 
S472 CCAGAAAGCGCAGCGAGTAC RT-PCR 	intron 	I reverse 	primer 
(Figure 5. 4, p121). 
S473 GACATCTGCTACGGCTCCAT RT-PCR intron 2 forward primer, 
used to amplify 549 bp across intron 2 
of DniCBP80R (Figure 5.4, p121). 
S474 TCG'FFGGCGTACTTGTCA'FIT RT-PCR 	intron 	2 reverse primer 
(Figure 5.4, 	p121 and 	Figure 	5.5, 
p123). 
S299 GGCTCGAGGGAAAGTCTGACGAGGAG N-T DrnCBP80R forward primer with 
incorporated 	Xho I restriction site, 
used to amplify 	1495 	bp N-T of 
DnzCBP80R (Figure 5.3, p1  18). 
S300 GGTCTAGATFGGTGGTACGAAAGTC N-T DmCBP80R reverse primer with 
incorporated Xba 	I restriction 	site 
(Figure 5.3, p118). 
D. RLI9, RpAI and RpS3 Oligos 
S226 GGCTCGAGTVT'CCTAGCCACGACGAG Forward primer, used to amplify RpL19 
for northern analysis. 
S227 GGTCTAGAGGGATCCAACCAGACCT RpLJ 9 reverse primer. 
S224 GGCTCGAGCCGTTCACCAFTCTAC Forward primer, used to amplify RpAJ 
for northern analysis. 
S225 GGTCTAGAGCACCCCGCCGACTGrI' RpA] reverse primer. 
S222 GGCTCGAG'TTFCCAAGAAACGCAAG Forward primer, used to amplify RpS3 
for northern analysis. 
S223 GGTCTAGACCAAAGGGGGTCACACG I RpS3 reverse primer. 
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2.1.8 Plasmids 
-: 
p2-3 Transposase source. C. Girdham 
pBSK-D,nCBP20 DmCBP20 604 bp ORF cloned into the EcoR I and J. Lewis 
Xho I restriction sites of pBSK.  
pBSK-DmCBP80 DmCBP80 3274 bp ORF cloned into the EcoR I and J. Lewis 
Xho 1 restriction sites of pBSK.  
pBSK-HsCBP20 HsCBP20 600 bp ORF cloned into the EcoR I This work 
restriction site of pBSK.  
pBSK-HsCBP80 HsCBP80 2828 bp ORF cloned into the EcoR I This work 
restriction _site _of_pBSK.  
pCasPeR 4—DmCBP20 D,nCBP20 genomic amplified from fly DNA using This work 
S264 and S265 (Table 2.1.7A) to generate 1053 bp of 
D171CBP20 genomic, which was cut with Xba I and 
Xho I (restriction sites incorporated into the primers) 
and cloned between the Xba I and Xho I sites of 
pCasPeR 4.  
pUAST—DmCBP20 pBSK-DinCBP20 cut with EcoR I and Xho I to This work 
release 604 bp of DmCBP20 ORF, which was then 
cloned between the EcoR I and Xho 	I sites of 
pUAST.  
pUAST— DmCBP2OAC 195 DmCBP20 ORF amplified from pBSK-DniCBP20 This work 
using S048 and S078 (Table 2.1.7A) to generate 283 
bp of DmCBP20C 	, which was cut with Xba I 
and Xho I (restriction sites incorporated into the 
primers) and cloned between the Xba I and Xho I 
sites of pUAST.  
pUAST—DmCBP20IXC 1125 As above, except 372 bp of D,nCBP20AC 	-25  This work 
amplified with S048 and S079 (Table 2.1.7A).  
pUAST—DmCBP80 pBSK-DmCBP80 cut with EcoR I and Xho I to This work 
release 3274 bp of DmCBP80 ORF, which was then 
cloned between the EcoR I and Xho 	I sites of 
pUAST.  
pUAST—DrnCBP80AC 1,178 DmCBP80 ORF amplified from pBSK-DrnCBP80 This work 
using S102 and S103 (Table 2.1.7B) to generate 537 
bp of DmCBP80AC 1178'  which was cut with Xba I 
and Xho I (restriction Sites incorporated into the 
primers) and cloned between the Xba I and Xho I 
sites of pUAST.  
pUAST—DrnCBP80AC 1424 As above, except 1275 bp of DmCBP80AC 1424 This work 
amplified with S102 and S105 (Table 2.1.7B).  
pUAST—DrnCBP80AC 1510 As above, except 1532 bp of DmCBP80AC 1-510 This work 
amplified with S102 and S106 (Table 2.1.713).  
pUAST—DnICBPSOAC 1-648 As above, except 2354 bp of DmCBP80AC 1648  This work 
amplified with S102 and S107 (Table 2.1.713).  
pUAST—HsCBP20 pBSK-HsCBP20 cut with EcoR Ito release 600 bp of This work 
HsCBP20 ORF, which was then cloned between the 
EcoR I site of pUAST.  
pUAST—HsCBP80 pBSK-HsCBP80 cut with EcoR I to release 2828 bp This work 
of HsCBP80 ORF, which was then cloned between 
the EcoR I site of pUAST.  
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2.1.9 Antisera 
w 	Anthody:r Reference/ Source 
anti-1426 Rabbit polyclonal raised against E-{sCBP20. 1/aLirralde ci al., 1994 
anti-Actin Rabbit polyclonal raised against DrnActin. Sigma 
anti-DmCBP80R Rabbit 	polyclonal 	raised 	against 	DmCBP80R This work 
carboxyl-peptide sequence MSEDASDLRPEISKT.  
anti-DIG AP anti-DIG antibody alkaline phosphatase conjugate. Boehringer 
Mannheim 
anti-mouse IgG-HRP anti-mouse lgG 	horse radish peroxidase 	linked Amersham 
whole antibody generated from sheep.  
anti-rabbit IgG-HRP anti-rabbit IgG horse radish peroxidase linked whole Amersham 
antibody generated from donkey.  
anti-8WG16 Mouse 	monoclonal 	raised 	against 	non- Yuryev et al., 1996 
phosphorylated CTD heptapeptide repeats on largest 
subunit 	wheat _of_ _germ _RNAP_II.  
anti-YP Rabbit polyclonal raised against major yolk proteins Mary Bownes 
YP!,_YP2_  and _YP3.  
anti-Y12 Mouse monoclonal raised against Sin epitope. Brahms et at., 2000 
2.2 METHODS 
2.2.1 Growth of bacteria 
E. coli strains (Table 2.1.5) were grown at 37°C in Luria-Bertani broth (LB) or Super 
broth media (Table 2.1.3). To maintain selection for plasmid DNA, transformed 
bacteria were grown in medium containing ampicillin to a final concentration of 100 
JLg/ml. 
2.2.2 Transformation of competent cells 
Competent cells (Table 2.1.5) were prepared using the CaCl2 procedure described in 
Sambrook et al., 1989. Competent cells were thawed on ice and mixed with the DNA 
to be transformed. Cells were placed on ice for 45 minutes and then heat-shocked at 
42°C for 2 minutes. Immediately after heat-shock, 850 JL1 of LB (Table 2.1.3) was 
added and the cells incubated for one hour at 37°C with gentle shaking. The cells 
were then spread onto LB plates supplemented with 50tg/ml of ampicillin and 
incubated at 37°C overnight. 
49 
Chapter 2 Materials and Methods 
2.2.3 Phenol-chloroform extraction 
Nucleic acids were separated from solutions containing residual proteins by adding 
an equal volume of phenol: chloroform: isoamyl alcohol (25:24:1), vortexing briefly 
and centrifuging at 14, 000 rpm for 2 minutes. The upper aqueous phase contained 
the nucleic acids and was transferred to a fresh eppendorf. 
2.2.4 Precipitation of nucleic acids 
Nucleic acids were precipitated from solution by mixing with 2.5 volumes of 
absolute ethanol containing 0.1 volumes of 3 M NaOAc, pH 5.2 and freezing for 20 
minutes at -70°C. Nucleic acids were pelleted by centrifuging at 14, 000 rpm for 30 
minutes at 4°C. The pellet was washed with 70% (v/v) ethanol, dried under vacuum 
and then resuspended in an appropriate volume of 1 x TE (Table 2.1.1) or dH70. 
2.2.5 Quantification of nucleic acids 
The concentration of DNA or RNA was determined either by spectrophotometry or 
visual comparison to a known quantity of molecular weight standards by agarose gel 
electrophoresis. The absorbence of diluted solutions was measured at 260 nm using a 
Cecil CE 2040 spectrophotometer and quartz cuvette. For double stranded DNA, an 
0D260 value of 1.0 represents a DNA concentration of approximately 50 /.tg/ml. For 
single stranded DNA, an OD,60 value of 1.0 represents a DNA concentration of 
approximately 33 jg/ml. For single-stranded RNA, an 0D260 value of 1.0 represents 
a RNA concentration of approximately 40 [tg/ml. 
The purity of the DNA or RNA sample was then determined by measuring the 
absorption at wavelengths of 260 nm and 280 nm. Protein-free preparations of DNA 
and RNA should give an 0D260:OD,80 ratio close to 1.8 and 2.0 respectively. 
2.2.6 Genomic DNA preparation from adult flies 
Genomic DNA was extracted from 50 adult flies snap frozen in liquid nitrogen. Flies 
were homogenised in 400 l of cold Grinding buffer (Table 2.1.1) using a Polytron 
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(Kinematika). An equal volume of Lysis buffer (Table 2.1.1) was added, the sample 
vortexed and placed at 65°C for 30 minutes. Ninety microlitres of 8 M KOAc was 
then added and the sample incubated on ice for 45 minutes. The tube was centrifuged 
at 14, 000 rpm for 15 minutes and the supernatant removed and phenol-chloroform 
extracted (Section 2.2.3) twice. The DNA was precipitated by mixing with 2 volumes 
of absolute ethanol containing 0.1 volumes of 5 M NaCl and incubated at room 
temperature for 2 minutes. DNA was pelleted by centrifuging at 14, 000 rpm for 5 
minutes at room temperature. The pellet was washed twice with 70% (v/v) ethanol, 
air dried and resuspended in 50 jtl of 1 x TE (Table 2.1.1). Genomic DNA was then 
stored at -20°C. 
2.2.7 Plasmid DNA preparation 
Small scale plasmid preparations were purified using the UltraClean Plasmid 
Miniprep Kit (MoBio), following the manufacturer's instructions. DNA was 
extracted from 2 ml of E. coli culture and resuspended in 50 pJ of dH2O. Larger scale 
plasmid preparations were isolated using the QlAfilter Maxiprep Kit (Qiagen), 
following the procedures detailed in the manufacturer's handbook. DNA was 
extracted from 200 ml of E. coli culture, resuspended in 500 Itl of 1 x TE (Table 
2.1.1) and stored at -20°C. 
2.2.8 Agarose gel electrophoresis 
DNA fragments were separated on 1-1.5% (wlv) agarose gels. Gels were prepared by 
melting the appropriate amount of agarose in 1 x TBE (Table 2.1.1) and adding 
ethidium bromide to a final concentration of 0.1 Ag/ml. Prior to loading, DNA 
samples were mixed with 0.1 volumes of 10 x DNA loading buffer (Table 2.1.1). 
Electrophoresis was performed in 1 x TBE at 100 V for approximately 40 minutes 
and the DNA was visualised by UV illumination. 
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2.2.9 Restriction endonuclease digestion 
DNA was digested using the buffer and temperature conditions recommended by the 
manufacturer. Typically, digests were performed in volumes of 20-200 ttl and 
incubated for a period of 2 hours at 37°C. 
2.2.10 Removal of 5' phosphates from DNA 
Calf intestinal alkaline phosphatase (ClAP) was used to dephosphorylate linearised 
vector prior to insert ligation. DNA was incubated with 10 units of ClAP for 30 
minutes at 37°C. The enzyme was then deactivated by adding 5 mM EDTA and 
incubating at 75°C for 10 minutes. 
2.2.11 Ligation 
Ligations were set up in a final volume of 20 Al containing 0.5-1 pg total DNA, 1 x 
ligase buffer and 1 unit of T4 DNA Ligase. Generally the vector and insert were 
present in a 1:3 molar ratio, where the size of the insert was substantially smaller 
than the vector. For equal size fragments an equimolar 1: 1 ratio was used. Ligation 
reactions were incubated overnight at 16°C and then used to transform competent 
cells (2.2.2). 
2.2.12 Polymerase chain reaction 
Specific regions of DNA were amplified using the polymerase chain reaction (PCR). 
A typical 100 Al reaction mix was set up on ice as follows: 
Plasmid DNA 	 10-30 ng 
or Genomic DNA 	 50 ng 
Primers 	 0.5 pmol 
dNTPs 200 /LM 
Polyrnerase buffer 	 1 x 
Taq DNA polymerase 5 units 
dH20 	 up to 100 Al 
Vent polymerase was used for applications that required higher fidelity. 
Consequently, a MgCl, titration of 2, 4, and 6 mM was also included. 
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All PCRs were performed in a Biometra UNO thermoblock (Genetic Research 
Instrumentation). A typical programme is described below: 
Step 1 Denaturation: 
	
94°C for 10 minutes 
Step 2 Denaturation: 
	
94°C for 30 seconds 
Step 3 Annealing: 
	
55°C for 30 seconds 
Step 4 Extension: 
	
74°C for 1 minute 
30-40 cycles of Steps 2-4 
Step 5 Final extension 
	
74°C for 10 minutes 
2.2.13 Purification of DNA from agarose gels 
DNA was isolated from agarose gel slices using the QlAquick Gel Extraction Kit 
(Qiagen) following the manufacturer's guidelines. DNA fragments were separated by 
agarose gel electrophoresis (Section 2.2.8) and the bands visualised on an UV 
transilluminator. The desired band was excised with a clean razor blade and purified. 
DNA was typically eluted in 30 tl of dH20 and stored at -20°C. 
2.2.14 Automated DNA sequencing 
DNA sequencing reactions were performed using the dRhodamine Terminator Cycle 
Sequencing Kit (Perkin-Elmer Corporation) in a Biometra UNO thermoblock 
(Genetic Research Instrumentation). A typical reaction mix was set up as follows: 
Plasmid DNA 	 500 ng 
or PCR product 30 ng 
Primer 	 3.2 pmol 
Terminator mix 	 4 pd 
Twenty-five cycles as described below were performed: 
Step 1: 96°C for 30 seconds 
Step 2: 50°C for 15 seconds 
Step 3: 60°C for 4 minutes 
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DNA was precipitated from the reaction mix by adding 25 itl of absolute ethanol and 
1 ttl of 3 M NaOAc, pH 5.2, incubating on ice for 15 minutes followed by 
centrifuging at 14, 000 rpm for 30 minutes. The pellet was washed with 250 tl of 
70% (v/v) ethanol and dried under vacuum. The extension products were separated 
on an ABI PRISM 377 DNA sequencer (Perkin-Elmer Corporation) run by Nicola 
Wrobel (University of Edinburgh) and the sequences analysed using the Gene Jockey 
II programme. 
2.2.15 Radio-labelling DNA fragments by random priming 
DNA fragments were labelled with approximately 5000 Ci/mmol [32P]-dCTP 
(Amersham) using the Megaprime DNA Labelling System (Amersham). DNA 
labelling reactions were set up according to the manufacturer's protocol. 
2.2.16 Removal of unincorporated nucleotides by spin 
chromatography 
Random primed DNA was separated from unincorporated nucleotides using spin 
chromatography. An one ml syringe column plugged with siliconised glass wool was 
packed by adding Sephadex G-50 (Amersham) and centrifuging for 3 minutes at 
2000 rpm. This procedure was repeated until the gel matrix was packed to a volume 
of 1 ml. The spin column was equilibrated with 100 Itl of 1 x TE (Table 2.1.1) and 
placed into a 15 ml falcon tube containing a lidless eppendorf. The probe volume 
was increased to 100 fLl with dH20, added to the spin column and centrifuged as 
before. The eluate was collected in the lidless eppendorf and the concentration of 
labelled probe calculated by scintillation using a Packard Tri-Carb 2100TR Liquid 
Scintillation Analyser. 
2.2.17 Total RNA preparation 
Total RNA was prepared using the RNeasy RNA Extraction Kit (Qiagen) following 
the procedures detailed in the manufacturers handbook. RNA specifically used in 
Reverse Transcription (RT)-PCR was extracted using the Absolutely RNA RT-PCR 
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Kit (Stratagene), according to the manufacturer's instructions. Generally RNA was 
isolated from approximately 25 mg of fly tissue snap frozen in liquid nitrogen, eluted 
with 30 tl of RNase-free dH20 and stored at —20°C for 1 month. 
2.218 Northern blotting 
RNA fragments were separated by electrophoresis in a 1% (wlv) formaldehyde gel. 
Gels were prepared by dissolving 0.9 g of agarose in 81.6 ml of dH20 containing 2 
ml of 50 x MOPS (Table 2.1.1). The mixture was cooled to 50°C and 16.8 ml of 37% 
(v/v) formaldehyde was added. Total RNA (Section 2.2.17) was mixed with 0.2 
volumes of RNA loading buffer (Table 2.1.1), heated to 95°C for 5 minutes and then 
chilled on ice immediately prior to loading. Electrophoresis was performed in 1 x 
MOPS buffer at 100 V for approximately 1.5 hours. A photograph was taken with a 
ruler placed next to the RNA marker (Promega) lane, using a HeroLab Gel 
Documentation System. Prior to RNA transfer, the formaldehyde gel was washed 
twice in 10  SSC (Table 2.1.1) for 20 minutes. 
RNA was transferred from the formaldehyde gel to a Hybond-N membrane 
(Arnersham) by capillary action (Stratagene handbook) in 10 x SSC (Table 2.1.1). 
After capillary transfer, the membrane was briefly rinsed in 10 x SSC, blotted dry 
and irradiated in an UV Stratalinker (Stratagene) at 1200 mJ. 
Radio-labelled DNA probe (Section 2.2.15) was then hybridised to the Hybond-N 
membrane using the QuikHyb Hybridisation Solution (Stratagene) following the 
protocol detailed in the manufacturer's instructions. 
2.2.19 RT-PCR 
RT-PCR was performed using the Omniscript Reverse Transcriptase Kit (Qiagen) in 
a two step reaction. First strand cDNA synthesis used 500 ng of total RNA and 
oligo(dT) priming according to the procedure detailed in the manufacturer's 
handbook. cDNA product was subsequently amplified using PCR with Taq DNA 
polyrnerase (Section 2.2.12). 
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2220 Synthesis of digoxygenin-labelled RNA 
RNA labelled with digoxygenin (DIG)-1 1-UTP was synthesised using the DIG RNA 
Labelling Kit (Boehringer Mannheim). Probes were labelled according to the 
instructions set out in the manufacturer's manual. 
22.21 mRNA in situ hybridisation in wholemount tissues 
In situ hybridisation to mRNA in wholemount tissues was performed using the 
method of Tautz et al., 1989 with modifications. 
In brief, fixed tissue samples (Section 2.2.28) were re-hydrated in 50% methanol in 
PBS-Tw (Table 2.1.1) for 5 minutes and rinsed in PBS-Tw for 5 minutes. The 
samples were then post-fixed in 3.7% formaldehyde in PBS-Tw for 20 minutes with 
gentle shaking. The excess fix was removed by washing the sample 5 x 5 minutes in 
PBS-Tw. Samples were then washed in 50% Hybridisation solution (Hybe) (Table 
2.1.1) in PBS-Tw for 10 minutes followed by a wash in Hybe for a further 10 
minutes. Subsequently, the tissues were pre-hybridised in Hybe for 1 hour at 70°C. 
DIG labelled RNA probe (Section 2.2.20) was diluted to 5 ng/fLl in Hybe (Table 
2.1.1), added to the sample and hybridised overnight at 70°C. RNA probe was then 
removed and the sample washed at 70°C in the following series: Hybe for 30 
minutes, 50% Hybe in PBS-Tw (Table 2.1.1) for 30 minutes and 4 x 30 minutes in 
PBS-Tw. The anti-DIG AP antibody (Table 2.2.9) was diluted 1:2000 in PBS-Tw, 
added to the samples and incubated at room temperature for 2 hours on a rotating 
wheel. The excess antibody was then removed by washing 3 x 20 minutes in PBS-
Tw. 
DIG-labelled RNAs were detected using NBT/BCIP stock solution (Boehringer 
Mannheim). The colour solution was prepared according to the manufacturer's 
protocol and the reaction was then terminated by rinsing tissues in 200 mM EDTA in 
PBS-TW (Table 2.1.1) several times. 
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2.2.22 Quantification of protein 
Bradford method 
Spectrophotometric quantification of proteins was determined by the Bradford 
method. A series of bovine serum albumin (BSA) standard solutions were prepared 
with concentrations ranging from 2.5-30 jig. Two millilitres of Bradford reagent was 
added to each standard solution, vortexed and allowed to stand for 2 minutes. The 
0D595 of each sample was measured and the values used to plot a graph of BSA 
concentration versus 0D595. The protein of unknown concentration was 
simultaneously treated in the same manner and the concentration was extrapolated 
from the standard plot. 
Sypro-orange staining of SDS-polyacrylamide gels 
Quantification of proteins on a SDS-polyacrylamide gel was performed using the 
sypro-orange (Amersham) detection method. Sypro-orange staining can detect 1-2 ng 
of protein per band, in contrast to coomassie brilliant blue, which detects 0.3-1 jig 
protein per band. The SDS-polyacrylamide gel was stained with sypro-orange 
according to the protocol described in the manufacturer's manual. The sypro-orange 
stained SDS-polyacrylamide gel was scanned using the Storm 860 Imaging System 
set on blue fluorescence mode. The area quantitation was then calculated using the 
ImageQuant program. 
2.2.23 SDS-polyacrylamide gel electrophoresis 
The Bio-rad mini gel apparatus was assembled according to the manufacturer's 
instructions. The resolving gel solution was prepared, poured between the glass 
plates and overlaid with dH20. After polymerisation, dH2O was removed, the 
stacking gel poured and the comb was inserted in the top of the gel. When set, the 
comb was taken out and the wells washed with dH 2O. Protein samples were mixed 
with 0.3 volumes of 3 x SDS loading buffer (NEB), and together with 5 jil pre-
stained protein marker (NEB), were heated to 95°C for 5 minutes. Samples were then 
57 
Chavter 2 Materials and Methods 
briefly centrifuged and loaded onto the gel. Electrophoresis was performed in 1 x 
Tris-Tricine buffer (Table 2.1.1) at 130 V for approximately 40 minutes. 
yffir 	 39 411 WPI iQ 
ProSieve 50 gel solution (FMC) 1.6 ml 2 ml 
1.5 M Tris-HC1, pH 8.8 2.5 ml 2.5 ml 
10%SDS 100 Al 100 Al 
dH7O 5.7 ml 5.3 ml 
10%APS 100d 100 /A 
TEMED 4 isl 4p1 
ProSieve 50 gel solution (FMC) 1500 p1 
1 M Tris-HC1, pH 6.8 650 Al 
10%SDS 50p1 
dH2O 3.75 ml 
10%APS 50p1 
TEMED 5 p1 
2.2.24 Western blotting 
Proteins were transferred electrophoretically from the SDS-PAGE gel to a Hybond-
ECL membrane (Amersham) using the Bio-rad Transfer System and following the 
manufacturer's instructions. Electrophoretic transfer was performed in 1 x Transfer 
buffer (Table 2.1.1) at 400 mA for 1-2 hours. The protein transfer was then 
confirmed by staining the membrane with Ponceau S. 
Hybond-ECL membranes were immunostained according to the following 
procedure: 
The membrane was incubated for 1 hour at room temperature in 5% Blocking 
solution (5% (wlv) dry milk in PST-Tw (Table 2.1.1) with constant shaking. Primary 
antiserum (Table 2.1.9) was diluted in 2% Blocking solution (2% (w/v) milk in PST-
Tw), applied to the membrane and incubated for 1 hour at room temperature with 
constant shaking. The membrane was then washed twice for 5 minutes in 2% 
Blocking solution. Secondary antiserum (Table 2.1.9) was diluted in 2% Blocking 
solution, applied to the membrane and incubated for 45 minutes at room temperature 
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with constant shaking. The membrane was then washed as before with an additional 
10 minute wash in PBS-Tw followed by a 5 minute rinse in PBS. 
Immunodetection of antibodies was performed using enhanced chemiluminescence 
(ECL). Three millilitres of the ECL developer solution (Amersham) was prepared as 
detailed in the manufacturer's protocol, applied to the membrane and incubated for 1 
minute at room temperature. After incubation the developer solution was removed, 
the membrane was placed in Saran wrap and exposed to Kodak XAR film. Exposure 
times were varied according to the strength of the signal. Kodak XAR films were 
developed in a Konica SRX-101A developer. 
2.2.25 Preparation of nuclear extract 
HeLa nuclear extract was obtained from 4C Mons Belgium. Drosophila nuclear 
extract was prepared according to the procedure described in Dignam et at., 1983 
with modifications. 
Dme12 cells were grown in spinner flasks at 37°C in Drosophila Serum Free Media 
(Sigma) supplemented with 200 mM of L-glutamine. Cells were grown to a density 
of 5 x iO total cells prior to extract preparation. Dme12 cells were harvested by 
centrifuging for 10 minutes at 2000 rpm and resuspended in 5 pellet volumes of cold 
PBS (Table 2.1.1). Subsequent steps were performed at 4°C. Cells were pelleted by 
centrifuging for 10 minutes at 1000 g and resuspended in 5 pellet volumes of Buffer 
A (Table 2.1.1). The cells were then incubated on ice for 10 minutes, centrifuged 
again at 1000 g for 10 minutes and resuspended in 2 pellet volumes of Buffer A. The 
suspension was transferred to a Dounce homogeniser and homogenised by 15 slow 
strokes of the pestle. When approximately 80% of the cells were disrupted, as 
determined microscopically, the lysate was centrifuged for 10 minutes at 1000 g. The 
pellet of crude nuclei was resuspended in 3 ml of Buffer C (Table 2.1.1) using 10 
slow strokes of the Dounce homogeniser. The suspension was then incubated for 30 
minutes and centrifuged at 25 000 g for 30 minutes. The supernatant was dialysed 
(10 kDa cut-off, Pierce) against 3 changes of 1 litre Buffer D (Table 2.1.1) over a 
period of 6 hours. The dialysate was centrifuged at 25 000 g for 20 minutes and the 
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resulting precipitate discarded. The final supernatant, designated the nuclear extract 
was aliquoted into eppendorfs and stored at -70°C. 
2.2.26 Co-immunoprecipitation of proteins 
Protein A-Sepharose beads (Amersham) were equilibrated in NT buffer (500 mM 
NaCl and 50 mM Tris.Cl, pH 7.5) by washing twice for 10 minutes. Washed beads 
were pelleted by centrifuging at 3000 rpm for 1 minute and resuspended in 300 /21 of 
NT buffer. The appropriate antiserum (Table 2.1.9) was added and allowed to bind 
the protein A-Sepharose for 1 hour at room temperature on a rotating wheel. The 
bound antibodies were then washed 3 x 10 minutes in NT buffer before being 
resuspended in 500 /21 of cold Immunoprecipitation (IP) buffer (Table 2.1.1). Nuclear 
extract was added and the bound antibodies were incubated on a rotating wheel for 2 
hours at 4°C. The suspension was then washed 3 x 10 minutes with IP buffer and the 
beads resuspended in 30 /21 of 3 x SDS loading buffer (NEB). The samples were 
vortexed, heated to 95°C for 5 minutes and the proteins analysed by SDS-
polyacrylamide gel electrophoresis and western blotting (Section 2.2.24). 
2.2.27 Maintenance of fly stocks 
Flies stocks were maintained in vials or bottles containing Dundee Food (Table 
2.1.4) at 25°C. All crosses were carried out at 25°C unless otherwise stated. 
2.2.28 Embryonic and pupal hatching frequencies 
Adult flies containing the homozygous lethal allele over a balancer chromosome 
were placed in a population cage with a detachable apple juice plate (Table 2.1.4). 
The caged flies were allowed to mate for 24 hours, after which 100 embryos were 
carefully removed and aligned on a new apple juice plate. The embryos were then 
left to develop for a further 48 hours. The number of unhatched embryos were 
counted and the % hatched determined. 
Adult flies containing the homozygous lethal allele over a balancer chromosome 
were mated and the progeny allowed to develop. At third instar stage, 50 larvae were 
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carefully transferred to fresh vials containing Dundee Food (Table 2.1.4). The larvae 
were left for 48 hours to pupate and eclose. The pupal lethals were counted and the 
% pupated determined. 
2.2.29 Fixation of wholemount tissues 
Embryos were collected from a large population cage containing a detachable apple 
juice plate (Table 2.1.4). The plate was removed and the embryos were rinsed into a 
microsieve with d1420 using a small paintbrush. The embryos were then 
dechorionated in 50% bleach for 3 minutes and placed into a scintillation vial 
containing 50% heptane, 3.7% formaldehyde in PBS (Table 2.1.1). Embryos were 
fixed for 20 minutes, the formaldehyde removed and 2 volumes of methanol were 
added. The vial was shaken vigorously and allowed to stand for 30 seconds. The 
devitellinised embryos settled onto the bottom of the vial and were transferred to an 
eppendorf, washed twice in methanol and stored in methanol at -20°C. 
Third instar larvae were isolated from bottles containing Dundee Food and washed in 
PBS (Table 2.1.1) to remove excess food. Individual larvae were then transferred to a 
chilled watchglass containing PBS and the imaginal discs were dissected. Discs were 
fixed in 3.7 % formaldehyde in PBS for 1 hour with gentle shaking. The excess fix 
was then removed by rinsing 3 x 5 minutes in PBS-Tw (Table 2.1.1). Larval discs 
were progressively dehydrated through an ethanol series of 5 minute washes 
containing 30%, 50%, 70% ethanol in PBS-Tw respectively and stored in absolute 
ethanol at -20°C. 
Newly eclosed flies were fattened for 3 days in bottles containing Dundee Food 
supplemented with fresh yeast. Ovaries from adult females were dissected in PBS 
(Table 2.1.1) and fixed in 3.7 % formaldehyde in PBS for 20 minutes. The excess fix 
was removed by washing 3 x 5 minutes in PBS-Tw (Table 2.1.1) and the ovaries 
were placed in methanol and stored at -20°C. 
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2.2.30 DAPI staining of ovaries 
Formaldehyde fixed ovaries were washed 3 x 10 minutes in PBS-Tw (Table 2.1.1) 
and DNA stained with 0.1 /Lg/ml of 4, 6-diarnidino-2-phenylindole (DAPI) for 3 
minutes. The ovaries were then mounted in vector shield and analysed by 
fluorescence microscopy. 
2.2.31 Mounting and microscopy of wholemount tissues 
Embryos, larval discs, testes and ovaries were mounted in 80% glycerol in PBS-Tw 
(Table 2.1.1) for imaging. Fly wings were mounted in Hoyer's solution (30% (wlv) 
gum arabica, 85% (wlv) chloral hydrate, 20% (vlv) glycerol) and dried at 65°C with 
a lead weight placed on top. DIC and fluorescence images were observed using an 
Olympus AX-70 'Provis' fluorescence microscope and digital images were taken 
using a cooled Charge Coupled Device camera with Vysis QUIPS software. 
Fly eyes and thoraces were observed under an Olympus SZH1O light microscope and 
digital images were captured using an Olympus C-2020Z camera. 
Flies prepared for scanning electron microscopy (SEM) were desiccated in silica gel 
and mounted on stubs. The stubs were subsequently coated with gold by John 
Findlay (University of Edinburgh) and the specimens examined using SEM. 
2.2.32 P-element mediated transformation 
Three micrograms of recombinant pUAST (Table 2.1.8) was mixed with 1 pg of 
transposase, pA2-3 (Table 2.1.8). The DNA was precipitated by mixing with 2.5 
volumes of absolute ethanol containing 0.1 volumes of 3 M NaOAc, pH 5.2 and 
freezing for 20 minutes at -70°C. DNA was then pelleted by centrifuging at 14, 000 
rpm for 10 minutes at 4°C. The pellet was washed with 70% (vlv) ethanol, dried 
under vacuum for 5 minutes and resuspended in 10 1d of Injection buffer (5 mM 
KC1 and 0.1 mM phosphate buffer, pH 6.8). Prior to loading a femtotip injection 
needle (Eppendorf), the DNA was briefly centrifuged to remove any debris. The 
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loaded needle was then carefully mounted in the micro-manipulator apparatus set up 
in the 18°C constant temperature room. 
Freshly eclosed w" adults were fattened for 3 days in bottles containing Dundee 
Food supplemented with fresh yeast. Flies were then transferred into a large 
population cage with a detachable apple juice plate (Table 2.1.4) and placed at 18°C. 
Newly laid embryos were collected every hour on an apple juice plate, washed with 
dH2O and dechorionated in 50% bleach for 3 minutes. After a brief rinse in dH20, 
approximately 50 embryos were lined along the edge of an agar strip with the 
posterior ends orientated just over the edge of the strip. The line of embryos was then 
transferred to the edge of a coverslip coated with heptane glue. The coverslip was 
secured on a glass slide with a drop of halocarbon oil, series 900 (Halocarbon 
Products Company) and desiccated in silica gel for approximately 3 minutes at room 
temperature. After this time, the embryos were covered with halocarbon oil, series 
700 (Halocarbon Products Company) and mounted on the stage of the micro-
manipulator apparatus for injection. 
DNA was injected into the posterior pole of pre-blastoderm embryos. Embryos at 
later stages of development were destroyed by tearing the vitelline membrane. The 
injected embryos were covered with halocarbon oil, series 900 (Halocarbon Products 
Company) and allowed to develop at 18°C for 2 days. After hatching, first instar 
larvae were transferred into vials containing Dundee food (Table 2.1.4) and 
incubated at 25°C until eclosure. Individual flies were subsequently crossed to w"8 
males or virgin females and the progeny were screened for transformants containing 
coloured eyes. As a result, homogenous stocks were established and the transgene 
insertion was genetically mapped. 
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CHAPTER 3 
Characterisation of DmCBC 
3.1 INTRODUCTION 
The Drosophila melanogaster homologue of CBP20 was initially identified in a 
TBLASTN search of the BDGP nucleotide sequences using the HsCBP20 peptide 
sequence. This identified a 330 nucleotide sequence tagged site (STS), Dm1885 that 
showed strong homology to the amino-terminal fragment of HsCBP20 (Joe Lewis, 
unpublished data). Interestingly, Dm1885 was also found to be associated with the 
lethal P-element insertion P(lacZ rf )l(3)05697. Chapter 4 subsequently describes 
how P(lacZ ry)1(3)05697 was mobilised to generate excision alleles in DmCBP20. 
A fragment corresponding to Din 1885 sequence was PCR amplified from embryonic 
cDNA and used to probe a third instar larval library for full-length cDNAs (Joe 
Lewis, unpublished data). As a result, the full-length cDNA for DmCBP20 was 
isolated and found to be 604 bp in length. 
Similar to DmCBP20, the Drosophila melanogaster homologue of CBP80 was 
identified by using the HsCBP80 peptide sequence in a TBLASTN search of the 
BDGP database. This identified the STS, Dm84H4T that showed high homology to 
amino acids 249-345 of HsCBP80 (Joe Lewis, unpublished data). Likewise, the 
sequence corresponding to Dm84H4T was PCR amplified from adult fly genomic 
DNA and used to screen a third instar larval library for full-length cDNAs (Joe 
Lewis, unpublished data). A full-length cDNA for DmCBP80 was isolated and found 
to be 3, 224 bp in length. 
Searches of FlyBase revealed that apart from one P-insertion in DmCBP20, no 
known mutant alleles for either DmCBP20 or DmCBP80 have been described to 
date. Initial biochemical studies using the Drosophila cap-binding proteins showed 
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that DmCBC behaves in a manner analogous to HsCBC. Co-expression of 
DmCBP20 and DmCBP80 in Sf9 cells results in a stable heterodimeric CBC that 
specifically binds the cap structure. In addition, either subunit on its own does not 
exhibit detectable cap-binding activity unless complexed together to form an active 
CBC (Izaurralde et al., 1994 and Joe Lewis, unpublished data). 
The principal aims of this thesis were to firstly, use Drosophila melanogaster as a 
tool to identify CBC-interacting genes and secondly, determine whether CBC is 
required for fruit-fly development. In order to achieve this, it is important to 
commence with an initial characterisation of CBC in Drosophila melanogaster. As a 
result, this Chapter primarily analyses the DmCBC sequence data available along 
with the expression of DmCBC RNA throughout fruit-fly development. 
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3.2 RESULTS 
3.2.1 Gene structure and mapping of DmCBP20 and 
DmCBP8O 
The gene structure for both DrnCBP20 and DrnCBP80 as predicted by Genescan is 
presented in Figure 3.1. DmCBP20 consists of three exons, which span 746 bp of 
genomic DNA with two short introns that are 88 bp and 90 bp in length. The 
Bloomington stock, P(lacZ ry)1(3)05697 contains a P-element inserted into the 5' 
non-coding region of the first exon, 8 bp upstream of the initiation methionine 
(Figure 3.1, A). The chromosomal location of DmCBP20 was mapped to the right 
arm of chromosome 3 on polytene segment 90E1-2 by in situ hybridisation on 
polytene chromosome squashes using 1(3)0569 7 as a probe (Alan Spradling). In 
contrast to DrnCBP20, the gene structure of DrnCBP80 is relatively complex (Figure 
3. 1, B). DmCBP80 contains seven exons and six introns that encompass 8, 299 bp of 
genomic DNA. To date, no P-elements insertions have been identified within the 
DrnCBP80 locus. DmCBP80 has been mapped to 4C7-8 on the X-chromosome by 
both the BDGP and in situ hybridisation on polytene chromosomes using DmCBP80 
cDNA as a probe (Joe Lewis, unpublished data). 
Figure 3.1 Gene Structure and Mapping 
of DmCBP20 and DmCBP80 
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Figure 3.1 Gene structure and chromosomal locations of DmCBP20 and 
DmCBP80. Schematic representation of gene structures as predicted by 
Genescan and chromosomal mapped regions. A. DmCBP20 is mapped to 
right arm of chromosome 3 on polytene segment 90E1-2 by in situ 
hybridisation on polytene chromosomes using 1(3)05697 as a probe (Alan 
Spradling). DmCBP20 has three exons depicted by rectangles and two introns 
represented by black lines, which span a total of 746 bp genomic DNA. P-
element P(IacZ rt)I(3)05697  is inserted into the 5' non-coding region of the 
first exon, 8 bp upstream of the initiation methionine. B. DmCBP80 is mapped 
to 4C7-8 of X-chromosome by both the BDGP and in situ hybridisation on 
polytene chromosomes using DmCBP80 cDNA as a probe (Joe Lewis, 
unpublished data). DmCBP80 has seven exons and six introns that span a 
total of 8, 299 bp genomic DNA. Start of transcription unit is depicted by black 
arrow along with poly(A) sites. Translation unit is outlined by start and stop 
annotations.  
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3.2.2 Drosophila melanogaster and human CBP20 and CBP80 
homologues are strongly conserved 
To determine whether Drosophila melanogaster is a suitable model by which to 
study the biology of CBC in vivo, it is important to compare the predicted amino acid 
sequences of human and Drosophila cap-binding proteins. The conceptual protein 
product of DmCBP20 is 154 aa in length compared with 156 aa for HsCBP20. Figure 
3.2, A clearly shows that DmCBP20 is highly conserved throughout its length to 
HsCBP20 exhibiting 78% identity and 88% homology. Extensive homology is 
particularly apparent within the RNA-binding domain that is comprised of two RNP 
motifs and the carboxyl-rich RGG tail, which is thought to stabilise the interaction 
between CBC and the cap (Birney et al., 1993; Burd and Dreyfuss, 1994; Mazza et 
al., 2001). In contrast, more sequence divergence and length heterogeneity is 
observed between the amino-terminals of human and Drosophila CBP20 proteins. 
Similar to DmCBP20, DmCBP80 shows strong conservation to its human 
homologue. The conceptual translation of DmCBP80 is predicted to encode a 
polypeptide that is 800 aa compared with 790 aa for HsCBP80. As can be observed 
from Figure 3.2, B, there is a high level of identity and similarity between DmCBP80 
and HsCBP80 throughout their length at 57% and 75% respectively. Both DmCBP80 
and HsCBP80 have a predicted bipartite NLS at the amino-terminus (Mattaj, 1993; 
Izaurralde et al., 1994). This NLS has been shown to be functional in humans since 
mutation of this sequence inhibits the nuclear import of HsCBP80 (Izaurralde et al., 
1995). In the absence of HsCBP80, HsCBP20 is not actively transported into the 
nucleus. This suggests that the NLS is required for the active nuclear import of CBC. 
In addition, DmCBP80 contains the recently described MIF4G domain that 
represents significant sequence similarities between the middle portion of eIF4G and 
domains in NMD2/Upf2 and CBP80 (Ponting, 2000; Mazza et al., 2001). Although 
the functional significance of this domain is currently unknown, the MIF4G domain 
is thought to mediate protein-protein interactions during NMD (Ishigaki et al., 2001). 
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Figure 3.2 Sequence alignments of CBP20 and CBP80 homologues. 
A. Conceptual translation of DmCBP20 (Q9V3L6) aligned to HsCBP20 
(P52298) using Clustal X (Thompson etal., 1998). The highly conserved RNA-
binding domain comprised of two RNP motifs is indicated along with the 
arginine-glycine (RGG) rich carboxyl-domain. B. Conceptual translation of 
Drosophila me!anogaster DmCBP80 (Q91-1980) compared to Homo sapiens 
HsCBP80 (009161). The conserved MIF4G domain is presented boxed. 
Identical and related amino acids are illustrated by (*) and () respectively. (:) 
indicates similar amino acids and discontinuities in the alignments are 
represented by dashes. Blue represents hydrophobic/ aromatic amino acids. 
Orange depicts basic and glycine residues. Purple shows acidic amino acids. 
Green and yellow illustrates hydrophilic and proline residues respectively. 
Significance of DmCBP80R sequence is referred to in Chapter 5. 
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Collectively, this data shows both DmCBP20 and DmCBP80 are highly homologous 
to the corresponding human proteins. This strongly suggests that CBC function 
might also be conserved between Drosophila and human species. 
3.2.3 DmCBP20 and DmCBP80 mRNAs are ubiquitously 
expressed throughout development 
As a first step to characterising DmCBC, northern analysis was used to determine at 
which stages in Drosophila development DmCBP20 and DmCBP80 transcripts were 
expressed. Total RNA was extracted from staged embryo collections, three larval 
instars, adult flies and isolated ovaries. The amounts of total RNA were normalised 
to the level of ribosomal RNAs (rRNAs) and analysed by northern blotting (Figure 
3.3, lowest panel). Full-length DrnCBP20 and DmCBP80 cDNAs were then used to 
probe the developmental northern and exposed overnight. As can be observed from 
Figure 3.3, single transcripts for both DmCBP20 and DmCBP80 were observed at 
the predicted mRNA size of approximately 600 bp and 3.3 Kb respectively. In 
addition, DrnCBP20 and DmCBP80 mRNAs were found to be expressed throughout 
Drosophila development with both subunits showing similar steady state levels at the 
same stages. The rRNA doublet bands observed in lanes 8 and 9 were due to the 
specific cleavage of the large ribosomal subunit RNA (lowest panel). 
Figure 3.3 shows that high levels of DmCBP20 and DmCBP80 mRNAs exist in the 
early embryo (lane 1). The steady state levels of both RNAs decrease as 
embryogenesis proceeds (lanes 2-5) with the lowest levels being observed in first and 
second larval instars (lanes 6 and 7). The mRNA steady state levels increase again in 
third instar larvae, adult male and female stages (lanes 8-10). Most notably, adult 
females show higher steady state levels for DmCBP20 and DmCBP80 mRNAs than 
adult males. To determine whether this enrichment of mRNA was due to ovarian 
expression, ovaries were dissected from mature adult females and the RNA 
extracted. 
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Figure 3.3 DmCBP20 and DmCBP80 mRNAs are expressed throughout 
development. Developmental northern analysis of DmCBP20 and DmCBP80 
transcripts. Staged embryos were collected and matured for the following time 
points: 0-4 hours, 4-8 hours, 8-12 hours, 12-16 hours, and 16-22 hours along 
with first, second and third instar larvae, adult males and females and isolated 
ovaries. Total RNA was extracted under denaturing conditions and resolved 
by northern blotting. Nitrocellulose filters were probed with either full-length 
DmCBP20 or DmCBP80 cDNA as indicated and exposed. Single transcripts 
were observed for DmCBP20 and DmCBP80 at approximately 600 bp and 33 
Kb respectively. 10 ILg of RNA per lane was loaded as judged by ethidium 
bromide staining of ribosomal RNA5 (rRNAs). As an additional loading control, 
the filter was re-probed with full-length ribosomal protein, DmRp49 cDNA. 
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Northern analysis showed that the signals for DmCBP20 and DmCBP80 were indeed 
elevated in ovarian RNA compared to total female RNA suggesting that the 
components of DmCBC are maternally derived (compare lanes 10 and 11). As an 
additional loading control, the nitrocellulose membrane was re-probed using full-
length cDNA from the ribosomal protein, DrnRp49 that is highly expressed 
throughout Drosophila development (third panel). 
The next question to address was whether DmCBP20 and DmCBP80 mRNAs were 
expressed ubiquitously or restricted to specific cell types/ tissues in fruit-fly 
development. To test this, RNA in situ hybridisation was used to detect DmCBP20 
and DmCBP80 RNAs during oogenesis, embryogenesis and selected third instar 
larval imaginal discs. Full-length DmCBP20 and DmCBP80 cDNAs were used to 
generate DIG-labelled anti-sense RNA that specifically detects mRNA and sense 
RNA, which serves as a negative control. DmCBP20 and DmCBP80 DIG-labelled 
RNA probes were hybridised to fixed ovarioles, staged embryo collections and eye-
antenna, haltere, brain, leg and wing imaginal discs. As can be observed from Figure 
3.4, DmCBP20 and DmCBP80 mRNAs were expressed ubiquitously throughout 
oogenesis, embryogenesis and larval leg and wing imaginal discs. In keeping with 
the results from the developmental northern, both cap-binding proteins showed 
similar expression patterns in the same tissues. No mRNA expression was observed 
in the controls that used sense DmCBP20 and sense DmCBP80 as probes. This 
suggested that the staining detected was specific for DmCBP20 and DmCBP80 
mRNAs (data not shown). 
Figure 3.4 shows that DmCBP20 and DmCBP80 mRNAs were detected in all 
ovarian tissues (Panel A, [i] and [ii]). Furthermore, the expression levels of RNAs 
encoding both subunits appears to steadily increase as oogenesis proceeds posteriorly 
towards the mature egg. Staining is lowest in the germanium and earliest egg 
chambers staged around 2-4. Detection levels appear to increase as the egg chambers 
mature with the highest levels being observed in the later stages of oogenesis, around 
stage 11. This is consistent with the time mRNA is deposited from the nurse cells 
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into the developing oocyte. These data taken together with the northern analysis 
strongly support a maternal contribution of both cap-binding proteins. 
DmCBP20 and DmCBP80 RNAs were also distributed ubiquitously in early, middle 
and late staged embryos (Panel B, [i]-[vi]). The intense staining observed in the germ 
band extension and central nervous tissue of middle and late staged embryos 
respectively was deemed non-specific since these tissues also preferentially localised 
sense RNA probe (Panel B, [iii]-[vi] and data not shown). Likewise, RNA in situ 
hybridisation performed on selected imaginal discs of third instar larvae showed that 
DrnCBP20 and DmCBP80 RNAs were not restricted to specific tissues or cells. The 
ubiquitous staining observed in leg and wing discs was also found to be 
representative for the other eye-antenna, haltere and brain imaginal discs examined 
(Panel C, [i]-[iv] and data not shown). 
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Figure 3.4 DmCBP20 and DmCBP80 mRNAs are ubiquitously expressed 
in development. RNA in situ hybridisation performed on fixed A. ovarioles B. 
early [i-i], middle [iii-iv] and late [v-vi] staged embryos C. third instar larval 
leg and wing imaginal discs. DmCBP20 and DmCBP80 mRNAs were detected 
using DIG-labelled anti-sense RNA. 
r 3 Characterisation of DmCBC 
3.3 DISCUSSION 
3.3.1 Drosophila melanogaster and human CBP20 and CBP80 
homologues are strongly conserved 
Comparison of the conceptual protein products of DmCBP20 and DmCBP80 show 
they are highly homologous to the corresponding human proteins. CBP80 
homologues share a high degree of conservation throughout their length. Both have 
the bipartite NLS that is functionally required for the nuclear import of HsCBP80, in 
addition to the recently described MIF4G domain that implicates CBP80 in NMD 
(Izaurralde et al., 1995; Ponting, 2000; Ishigaki et al., 2001). In comparison to 
CBP80, Drosophila and human homologues of the smaller subunit appear to be more 
extensively conserved. CBP20 homologues share the conserved RBD along with the 
carboxyl-terminal RGG tail that is thought to stabilise the interaction between CBC 
and capped RNA (Birney et al., 1993; Burd and Dreyfuss, 1994). This is consistent 
with CBP20 having a phylogenetically conserved functional role in binding capped 
RNA (Mazza et al., 2001). 
Taken together, the protein sequence data strongly suggests that CBC function might 
also be conserved between Drosophila and human species. Indeed, the role of CBC 
in at least pre-mRNA splicing is conserved between yeast and humans. In splicing, 
CBC increases the efficiency of Ui snRNP binding to the cap-proximal 5' splice site. 
This enhances commitment! E complex assembly and consequently the rate of 
splicing of the cap-proximal intron (Izaurralde et al., 1994; Lewis et al., 1996). 
However, a striking difference between these two species is that in yeast CBC 
interacts specifically and directly with the components of Ui snRNP. In contrast, the 
mechanism of CBC action is currently unknown in mammals. The interaction 
between HsCBC and Ui snRNP appears to be indirect and mediated by yet 
unidentified adaptor molecules. There is extensive conservation between the 
components of the spliceosome in vertebrate and Drosophila systems (Mount and 
Salz, 2000). In addition the complexity of splicing, as well as other RNAP II 
processing events such as RNA 3'-end formation, appear to be similar between 
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Drosophila and mammals. This strongly suggests that Drosophila would be a model 
system for dissecting the biology of CBC in vivo. 
3.32 DmCBP20 and DmCBP80 mRNAs are ubiquitously 
expressed throughout development 
Results from the northern analysis indicate that single transcripts exist for DmCBP20 
and DmCBP80. As expected from the components of a heterodimer that are only 
functional as a complex, the expression pattern of both transcripts parallel each other 
throughout the Drosophila developmental stages. In addition, RNA in situ analysis 
shows that DmCBP20 and DmCBP80 mRNAs are distributed ubiquitously and not 
restricted to specific tissues. This is consistent with CBC playing a key role in RNAP 
II transcript metabolism of all cells in Drosophila development. 
Elevated levels of DmCBP20 and DmCBP80 mRNAs exist during oogenesis and 
early embryogenesis, which suggests both subunits are maternally derived. A 
maternal contribution is further corroborated by RNA in situ analysis, which shows 
CBC expression to progressively increase as oogenesis proceeds until they are 
deposited from the nurse cells into the maturing oocyte. The high levels of 
DmCBP20 and DmCBP80 RNAs during early development might reflect a greater 
requirement for CBC in general RNA metabolism during the accelerated cell cycles 
at these stages. This profile matches that of other genes that participate in RNAP II 
transcript processing such as the splicing factors sans fille and noisette (Flickinger 
and Salz, 1994; Meyer et al., 1998). Alternatively, it might indicate that either or 
both cap-binding subunits have novel functions during early Drosophila 
development. 
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3.4 CONCLUSIONS 
Initial characterisation of DmCBC suggests Drosophila melanogaster is a good 
model organism for understanding the mechanisms and functions of CBC. 
DmCBP20 and DmCBP80 mRNAs are ubiquitously expressed in all tissues 
throughout Drosophila development. Apart from one P-element in DrnCBP20, no 
known alleles have been described for either cap-binding protein to date. 
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CHAPTER 4 
P-element induced mutagenesis of DmCBP20 
and DmCBP80 
41 INTRODUCTION 
The results from the previous Chapter have shown that both CBP20 and CBP80 are 
highly conserved between Drosophila melanogaster and human species. This 
suggests that the function of CBC might also be evolutionarily conserved. In 
addition, DmCBP20 and DmCBP80 mRNAs are ubiquitously expressed in all tissues 
throughout fruit-fly development. Elevated levels of both subunits exist in the 
earliest stages of development, which suggests a greater requirement for CBC during 
these stages. It is possible that DrnCBC plays a general role in RNAP II transcript 
metabolism or alternatively, either/ both subunits might have novel functions in early 
development. In order to address this, mutants in the CBC heterodimer can be 
analysed to study the biology of CBC in vivo and determine whether novel functions 
of CBC exist in Drosophila development. 
Searches of FlyBase indicated that apart from one P-insertion in Din CBP2O, no 
known mutant alleles in DmCBP20 and DmCBP80 have been described to date. As a 
result, various physical and chemical mutagenesis strategies were considered by 
which to create mutants alleles in DmCBP20 and DmCBP80. Since a P-element 
already resides within the DmCBP20 locus, it was reasoned that P-element induced 
mutagenesis would be a straightforward method of generating mutants in the CBC 
heterodimer. 
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In Drosophila, the primordial P-element is a transposable element that can catalyse 
its own excision and insertion events within the genome. However, the activities of 
the P-element have been separated into two distinct genetic elements that either 
contain the transposable or the transposase activity. The transposable element is 
defective in the production of transposase but contains the inverted terminal repeats 
necessary for its own transposition. In contrast, P(ryA2-3) encodes the transposase 
source required to catalyse movement but is itself stably integrated into the genome 
(Robertson et at., 1988). In order to mobilise the transposable element within the 
genome, genetic schemes can be designed whereby both the transposable element 
and P(iyA2-3) are expressed in the male or female germline. 
P-element transposition is a useful tool by which to create mutations in a particular 
gene. P-elements can be mobilised to generate new insertions in a gene of interest by 
local hopping. Alternatively, an existing P-insertion can be excised to produce 
additional mutant alleles. Local hopping describes the phenomenon whereby P-
elements once mobilised, preferentially re-insert close to or within 200 Kb of their 
original insertion site (Tower et at., 1993; Zhang and Spradling, 1993). 
Consequently, local hopping has been successfully used to transpose nearby P-
elements into a gene of interest to create P-element induced alleles (Littleton et at., 
1993; Segalat et at., 1992). Not only are P-elements transposed to new chromosomal 
locations but P-element excision can also produce new alleles. Figure 4.3, B 
illustrates the different excision alleles generated by P-element mobilisation. In 
summary, precise excision of the P-element results in alleles of the wild-type 
genomic sequence. Whilst imprecise excision alleles have portions of genomic 
sequence deleted or alternatively, contain residual P-element sequences. 
The aim of this Chapter was to use P-element induced mutagenesis to create 
mutations in the cap-binding components of the CBC heterodimer. The generation of 
such mutants might uncover novel functions of CBC in fruit-fly development. P-
element induced mutagenesis was used to firstly, create P-insertion alleles of 
DmCBP80 by local hopping. And secondly, to generate DmCBP20 excision alleles 
by mobilising the P-element residing within the DmCBP20 locus. 
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4.2 RESULTS 
4.2.1 Generating P-insertions in DmCBP80 
Since no known mutant alleles have been described for DmCBP80 to date, P-element 
induced mutagenesis was used to create lesions in DmCBP80. Searches of all the 
known P-element lines on FlyBase revealed that no P-elements were found in the 
DmCBP80 locus. Therefore, the strategy employed was to generate P-insertion 
alleles of DrnCBP80 by local hopping. In order to isolate P-insertions in DmCBP80, 
a local mutagenesis strategy was designed to transpose a nearby P-element into 
DinCBP80, which is mapped to polytene segment 4C7-8 on the X-chromosome. The 
starter-element used for the local transposition was the homozygous viable line 
P(lacW w+)bix'35.  P(lacW  w+)biv35  is inserted into the 5' non-coding region of the 
gene bifid (bi) that is mapped to 4C2-3. The starter-element is located approximately 
220 Kb from DinCBP80 and therefore has a good chance of re-inserting into the 
DmCBP80 locus by local hopping (Tower et al., 1993; Zhang and Spradling, 1993). 
It is important to note that at the time this P-hop was performed, Din CBP2O was 
identified as an essential gene. As a result, the Din CBP8O P-mutagenesis screen was 
based on the assumption that like CBP20, CBP80 was also an essential gene in 
Drosophila. 
A genetic scheme was subsequently designed to recover homozygous lethal insertion 
alleles of P(lacW w)bi' 35 (Figure 4.1). P(lacW w)bi'35 is genetically marked with 
white (w) and adults have white eyes that are orange equatorial to the polar tips. To 
mobilise the P-element, P(lacW w+)bix'35  was crossed with the transposase source 
P(ryA2-3) and the Fl progeny scored for coloured eyes. New P-insertions were 
identified by eye colours that differed from P(lacW w+)bix35  and ranged from light 
orange to red due to different chromosomal insertion positions. Whilst the Fl 
progeny that had white eyes were discarded since they represented lines where the P-
element had excised and not re-inserted. 
Figure 4.1 Generating P-insertions in 
DmCBP80 by Local Hopping 
FO 
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Figure 4.1 Genetic scheme for generating P-insertions in DmCBP80 by 
local hopping. Homozygous viable P(IacW w)bP'35 was mobilised and new 
homozygous lethal P-elements on the X chromosome screened for insertions 
in DmCBP80. FO. P(IacW w1 )bP<'35 is inserted into bifid located approximately 
220 Kb from DmCBP80. P(IacW w)bP'35 is marked with white and adult have 
white eyes that are orange equatorial to polar tips. P(IacW w4)bP 35 virgins are 
mated to males carrying transposase activity P(ry+A2-3) marked with stubble. 
Fl. Male progeny with coloured eyes and stubble contain both P(IacW 
w)bP 35 and transposase activity. They are mated to homozygous balancer 
FM6 virgins. F2. Progeny carrying bar eyes with different eye colours from 
P(IacW w)bP 35 contain new P-insertions (indicated by asterisk). They are 
crossed with FM6 balancer flies. F3. Progeny scored for hemizygous X-linked 
lethal P-insertions and heterozygous balanced stocks established. X-linked 
lethals are then tested for complementation with Df(1)bi-D3, which uncovers 
DmCBP80 and analysed by southerns. 
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Upon mobilisation of P(lacW w)bi"35 in a total of 500 independent lines, 280 lines 
(56%) were found to contain new chromosomal P-insertions. Since DmCBP80 was 
assumed to be essential, these lines were subsequently screened for homozygous 
lethal insertions on the X-chromosome. The remaining 220 lines were found to have 
white eyes, indicating that the P-element had excised to generate a deletion in the 
white gene. The X-linked homozygous lethal insertions were then tested for lesions 
in or near the DinCBP80 locus by complementation with Df(1)bi-D3. A total of 10 
lines (2%; 10 from 280) failed to complement Df(J)bi-D3. These 10 X-linked lethal 
lines were then recovered in the absence of the transposase activity and the P-
insertions characterised by southern analysis. Genomic DNA was extracted from the 
X-linked lethal balanced lines and digested with Barn HI to release DmCBP80 
genomic fragment. DNA was then resolved by southern blotting and the filters 
probed with full-length DmCBP80 cDNA and exposed (data not shown). This 
determined that none of the X-linked homozygous lethal insertions were found to 
reside within the DmCBP80 locus. 
The local hopping strategy was not successful in generating a P-element induced 
allele of DniCBP80. P-element insertional mutagenesis might have failed either 
because not enough flies were screened or the assumption that P-insertions in 
DrnCBP80 would be homozygous lethal was incorrect. Alternatively, DrnCBP80 
might not be readily mutable by P-elements. P-element induced mutagenesis is 
unpredictable, P-elements are found to preferentially insert in some loci and rarely in 
others. However, what defines certain loci as hot spots for P-insertions and others as 
not is currently unknown. 
4.2.2 Generation of P(IacZ ry)I(3)05697 excision alleles 
The amino-terminal fragment of Din CBP2O was originally identified as the STS, 
Dm1885 that is associated with the homozygous lethal P-insertion P(lacZ 
ry)1(3)05697 (Alan Spradling). Comparison of Dm1885 with the DmCBP20 cDNA 
sequence showed that P(lacZ ry)1(3)O5697 is inserted into the 5' non-coding region 
of the first exon, 8 bp upstream of the initiation methionine (Figure 4.3, A). 
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Characterisation of P(lacZ ry)1(3)05697 using embryonic and pupal hatching 
frequencies staged the lethality of homozygous mutants to either first or second 
larval instar stages (data not shown). In order to test whether the P-insertion in 
DmCBP20 was the cause of lethality and also generate P-excision alleles, P(lacZ 
ry)1(3)05697 was mobilised. A genetic scheme was subsequently designed to 
recover both imprecise and precise excision alleles of P(lacZ ry) 1(3)0569 7 (Figure 
4.2). P(lacZ rf) 1(3)05697 is genetically marked with rosy (rf), therefore the 
presence of the P-element can be followed by iy eye colour. P(lacZ ry) 1(3)0569 7 
was transposed by crossing with transgenic flies expressing P(ry42-3) transposase 
activity. P(lacZ rf) 1(3)05697 excision alleles were subsequently identified by non-
rosy eyes and recovered in the absence of the P-element. 
In summary, P(lacZ iy) 1(3)05697 was transposed in 232 independent lines. This 
generated 69 homozygous viable excision lines, of which 2 lines (3%) were male and 
female sterile, 31 lines (45%) were male sterile and 36 lines (52%) were revertants to 
wild-type DmCBP20. The remaining 163 homozygous lethal excision lines were 
shown to either have residual P-element sequences or deletions in DmCBP20 gene 
locus (Figure 4.3, B and Q. Finally, no temperature sensitive lines were found at 
29°C. 
4.2.3 CBP20 is an essential gene in Drosophila melanogaster 
Upon the mobilisation of P(lacZ rt)1(3)05697  in a total of 232 independent lines, 
163 imprecise excision lines (70%) were found to be homozygous lethal 
(Dn7CBP20t11) (Figure 4.3, C). All 163 DmCBP20111 alleles failed to be 
complemented by either the starter-element P(lacZ ry)1(3)05697 or Df(3R)P14 sr', 
which uncovers the DmCBP20 locus (data not shown). These results suggest that all 
163 DmCBP20111 lines had P-element induced lesions that resided within the 
DmCBP20 locus. It was therefore reasoned that these mutations were probably due to 
either deletions in Din CBP2O genomic sequence or residual P-element sequences. 
M. 
Figure 4.2 Generation of P(lacZ ry4 )I(3)05697 
excision alleles 
FO 
w± P(lacZ ry)1(3)05697 
w,+, 	TM3Sb 
P(ryLt2-3) Sb 
X 	CyO, TM6 Ubx bx ry e 
Select  stubble males 
with rosy eyes 
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w;+;P(ry2-3) Sb 
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Figure 4.2 Genetic scheme for generating excision alleles of P(IacZ r) 
1(3)05697. Homozygous lethal P(lacZ ry)I(3)05697 located in the first exon of 
DmCBP20 was mobilised and excision alleles screened for mutations in 
DmCBP20. FO. P(lacZ ty)1(3)05697 virgins are mated to males carrying 
transposase activity P(ry+zi2-3) marked with stubble. Fl. Male progeny with 
rosy eyes and stubble contain both P(lacZ nt)I(3)05697  and transposase 
activity. They are mated to double balancer TM2/ TM6 virgins. F2. Progeny 
with non-rosy eyes represent lines where the P-element has excised 
(indicated by asterisk). The excision lines are then tested for complementation 




Figure 43 Mobilisation of P(IacZ nf)I(3)05697  










- 	Excision Alleles Number of Lines 
A. Homozygous viable 69 
Female sterile 2 
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Revertants 36 
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Figure 4.3 Mobilisation of P(IacZ ry)I(3)05697. A. Schematic 
representation of DmCBP20 gene structure with positions of primers used for 
characterisation of P(IacZ ty')I(3)05697 excision lines. B. P-element 
mobilisation generates four distinct classes of mutations: [i] P-element re-
inserts in a new chromosomal location. [ii] P-element excises precisely from 
insertion site. Imprecise excisions generate lesions within P-insertion site that 
[iii] contain residual P-element sequences or [iv] delete portions of the 
genomic sequence. C. Summary of excision lines generated from mobilisation 
of P(IacZ iy1)I(3)05697.  
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To differentiate between deletion and P-element retention mutations, a mass PCR 
screen was employed to primarily detect DmCBP20111 alleles that contained residual 
P-element sequences. Figure 4.3, A illustrates schematically the primer pair (oligos 
S264 + S265) designed to amplify across 445 bp of DmCBP20 around the P(lacZ 
rf)1(3)05697 insertion site. Genomic DNA was extracted from all 163 
DnlCBp20hlL/ TM3 lines and used in a standard Taq PCR reaction. The PCR 
products were subsequently resolved and analysed on 3% nusieve gels (Appendix 
A). This allowed the detection of Dn2CBP20F!  lines containing residual P-element 
sequences, since one wild-type band from the balancer chromosome was amplified 
along with a band from DmCBP20'11 chromosome. In order to substantiate that the 
PCR amplified bands did correspond to wild-type and imprecise excision alleles, 
selected DNA bands were gel purified and sequenced (data not shown). 
The results from the PCR screen are presented in Appendix A. In summary, from 
163 DmCBP2O111 lines screened, 51 lines (31%) were identified as containing 
residual P-element sequences that ranged from approximately 25 to 1, 700 bp in size. 
It was reasoned that the remaining 112 lines either contained deletions in DmCBP20 
genomic sequence or very small residual P-element sequences that were not detected 
on the agarose gels. To test this, putative DmCBP20 deletion lines #1, #2 and #3 
were characterised by southern analysis. This confirmed that these DmCBP20111  
lines indeed contained small deletions in P(lacZ ry)1(3)05697 insertion site, which 
removed approximately 200 bp of genomic sequence (E. Thompson). 
Out of 163 DmCBP20JL  lines screened, 7 lines were selected for further analysis. 
They included the three deletion lines described above and P-element retention lines 
#6, #121, #16 and #65 that contained approximately 25, 100, 400 and 1, 700 bp of 
residual P-element sequences respectively. To determine the stage of lethality, 
embryonic and pupal hatching frequencies were performed and the lethal phase 
found to occur during the first or second larval instars. Moreover, closer examination 
of homozygous DmCBP20111 first instar larvae showed no obvious morphological 
of 
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defects when compared to wild-type larvae (data not shown). 
In order to verify that the lethality observed in homozygous DmCBP2611 ' mutants 
was due to the imprecise excision of P(lacZ ry)1(3)05697, rescue crosses were 
performed on the 7 selected DmCBP201J  lines. Two different DmCBP20 transgenes 
were constructed and over-expressed in flies. The first transgene expressed 
DmBP20 cDNA under the control of the constitutive armadillo promoter and the 
second transgene expressed DmCBP20 genomic fragment with its own promoter 
sequences. Transgenic lines over-expressing either DmCBP20 construct were crossed 
into DmCBP20t11' mutant background and the adult progeny scored for rescue of 
homozygous lethality. Both transgenes that expressed either DrnCBP20 cDNA or 
DmCBP20 genomic region generated viable adults homozygous for DmCBP20111 . 
Rescued flies expressing either transgene were phenotypically wild-type and fertile, 
which indicated that the rescue was complete. Furthermore, the rescue was 
independent of whether one or two copies of the transgene were present (data not 
shown). 
Taken together, these results suggest that CBP20 is an essential gene in Drosophila 
melanogaster. P(lacZ ry)1(3)05697 imprecise excision alleles either have small 
deletions or residual P-element sequences in the 5'UTR of DinCBP20 locus. These 
alleles appear to be hypomorphs and the mutations might affect the translation of 
DinCBP20. In order to confirm this, western analysis on staged embryos, first and 
second instar larvae of wild-type and homozygous Din CBP2OHL  mutants needs to be 
performed. This would be expected to show that in DmCBP20JJL  mutants, DmCBP20 
protein declines as development proceeds and the maternal contribution titrates out. 
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4.2.4 Testing for genetic interaction with DmCBP20" mutants 
After the initial characterisation of DmCBP2O111 , the next question to address was 
whether these mutants were useful tools to identify CBC-interacting genes. 
Therefore, a preliminary screen was performed where selected genes and deficiencies 
were tested for interaction with DrnCBP20111 . In particular, DmnCBP20111 #1 and #65, 
which have 200 bp of genornic sequence deleted and 1, 700 bp residual P-element 
sequence in the 5' UTR respectively, were selected for genetic analysis. Since 
DmnCBP20111 heterozygotes are phenotypically wild-type, they were crossed to 
selected alleles and Fl adult progeny scored for dominant phenotypes that included 
lethality, male/ female sterility and male:female ratio. The alleles tested for genetic 
interaction with DmnCBP2011 #1 and #65 included mutants in DmCBP80, RNAP II 
and third chromosome deficiency kit. 
Considering DmCBP20 and DmCBP80 must heterodimerise to form a functional 
CBC (Izaurralde et al., 1994), it was reasoned that an obvious gene to test for 
interaction with DmCBP20IL  would be its cap-binding partner DmCBP80. At the 
time these genetic interaction crosses were performed, the only available alleles in 
DinCBP80 were Df(])bi-D3, which uncovers the DmCBP80 locus and four 
transgenic lines that over-express DmCBP80 using the ubiquitous armadillo 
promoter. This determined that crossing DrnCBP80 alleles into the genetic 
background of either DmCBP20 11 #1 or #65 did not generate observable dominant 
adult phenotypes. 
Many lines of evidence have shown that RNAP II transcription is coupled in vivo to 
various mRNA processing events. Current evidence strongly supports a model 
whereby the CTD of the large subunit of RNAP II (RNAP II 215) not only recruits 
mRNA processing factors to nascent transcripts but also directly functions in RNA 
cap formation, pre-mRNA splicing and RNA 3'-end formation (Hirose and Manley, 
2000 and Chapter 1). Since CBC mediates the positive effects of the cap in splicing 
and RNA 3'-end formation, it was reasoned that CBC might also co-operate with the 
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CTD of RNAP II to facilitate these processes. As a result, DmCBP20111 #1 and #65 
were crossed to various alleles of the largest subunit of RNAP II listed in Appendix 
F. Similar to DmCBP80 alleles tested, the Fl adult progeny were viable and fertile 
exhibiting no dominant phenotypes. Finally, DmCBP2O11' #1 and #65 were crossed 
to a collection of deficiencies on the third chromosome. These deletions collectively 
uncovered approximately 65% of the third chromosome. However, no DrnCBP20-
interacting deficiencies were identified. 
Taken together, the data suggests that DmCBP2 eL  alleles were not ideal tools to use 
in screens for CBC-interacting genes. DmCBP20HL  heterozygote adults are 
phenotypically wild-type in appearance and do not provide a sensitised genetic 
background. As a result, the identification of CBC-interacting genes is limited by this 
strategy. 
4.2.5 DmCBP20 contributes to gametogenesis 
Mobilisation of P(lacZ ry)1(3)05697 in 232 independent lines generated 69 lines 
(30%) that were homozygous viable (Figure 4.3, Q. These excision lines were 
subsequently screened for temperature sensitivity at 29°C and male or female 
sterility. In order to test for temperature sensitivity at 29°C, homozygous viable lines 
were crossed to Df(3R)P14 sr' and the Fl progeny scored for viability at 25°C and 
29°C. This determined that none of the 69 homozygous viable lines were 
temperature sensitive at 29°C. Male or female sterility was assayed by crossing to 
wild-type Ore R adults and observing whether viable Fl adult progeny were 
generated. Surprisingly a very high number, approximately 45% (31 from 69 lines) 
of homozygous lines were found to be male sterile. In contrast, a relatively small 
number were identified as both male and female sterile (3%; 2 from 69). The 
remaining 36 homozygous lines (52%) were predicted to be precise excisions and 
therefore contain wild-type DmCBP20 sequences. To test this, genomic DNA was 
extracted from 6 randomly selected putative precise excision lines and full-length 
Din CBP2O genomic region was PCR amplified using oligos S264 and S265, gel 
purified and sequenced (data not shown). This confirmed that P(lacZ r/)1(3)05697 
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had precisely excised from the 5' UTR of DmCBP20 to generate a wild-type 
genomic sequence. 
4.2.6 Characterisation of DmCBP20M  mutants 
Out of 69 homozygous viable excision lines, two (3%) were initially identified as 
female sterile. However, further examination of homozygous males demonstrated 
that both lines were also male sterile. DmCBP20 male and female sterile 
(DmCBP20S) lines #54 and #84 were found to be lethal when crossed with Df(3R) 
P14 sr', which uncovers DmCBP20 locus (data not shown). In addition, both alleles 
failed to complement the original P-element, P(lacZ ry)1(3)05697. As a result, 
DmCBP201 #54/ P(lacZ ry)1(3)05697 progeny were lethal whilst DmCBP20'' 
FS 
#84/ P(lacZ ry)1(3)05697 were females sterile (data not shown). Taken together, 
these genetic crosses strongly suggest that lesions in DmCBP2O'" lines #54 and 
#84 occurred within DmCBP20 locus. 
In order to identify the mutations at DNA level, both DmCBP20 alleles were 
sequenced. Genomic DNA was extracted from homozygous DinCBP2011'11 #54 and 
#84 adults and DmCBP20 genomic region PCR amplified using the primers 
illustrated in Figure 4.3, A. DNA bands were subsequently extracted, gel purified 
and sequenced (data not shown). The results from the DNA sequencing showed that 
DmCBP2OM1 #54 and DmCBP2e FS #84 contained 65 bp and 30 bp of residual P- 
element sequences respectively. This data suggests that DmCBP2OM1 alleles might 
be hypomorphs where additional sequences in the 5' UTR might affect DmCBP20 
translation and consequently generate the sterility phenotype. 
The next question to address was whether gonads from DmCBP2U 	adults 
exhibited any gross morphological abnormalities. As a result, testes were dissected 
from homozygous #54 and #84 adults, squashed and examined by light microscopy 
(Mar Carmena and data not shown). This determined that the morphology of external 
genitalia from both DmCBP201 lines appeared normal with no obvious defects 
ME 
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compared to wild-type. All the early stages of spermatogenesis appeared to be 
present from germ stem cells to elongating sperm. Testes from DmCBP2O1'S  #54 
and #84 adults contained both pre-meiotic spermatocytes and post-meiotic 
spermatids, which indicated that meiosis was normal. In addition, cysts that 
contained elongating sperm were apparent. At the end of spermatid maturation these 
cysts form compact bundles of mature, individualised sperm (Venables and Eperon, 
1999). Although individualised sperm were observed in lines #54 and #84, it was 
unclear whether these sperm were present at the wild-type number (Mar Carmena 
and data not shown). 
These observations suggest that in DinCBP2t" #54 and #84 homozygous males, 
the early meiotic stages of spermatogenesis are similar to wild-type. However, it is 
possible that the defects that induce male sterility arise during the final stages of 
spermatid differentiation. Consequently, closer examination of the final stages of 
spermatogenesis is required, for example, to determine whether mature sperm are 
motile. Whilst EM studies would reveal if prominent structures in the spermatid tail 
such as the axoneme and mitochondria are present. 
In contrast to homozygous males, examination of ovaries dissected from matured 
homozygous females revealed gross morphological defects. Representative mutant 
ovarioles from both homozygous DmCBP2O'" lines are illustrated in Figure 4.4. As 
can be observed, the phenotypes of homozygous DmCBP2eFS #84 and 
DmCBP20l #54 ovarioles were distinct from wild-type (compare Panels A with B 
and Q. Closer examination of homozygous DmCBP2e FS #84 females showed they 
did not lay eggs and had ovaries that were approximately 30% smaller than wild-type 
(data not shown). A majority of ovarioles (74%) appeared to be mutant and this 
phenotype was consistent within an ovary (Figure 4.4, B). Generally, the early stages 
of oogenesis looked wild-type, however, developing oocytes appeared to 
progressively deteriorate from stage 6. 
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Figure 44 Homozygous DmCBP2OmFs 
and #84 Ovarioles have 
Gross Morphological Defects 
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C DmCBP2OmFs #54 
Figure 4.4 Homozygous DmCBP2OFS  #54 and #84 ovarioles have gross 
morphological defects. Ovaries were dissected and fixed from matured A. 
wild-type Ore R, B. homozygous DmCBP2OMFS  #84 and C. homozygous 
DmCBP2OMFS #54 adults. DNA was then stained with DAR and ovarioles 
visualised using DIG and fluorescence microscopy. 
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As can be observed from Figure 4.4 B, DAPI stained homozygous DmCBP20'S 
#84 ovariole clearly showed discrete DNA bodies from stage 7 onwards. This 
suggests that the egg chambers might undergo degeneration by apoptosis. Consistent 
with cell death, the nurse cells also looked abnormal and fragmented around these 
stages. Furthermore, ovarioles appeared to back-up as each ovariole typically 
acquired two stage 13-14 egg chambers. If mature egg chambers in backed-up 
ovarioles do not enter the oviduct they are eventually reabsorbed. This probably 
accounts for why homozygous DmCBP2O1"I
' s  #84 females do not lay eggs. 
Initial observations also showed that deteriorating egg chambers appeared to be 
fused, which suggests signalling defects might underlie the homozygous 
DmCBP20 FS #84 mutant phenotype. To test this, homozygous Din CBP2O'" #84 
ovaries were stained with DAPI, examined on an inverted Olympus 1X70 microscope 
and fluorescence images processed by deconvolution analysis (Gillian MacKay). As 
can be observed from Figure 4.5, each chamber was indeed individualised and 
surrounded by an intact cell membrane. This was further confirmed by staining 
homozygous DmCBP2 OMFS  #84 ovarioles with rhodamine-phalloidin that 
specifically detects actin (Gillian MacKay and data not shown). In addition, egg 
chambers that matured far enough contained mature oocytes that were determined 
with wild-type follicle cells. Whilst RNA in situ analysis of gurken mRNA, which 
contributes to anterior-posterior axis specification, showed that it was correctly 
localised in early oocytes in a posterior crescent between the nucleus and follicle 
cells (Nina MacDougall and data not shown). Taken together, these data suggest that 
in homozygous DmCBP20 FS #84 ovarioles cell signalling and specification of axis 
formation are wild-type. 
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Chambers are not Fused 
A Ore R DIC 
B DmCBP2OmFs #84 
Figure 4.5 Homozygous DmCBP2OIIIFS  #84 chambers are not fused. 
Ovaries were dissected and fixed from matured A. wild-type Ore R and B. 
homozygous DmCBP2IPIFS  #84 adults. DNA was then stained with DAR and 
ovarioles visualised using DIC and fluorescence microscopy on an inverted 
Olympus 1X70 microscope. Fluorescence images were then processed by 
deconvolution analysis. [i] Under DIC, the yellow arrow points to a 
homozygous DmCBP2OmFs #84 egg chamber that appears to be fused. [ii] 
DAR image shows the ovariole has two distinct egg chambers. 
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In contrast to homozygous DmCBP2OM  #84, homozygous DmCBP2OM  #54 
females did lay eggs, some of which were strikingly flaccid in appearance. Further 
examination of ovaries showed they were approximately 20% smaller than wild-type. 
A majority of ovarioles looked normal with only 23% exhibiting a mutant phenotype, 
which was consistent within an ovary (data not shown). A representative 
hornozygous DmCBP20' FS  #54 mutant ovariole is presented in Figure 4.4 C. 
Similar to D,nCBP20MI  #84,  DmCBP2OM!  #54 phenotype exhibited densely 
stained DNA bodies from stage 7 onwards. As before, this egg chamber degeneration 
is suggestive of apoptosis. 
Interestingly, initial observations showed approximately 30% of mature homozygous 
DmCBP20MJ #54 eggs were flaccid, which suggests defects might exist within the 
chorion egg shell. To test this, egg chorions were closely examined using dark field 
microscopy. This determined that the chorions were intact and looked normal. 
Moreover, prominent features of the chorion such as the two dorsal appendages and 
micropyle were wild-type (Mary Bownes and data not shown). It was therefore 
reasoned that the flaccid appearance of homozygous DrnCBP20"FS  #54 eggs might 
be due to a deficiency in the major yolk proteins. Yolk proteins are expressed in the 
fat body and follicle cells and transported to the ovaries where they accumulate in 
large amounts during stages 8 to 10 (Richard et al., 2001). As a result, levels of the 
three major yolk proteins were analysed by western blotting using the anti-yolk 
protein (YP) antibody directed against YP1, YP2 and YP3. This demonstrated that 
all three yolk proteins were present at similar levels to wild-type ovaries (Figure 4.6, 
B). Collectively, this data shows that the flaccid appearance of homozygous 
DmCBP2OM1 #54 mature eggs does not result from defects in major yolk proteins 
or egg shell formation. 
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Figure 4.6 DmCBP20 protein is lower in homozygous DmCBP20uFS  #54 
and #84 ovaries. Western blot analysis of DmCBP20 and major yolk proteins 
in DmCBP2OMFS  #54 and #84 ovaries compared to wild-type. Ovaries were 
dissected from matured Ore R wild-type, homozygous DmCBP20' #54 and 
homozygous #84 adults and total protein extracted. Equivalent amounts of 
total protein were loaded as quantitated by sypro-orange staining using Storm 
860 Phosphorimager in blue fluorescence together with ImageQuant software. 
Proteins were then resolved by SDS-PAGE, western blotted and nitrocellulose 
membrane probed with A. anti-1426 antibody and B. anti-yolk protein (YP) that 
detects major YPI-3. As an additional loading control, filter was re-probed with 
anti-DmActin antibody that is ubiquitously expressed throughout oogenesis. 
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In order to address whether DmCBP20 #54 and #84 mutations belong to the same 
complementation group, both alleles were crossed together and the Fl trans-
heterozygote progeny scored for sterility. This determined that both male and female 
DmCBP20' FS  #84/ DmCBP20Ml  #54 adults were fertile, which suggests that the 
two alleles belong to different complementation groups (data not shown). To 
examine the female trans-heterozygotes more directly, ovaries were dissected from 
matured adults and stained with DAPI. As can be observed from Figure 4.7, the 
morphology of DmCBP2O' 11 #84/ D,nCBP20i  #54 ovarioles appeared normal 
when compared to wild-type (compare Panels A and B). The characteristic discrete 
DNA bodies that were prevalent around stage 7 onwards in both homozygous 
DmCBP20 #54 and #84 ovarioles were absent. Furthermore, mature eggs from 
DmCBP20' #84/ DmCBP2OM #54 adults were wild-type in appearance. Ideally, 
western analysis of ovaries dissected from trans-heterozygotes would also be 
performed to support the genetic data. This would be expected show that DmCBP20 
protein level of DmCBP2O1VhI  #84/ DmCBP20S  #54 ovaries are higher compared 
to either homozygous DmCBP20 FS allele alone. Taken together, these genetic data 
suggest that mutations in DmCBP20M1 #54 and #84 do complement each other and 
might therefore induce different molecular defects. 
To confirm the sterility observed in homozygous DinCBP2OM1 #54 and #84 adults 
was due to the imprecise excision of P(lacZ ry4 )1(3)05697 from DmCBP20, specific 
rescue crosses were performed. Transgenic lines expressing either DmCBP20 cDNA 
expressed under a constitutive promoter or Din CBP2O genomic region were crossed 
into the homozygous DmCBP2O'1 Fs background. The adult progeny were 
subsequently scored for rescue of male and female homozygous sterility and in both 
cases, fertile adults were found homozygous for DmCBP20'1 "5. 
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Figure 4.7 DmCBP2OMFS  #54 complements DmCBP20 	#84. 
Complementation testing of DmCBP2OmFs alleles. Ovaries were dissected and 
fixed from matured A. wild-type Ore R and B. DmCBP2OmFs #54184 trans-
heterozygotes. DNA was then stained with DAR and ovarioles visualised 
using DIC and fluorescence microscopy. 
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Furthermore, morphological analysis of ovaries dissected from rescued 
DmCBP2O"1 #54 and #84 females showed they appeared normal with no obvious 
defects compared to wild-type ovaries (data not shown). This indicated that the 
rescue of homozygous DmCBP2OMI  #54 and #84 females was complete. 
The next question to address was whether CBC mRNA expression was disrupted in 
homozygous DmCBP20Ml  #54 and #84 lines. RNA in situ hybridisation was 
therefore used to detect the localisation of DmCBP20 and DmCBP80 transcripts in 
ovarian tissues. Full-length DmCBP20 and DmCBP80 cDNAs were used to generate 
DIG-labelled anti-sense RNA that specifically detects mRNA and sense RNA, which 
serves as a negative control. The RNA probes were then hybridised to fixed 
homozygous DmCBP20MI  #54, #84 and wild-type ovaries. As can be observed 
from Figure 4.8, the expression pattern of DmCBP20 and DmCBP80 RNAs were the 
same in DmCBP20'" and wild-type ovarioles. Transcripts encoding both cap-
binding proteins were ubiquitously expressed in all ovarian tissues from 
D,nCBP20I #54 and #84 mutants. As a result, the localisation of DrnCBP20 and 
DrnCBP80 RNAs did not appear to be affected in homozygous D,nCBP20MI  #54 
and #84 adults. 
Since RNA in situ hybridisation is a qualitative assay, it could not be used to assess 
the levels of DmCBP20 RNA present in DmCBP2OM1 #54 and #84 ovaries. 
Consequently, western blotting was used to examine the amount of DmCBP20 
protein in DmCBP2O111 mutants. Ovaries were dissected from mature wild-type, 
homozygous DmCBP2O''1 #54 and #84 adults and the total protein extracted. 
Equivalent amounts of protein were loaded as quantitated by sypro-orange 
fluorescence using the Storm 860 Phosphorlmager together with ImageQuant 
software (data not shown). Proteins were then resolved by SDS-PAGE and analysed 
by western blotting. CBP20 protein was detected using anti-1426 antibody that is 
directed against HsCBP20 but also cross-reacts with DmCBP20 (Izaurralde et al., 
1994). 
Figure 4.8 DmCBP20 and DmCBP80 mRNAs 
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Figure 4.8 DmCBP20 and DmCBP80 mRNAs are ubiquitously expressed 
in homozygous DmCBP2OmFs #54 and #84 ovarioles. RNA in situ 
hybridisation performed on fixed matured A. wild-type Ore R, B. homozygous 
DmCBP2OmFs #84 and C. homozygous DmCBP2OmFs #54 ovaries. 
DmCBP20 and DmCBP80 mRNAs were detected using DIG-labelled anti-
sense RNA. 
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The specificity of anti-1426 for CBP20 is observed in Figure 4.6, A where the 
antibody predominantly recognised a band corresponding to CBP20 in both HeLa 
nuclear extracts and ovaries (upper panel, compare lanes 1 and 4). The western blot 
shows that the levels of DmCBP20 protein appear to be reduced in homozygous 
DmCBP20M #54 and #84 ovaries (upper panel, compare lane 2 and 3). As an 
additional loading control the western blot was re-probed with anti-DmActin that is 
expressed ubiquitously throughout oogenesis (lower panel). Collectively, this data 
suggests that the additional residual P-element sequences in the 5'UTR of 
DmCBP20''5 #54 and #84 might affect DinCBP20 translation in gonads. This leads 
to lower levels of DmCBP20 protein, which consequently generates the sterility 
phenotype. 
4.2.7 Analysis of RNA processing in DmCBP20mFs  ovaries 
Current evidence has shown that CBC facilitates the positive effects of the cap in at 
least three major aspects of nuclear RNA processing: pre-rnRNA splicing, RNA 3'-
end formation and U snRNA export (Lewis and Izzauralde, 1997). To test whether 
the molecular defect in DmCBP20M  ovaries was due to splicing, northern blotting 
was used to assay for aberrant pre-mRNA splicing of endogenous ribosomal protein 
RNAs. Ribosomal proteins RpL19, RpS3 and RpA1 were specifically selected for 
analysis since they are ubiquitously expressed throughout oogenesis and have pre-
mRNAs that contain two introns, one intron and no introns respectively. 
Characterisation of CBC has shown that it mediates the stimulatory effect of the cap 
in the splicing of the cap-proximal intron (Izaurralde et al., 1994; Lewis et al., 1996). 
Therefore, if the sterility phenotype results from a general splicing defect, increased 
steady state pre-mRNA to mRNA ratios would be observed in RpS3 that contains 
one intron. In contrast, DmCBP261M1 mutants would be predicted to have no 
influence on the splicing of RpL19 that contains two introns or the steady state levels 
of RpA1, which contains no introns and effectively serves as a negative control. 
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Ovaries were dissected from matured Ore R wild-type, homozygous DmCBP20M FS 
#54 and DmCBP2O FS  #84 adults and the total RNA extracted. Equivalent amounts 
of RNA were loaded as determined by ethidium stained ribosomal RNAs and 
analysed by northern blotting. The nitrocellulose filters were probed with full-length 
RpL19, RpS3 and RpAJ cDNAs and the steady state ratios of pre-mRNA to mRNA 
quantitated using the Storm 860 Phosphorlmager together with ImageQuant 
software. This determined that neither DrnCBP20FS  #54 no'. #84 exhibited a 
significant increase in the steady state pre-mRNA to mRNA ratio in any of the 
ribosomal proteins (data not shown). It is possible that the northern analysis was not 
sensitive enough to detect a splicing defect in DrnCBP2OM1 ovaries. Alternatively, 
defects could result from other functions of CBC such as RNA 3'-end formation. It 
was therefore reasoned that a more sensitive assay such as RNase protection would 
be better suited to investigate aberrant pre-mRNA splicing in D,nCBP201 adults. 
In addition, RNase protection could assay whether a defect in poly(A) tail formation 
existed in DmCBP201 #54 and #84 ovaries. Unfortunately, these experiments 
were not completed due to lack of time. 
4.2.8 Characterisation of DmCBP20MS  male steriles 
In contrast to the two DmCBP20' 	mutations, mobilisation of P(lacZ rf)1(3)05697 
also generated a very high number of lines (45%; 31 from 69 lines) that were 
homozygous male sterile (DmCBP20'5). Initial genetic crosses showed that all 31 
DrnCBP20S lines failed to complement either Df(3R)P14 sr', which uncovers 
DmCBP20 locus or the original P-element. Flies that possessed the genotype 
DmCBP20M/ Df(3R)P]4 sr' were found to be lethal. Whilst DmCBP20/ P(lacZ 
ry)1(3)05697 adults were either semi-lethal, male or female sterile (data not shown). 
Taken together, these genetic crosses suggest that similar to DinCBP2OMFS, 
D,nCBP20s alleles appear to be hypomorphs with mutations that reside within the 
DmCBP20 locus. 
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In order to determine the mutations at DNA level, DmCBP20S  lines #1, #15 and 
#21 were randomly selected for further analysis. Genomic DNA was extracted from 
homozygous males and P(lacZ ry)1(3)05697 insertion site in DmCBP20 PCR 
amplified using oligos S264+ S265 illustrated in Figure 4.3, A. DNA bands were 
subsequently extracted, gel purified and sequenced. Similar to DinCBP201  
mutants, the results of the DNA sequencing showed that DmCBP2OMS  alleles #1, #21 
and #15 contained 53, 40 and 100 bp of residual P-element sequences respectively 
(data not shown). This suggests that like DmCBP20'11 alleles, additional sequences 
in the 5' UTR might affect the translation of DmCBP20 leading to the male sterility 
phenotype. 
To determine whether the homozygous male sterility could be rescued by DmCBP20 
transgenes, DmCBP2OMS  lines #1, #15 and #21 were subjected to the same rescue 
crosses previously performed on DinCBP2O" and DmCBP2O" FS mutants. 
Transgenic lines expressing either DmCBP20 cDNA expressed under a constitutive 
promoter or a fragment of genomic region encompassing DmCBP20 were crossed 
into the homozygous DmCBP20M  background. Homozygous Dn1CBP20S  adult 
male progeny were subsequently scored for fertility by crossing to wild-type females. 
As a result, homozygous DmCBP2O' S  males, which carried a copy of DmCBP20 
transgene were fertile (data not shown). This indicated that the male sterility 
observed was specifically due to mutations in DmCBP20 locus. 
The next question to address was whether testes from DmCBP20S  mutants 
exhibited any gross morphological abnormalities. Consequently, testes were 
dissected from homozygous #1, #15 and #21 adults, squashed and examined by light 
microscopy (Mar Carmena). Similar to DmCBP20Lh1  #54 and #84 males, the 
morphology of external genitalia from homozygous #1, #15 and #21 DmCBP20S 
lines appeared normal with no obvious defects compared to wild-type. All the stages 
of early spermatogenesis were present from germ stem cells to elongating sperm. 
Testes from DmCBP20 S  males contained wild-type pre-meiotic spermatocytes and 
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post-meiotic spermatids indicating that meiosis was normal. In addition, cysts 
containing elongating sperm were apparent in all DmCBP2OIS  adults examined 
(Figure 4.9 and data not shown). At the end of spermatid maturation these cysts form 
compact bundles of mature, individualised sperm (Venables and Eperon, 1999). 
Although mature sperm were present in line #21, none were observed in 
DmCBP2OMS   lines #1 or #15 (Mar Carmena). 
These observations suggest that like DmCBP201  #54 and #84, the early meiotic 
stages of spermatogenesis in homozygous DmCBP20 S males are wild-type. 
However, it appears that DmCBP20S  mutations might induce defects during the 
final stages of spermatid differentiation. As a result, this would affect the production 
of mature, viable sperm and cause the male sterility phenotype. 
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Figure 4.9 Homozygous DmCBP2OM#21 
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Figure 4.9 Homozygous DmCBP2OmF #21 testes do not have gross 
morphological defects. Testes were dissected from matured A. wild-type 
Ore R and B. homozygous DmCBP2OMF  #21 adults. Testes were then 
visualised using phase contrast microscopy. 1. Onion-stage spermatid cyst. 2. 
Cyst of elongated spermatids. 3. Cyst of 32 cells at anaphase/ telophase 
meiosis II. 
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4.3 DISCUSSION 
4.3.1 Generating P-insertions in DmCBP80 
The P-element mutagenesis was not successful in generating a P-induced allele of 
DmCBP80 by local hopping. Although the hop was performed on a small scale, a 
reasonable number (2%; 10 from 280 lines) of new P-insertions were homozygous 
lethal and mapped to 4C5-6; 4C7-8 on the X-chromosome near DmCBP80, which is 
located at 4C7-8. This result is encouraging and suggests that it is worthwhile 
repeating the local hop strategy but with specific modifications. Firstly, the 
mutagenesis should be scaled up and a genetic scheme designed whereby two or 
more starter-elements located within 200 Kb of DmCBP80 are transposed. Secondly, 
the assumption that P-insertion alleles in DmCBP80 would be homozygous lethal 
should be discarded and all transposon insertions mapped to 4C5-6; 4C7-8 on the X-
chromosome analysed molecularly. This assumption was based on the observation 
that DmCBP20 is an essential gene, together with data describing the characterisation 
of both subunits from Chapter 3. These results suggest that DmCBP20 and 
DmCBP80 behave similarly, as expected from the constituents of a cap-binding 
complex that is only functional as a heterodimer. Interestingly, Chapter 5 describes 
how a second CBP80 homologue has been identified in Drosophila melanogaster. In 
contrast to DmCBP80, DmCBP20 is a unique gene. This suggests that DmCBP20 
might have additional functions in conjunction with the second DmCBP80 
homologue, which unlike DmCBP80, render it essential. Finally, instead of southern 
analysis, an alternative molecular screening strategy is required if thousands of 
mutagenised flies are to be investigated within months. An assay such as PCR-
mediated by vectorette is suitable for a large insertional mutagenesis screen (Eggert 
et al., 1998a). This sensitive assay allows the detection of one fly with the correct P-
insertion from a pool of 100 flies containing alternative independent transposon 
integrations. As a result, the number of single PCR reactions for screening can be 
reduced along with the time taken for the P-element induced mutagenesis screen. 
106 
Chapter 4 P-element induced mutagenesis of DmCBP20 and DmCBP80 
4.3.2 CBP20 is an essential gene in Drosophila melanogaster 
Mobilisation of P(lacZ ry)1(3)05697, which is inserted into the 5' non-coding region 
of DmCBP20, generates a very high number (70%) of imprecise excision alleles that 
are homozygous lethal. Characterisation of DmCBP20" alleles show they either 
contain residual P-element sequences that range from 25 bp to 1.7 Kb or small 
genomic deletions of around 200 bp. Homozygous DmCBP20' mutants die during 
the first or second larval instar stages with no obvious morphological abnormalities. 
This lethality is rescued by expressing either DmCBP20 using its own promoter 
sequences or the ubiquitously expressed armadillo promoter. As a result, these data 
show that DmCBP20 is an essential gene in Drosophila melanogaster. This is not 
surprising considering CBC plays a key role in the metabolism of RNAP II 
transcripts in all cells. 
Although D,nCBP20F  mutants have not been analysed biochemically, the lesions in 
the 5' UTR suggest that translation of DmCBP20 might be affected. Chapter 3 has 
already shown that DmCBP20 is maternally derived. This suggests that even though 
the maternal contribution might be sufficient to propel development through 
embryogenesis, protein from D,nCBP2011 mutants might be insufficient to sustain 
Drosophila development beyond the first or second larval instar stages. 
The molecular defect(s) that lead to the homozygous lethality in DmCBP2011  
mutants are yet to be elucidated. However, selected Din CBP2O" lines have been 
crossed over GFP-marked balancers to form stable stocks. This will allow 
homozygous DmCBP2011  embryos and larvae to be readily detected and isolated. 
Therefore, defects in pre-mRNA splicing, RNA 3'-end formation or U snRNA export 
could be assayed in homozygous DmCBP2011  mutants using RNase protection assay 
and RNA in situ hybridisation respectively. It is thought that if DmCBP20 protein 
levels are lower in DmCBP20" mutants compared to wild-type, the lethality might 
not result from the disruption of one specific mRNA processing event. Instead, it is 
probably due to a culmination of defects in splicing, RNA 3'-end formation and U 
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snRNA export that ultimately disrupt RNAP II transcript metabolism and lead to 
lethality. 
4.3.3 Genetic and molecular analysis of DmCBP20' mutants 
Genetic interaction screens that use DmCBP20111 deletion line #1 and P-element 
retention line #65 do not identify any CBC-interacting genes or deficiencies. Adults 
that contain DmCBP20' mutation in combination with the deficiency that uncovers 
DmCBP80 or alleles that over-express DmCBP80 are viable and fertile with no 
obvious dominant phenotypes. Similarly, no dominant adult phenotypes are observed 
when the third chromosome deficiency kit or RNAP 11 215 alleles are crossed into 
DmCBP20ITh background. 
An interaction would be predicted between DmCBP20' alleles and mutants in the 
cap-binding partner DmCBPSO. However it is possible that these interactions are not 
strong enough to be manifested as observable external adult phenotypes. This 
suggests that Din CBP2Ot11 mutants do not provide a sensitised genetic background 
suitable for genetic modifier screens. Instead, biochemical analysis of DmCBP20 and 
Din CBP8O double mutants might be more successful in revealing molecular defects 
in CBC's function during splicing, RNA 3'-end formation or U snRNA export. As a 
result, Chapters 6 and 7 describe an alternative genetic approach where the GAL4-
UAS system is used to identify CBC-interacting genes. GAL4-UAS is used to over-
express the components of CBC in non-essential adult tissues to generate dominant 
phenotypes. These dominant phenotypes can then be used to facilitate genetic 
modifier screens to identify CBC-interacting genes. Therefore unlike DmCBP2OUhJ 
mutants, both strong and weak genetic interactors of CBC can be identified. 
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4.3.4 DmCBP20 contributes to gametogenesis 
Transposition of P(lacZ ry)1(3)05697 also generates adults that are either male 
sterile or male and female sterile. Two excision lines (3%), DmCBP20  #54 and 
DmCBP20'11 #84 are found where both females and males are homozygous sterile. 
In contrast, a surprisingly high proportion of homozygous excision lines (45%) are 
male sterile alone. Sequencing of the P-insertion site in DrnCBP20M'' and 
DmCBP20!IS lines #1, #15 and #21 show they retained short residual P-element 
sequences in the 5' UTR of DmCBP20. DmCBP20''1 #54 and DmCBP2011l  #84 
contain 65 bp and 30 bp of residual P-element sequences respectively. Whilst the 
three DmCBP20 lines retain 40 to 100 nucleotides in the 5' UTR. Rescue crosses 
further confirm the sterility observed in DmCBP20 FS and DmCBP20MS  lines is due 
to the imprecise excision of P(lacZ ry)1(3)05697. Consequently, fertility is restored 
to both homozygous females and males expressing DrnCBP20 transgenes under the 
control of the armadillo or its own promoter sequences. 
RNA in situ analysis of DmCBP20I  mutants demonstrate the localisation of 
DmCBP20 and DmCBP80 transcripts are not affected in ovaries isolated from either 
homozygous DmCBP201 #54 or DmCBP20FS  #84 adults. Both cap-binding 
proteins are ubiquitously distributed in all ovarian tissues. However, western analysis 
shows the levels of DmCBP20 protein are lower in Di-nCBP20IFS #54 and #84 
ovaries compared to wild-type. 
Taken together, these data implicate a role for DmCBP20 during gametogenesis. It is 
interesting to note that 45% of homozygous viable lines are male sterile in 
comparison to 3% that are both male and female sterile. This strongly suggests that 
DrnCBP20 makes a greater contribution to male fertility. The additional P-element 
sequences in the 5' UTR of DmCBP20M #54 and #84 might affect DmCBP20 
translation. As a result, the lower levels of DrnCBP20 protein are insufficient to 
support either oogenesis or spermatogenesis. Similar to DmCBP20 mutants, p- 
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element retention in DmCBP2O1IS  lines might also produce lower levels of 
DmCBP20 protein that cannot sustain spermatogenesis. 
4.3.5 Morphological and molecular analysis of DmCBP20MFS 
female steriles 
Morphological analysis of ovarioles dissected from mature homozygous 
DmCBP20MF #54 and DmCBP20I'S  #84 adults demonstrate gross morphological 
defects. Generally, both #54 and #84 ovarioles consistently show intense DNA 
bodies in egg chambers staged 6 onwards. This observation suggests that a 
checkpoint mechanism might exist around this stage that promotes the degeneration 
of defective chambers by apoptosis. A high proportion of homozygous 
DmCBP2O'11 #84 ovarioles (74%) are mutant in phenotype and adults do not lay 
eggs. Although initial observations suggest the egg chambers might have signalling 
defects, further investigations show this is not the case. In comparison to #84, 
relatively few (23%) homozygous DmCBP2t FS #54 ovarioles exhibit a mutant 
phenotype. As a result adult females do lay eggs, some of which are strikingly 
flaccid in appearance. This observation suggests that mature eggs might be defective 
in the chorion egg shell or major yolk proteins. However, further examinations 
demonstrate that this is not the case. 
Although DinCBP20 FS #54 and #84 ovaries have lower levels of DmCBP20, 
complementation testing show both mutations can rescue each other. This suggests 
that the molecular defect(s) incurred by the lower amounts of DmCBP20 during 
gametogenesis are different in both D1nCBP20 #54 and #84 lines. Northern 
analysis does not detect a defect in the splicing of RpS3 ribosomal protein RNAs in 
homozygous Din CBP2O'" #54 or #84 ovaries. RpS3 contains one intron and 
therefore is subject to CBC and cap-dependent intron removal. As a result, it is 
reasoned that a more sensitive assay such as RNase protection would be better suited 
for investigating aberrant splicing or RNA 3'-end formation. Alternatively, 
microarray analysis could be used to detect a splicing defect in general or a specific 
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subset of RNAs. 
4.3.6 Morphological analysis of DmCBP20MFS  and  DmCBP2OMS 
male steriles 
In comparison to ovaries from DmCBP20" adults, testes from homozygous 
DmC'BP2O'1'' and DmCBP20S  males exhibit no obvious abnormalities compared 
to wild-type controls. All the stages of early spermatogenesis are present from germ 
stem cells to elongating sperm. Furthermore, the morphology of both pre-meiotic 
spermatocytes and post-meiotic spermatids are normal. However, mature sperm are 
not observed in DmCBP20MS  lines #1 and #15. Whilst the number of individualised 
sperm in DmCBP20M1 #54 and #84 do not appear to be the same as wild-type. 
Taken together, these observations suggests that defects leading to DmCBP201  
and D,nCBP205 male sterility probably arise during the final stages of spermatid 
differentiation. 
During fruit-fly spermatogenesis, RNAP II transcription rarely occurs after meiosis. 
mRNAs are transcribed early and then sequestered in a stable form. Translation is 
regulated and therefore delayed until proteins are required for function in post-
meiotic cells (Standart and Jackson, 1994; Curtis et al., 1995). Current data has 
characterised roles for CBC in nuclear RNAP II transcript processing events such as 
splicing and RNA 3'-end formation that are coupled to transcription (Lewis and 
Izaurralde, 1997; Hirose and Manley, 2000). This suggests that if the mechanism of 
DmCBP20 action is the same in somatic and germ cells, DmCBP20 would only be 
required during active transcription in pre-meiotic cells. However, in all 
DmCBP20I and  DmCBP2OMS  males steriles examined, the morphology of pre-
meiotic spermatocytes and post-meiotic spermatids are wild-type. Instead, 
observations suggest the mature sperm are either absent or reduced in number 
compared to wild-type controls. As a result, Dm CBP20Vhl and DmCBP2O 
mutations appear to induce defects in the final stages of spermatid differentiation 
where RNAP II genes are transcriptionally silent. This in turn implicates novel 
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role(s) for DmCBP20 outwith nuclear RNA processing, in post-meiotic cells during 
the later stages of spermatogenesis. 
Since transcription is absent in post-meiotic cells, regulation of mRNA translation is 
an effective mechanism for controlling protein expression. Surprisingly little is 
known about the strategies and mechanisms involved in translation regulation during 
spermatogenesis. However, many nuclear RNA-binding proteins have been 
identified that mediate post-transcriptional regulation and are consequently essential 
for spermatogenesis (Venables and Eperon, 1999). These proteins are defined by a 
common RNA-binding domain termed the RNA recognition motif (RRM) or RNP 
motif (Karsch-Mizrachi and Haynes, 1993; Elliot et al., 1997; Haynes et al., 1997; 
McGuffin et al., 1998) Interestingly, CBP20 also has two RNP motifs that comprise 
a RNA-binding domain at the amino-terminus. In addition, a second CBP20 
homologue has recently been identified in humans termed HsCBP20 Related or 
HsCBP20R. Current data suggests the expression of HsCBP20 is predominantly 
restricted to adult testes (E. Thompson, unpublished data). As a result, these data 
point to role(s) for CBP20 during spermatogenesis in both humans and Drosophila. 
Moreover, the function of DmCBP20 appears to extend beyond the characterised role 
in nuclear processing of RNAP II transcripts. Instead, it is plausible to consider that 
DmCBP20 might also participate in mechanisms that regulate RNAP II translation 
during spermatogenesis. 
4.4 CONCLUSIONS 
An existing P-insertion in DmCBP20 was excised to produce additional DmCBP20 
mutant alleles. This generated a series of DmCBP20 male and female sterile, male 
sterile and homozygous lethal lines. DmCBP20 is an essential gene in Drosophila 
melanogaster. As expected from a key RNA processing factor, DmCBP20 functions 
in somatic tissues. In addition, DmCBP20 plays an important role during 
spermatogenesis and oogenesis. DmCBP20 appears to make a greater contribution to 
male fertility where it might have novel roles in RNAP II translation regulation. 
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CHAPTER 5 
Characterisation of DmCBP80R 
5.1 INTRODUCTION 
After the completion of the Drosophila inelanogaster genome sequencing project, 
the BDGP database was searched for sequences homologous to DmCBP20 and 
DmCBP80 (Adams et al., 2000). This determined that in Drosophila melanogaster, 
CBP20 is an unique gene. However, in fruit-flies, a second DmCBP80 homologue 
named CG7907 or DmCBP80 Related (DrnCBP80R) was also identified. Although 
single-copy genes for both cap-binding proteins are present in lower eukaryotes, 
humans have two HsCBP20 homologues and only one HsCBP80 homologue. 
Intriguingly, initial characterisation of HsCBP20 Related (HsCBP20R) has shown it 
is predominantly expressed in adult testes (E. Thompson, unpublished data). This 
raises the question of whether functional parallels can be drawn between human 
CBP20R and Drosophila CBP80R homologues. As a result, Chapter 5 presents an 
initial characterisation of Din CBP8OR by analysing the sequence and RNA data 
available. 
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5.2 RESULTS 
5.2.1 Identification of a second CBP80 homologue in 
Drosophila melanogaster 
In order to determine whether DmCBP80 is an unique gene, the predicted amino acid 
sequence of DrnCBP80 was used in a TBLASTN search of the genomic sequences in 
the BDGP database. This identified a second sequence homologous to DmCBP80 
named CG7907 or DinCBP80 Related (DrnCBP80R). The genome project has 
mapped DrnCBP80R to the right arm of chromosome 3 on polytene segment 93E1-2 
(inferred) and the predicted gene structure of DmCBP80R is presented in Figure 5.1. 
In comparison to DmCBP80, the gene structure of DmCBP80R is relatively simple. 
DmCBP80R consists of three exons, which span 2, 420 bp of genomic DNA with 
two short introns that are 88 bp and 90 bp in length respectively. Searches of FlyBase 
revealed no known mutant alleles have been described for DmCBP80R to date. 
Interestingly, no ESTs have been found to correspond to DmCBP80R suggesting that 
it might be expressed at low levels, show tissue-restricted expression or alternatively, 
be a pseudogene. 
The conceptual protein product of DrnCBP80R is 747 aa in length compared with 
800 aa of DmCBP80. Overall, both Drosophila proteins show 31% identity and 50% 
homology to each other throughout their length. As can be observed from Figure 5.2, 
A, high sequence identity is observed at the amino-terminals of DmCBP80 and 
DmCBP80R proteins. This includes the putative bipartite NLS and recently 
described MIF4G domain that implicates CBP80 in NMD (Ponting, 2000; Ishigaki et 
al., 2001). In contrast, greater sequence divergence and length heterogeneity is 
observed within the carboxyl-terminal regions of DmCBP80 and DmCBP80R. 
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Figure 5.1 Gene structure and chromosomal location of DmCBP80R. 
A. Berkeley genome project has mapped DmCBP80R (CG7907) to right arm 
of chromosome 3 on polytene segment 93E1-2 (inferred). B. Schematic 
representation of DmCBP80R gene structure as predicted by Genescan. 
DmCBP80R has three exons depicted by rectangles and two introns 
represented by black lines, which span a total of 2, 420 bp genomic DNA. 
Start of transcription unit is depicted by black arrow along with poly(A) sites. 
Translation unit is outlined by start and stop annotations. 
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Figure 5.2 CBP80 homologues in eukaryotes. A. Conceptual translation of 
DmCBP80 and DmCBP80R compared to HsCBP80 using Clustal X 
(Thompson et aL, 1998). The conserved MIF4G domain is presented boxed. 
Identical and related amino acids are illustrated by (*) and () respectively. (:) 
indicates similar amino acids and discontinuities in the alignments are 
represented by dashes. Blue represents hydrophobic/ aromatic amino acids. 
Orange depicts basic and glycine residues. Purple shows acidic amino acids. 
Green and yellow illustrates hydrophilic and proline residues respectively. B. 
Phylogenetic tree showing the high divergence of DmCBP80R from 
DmCBP80 and HsCBP80. The sequences used are: Saccharomyces 
cerevisiae ScCBP80 (P34160), Candida albicans CaCBP80 (BAA76378), 
Arabidopsis thaliana AtCBP80 (Q9LKN6), Caenorhabditis elegans CeCBP80 
(T15197), Drosophila melanogaster DmCBP80 (Q9U980), Homo sapiens 
HsCBP80 (Q09161), Drosophila melanogaster Related DmCBP80R 
(Q9VDA4) and Schizosaccharomyces pombe SpCBP80 (T39057). 
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The high level of divergence between the Drosophila homologues is more apparent 
by comparing the phylogenetic relationships of CBP80 from a wide variety of 
eukaryotes (Figure 5.2, B). The evolutionary tree shows that the duplication of 
Drosophila CBP80 was an ancient event in the arthropod lineage prior to the 
divergence of the different metazoan phyla. As a result, DmCBP80 is more closely 
related to HsCBP8O whilst DmCBP80R is more distantly related. The high level of 
divergence between the two Drosophila homologues suggests that DmCBP80R 
might have acquired new functions during evolution. However, in the absence of any 
functional data this is purely hypothetical. 
5.2.2 DmCBP80R mRNA is expressed in 3rd  instar larvae and 
adult males 
To address whether DrnCBP80R is a functional gene, northern analysis was used to 
assay if DmCBP80R mRNA is expressed in the various Drosophila developmental 
stages. A fragment corresponding to 1, 495 bp amino-terminus of DmCBP80R was 
PCR amplified from adult fly genomic DNA using oligos S299 + S300, gel purified 
and sequenced (Figure 5.3, A and data not shown). This fragment was subsequently 
used to re-probe the developmental northern originally used to characterise the 
expression of DmCBP20 and DrnCBP80 mRNAs described in Chapter 3. Total RNA 
was extracted from staged embryo collections, three larval instars, adult males and 
females and isolated ovaries. The amounts of total RNA loaded were then normalised 
to the level of ribosomal RNAs (Figure 5.3, B lowest panel). As an additional 
loading control, the filter was re-probed with full-length cDNA from the ribosomal 
protein DnzRp49, which is ubiquitously expressed throughout fruit-fly development 
(third panel). No mRNA corresponding to the predicted size of DmCBP80R was 
observed in any of the staged embryonic collections, three larval instars, adult 
females or isolated ovaries (upper panel and data not shown). However, a weak 
signal was reproducibly observed at the predicted mRNA size of approximately 2.5 
Kb, in preparations of adult males only (upper panel). 
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Figure 5.3 Expression of DmCBP80R mRNA. A. Schematic representation 
of DmCBP80R gene structure with positions of the primer pair S299 + S300 
used to amplify 1, 495 bp amino-terminal cDNA probe. B. Nitrocellulose filters 
used to characterise DmCBP20 and DmCBP80 transcripts were stripped and 
re-hybridised with the amino-terminal DmCBP80R probe and exposed. A 
single transcript was observed for DmCBP80R at approximately 2.5 Kb in 
adult males (M) only. No mRNA was detected in adult females (F). 10 .tg of 
total RNA per lane was loaded as judged by ethidium bromide staining of 
ribosomal RNAs (rRNA5). As an additional loading control, the filter was re-
probed with full-length ribosomal protein DmRp49 cDNA. 
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This contrasts to DmCBP80, where steady state levels of mRNA are apparent in both 
adult males and females (second panel). More notably, adult females show strikingly 
higher steady state levels of DmCBP80 than adult males. RNA analysis of 
DmCBP80 from Chapter 3 has already shown that the enrichment of DmCBP80 
mRNA in adult females is due to ovarian expression. This suggests that unlike 
DmCBP80, DmCBP80R transcripts are not maternally derived. 
Taking into account the northern data, it was reasoned that DmCBP80R expression 
might be restricted to specific cell types or tissues in fruit-fly development. In order 
to examine this more directly, RNA in situ hybridisation was used to determine 
whether DrnCBP80R RNA is expressed ubiquitously or in certain cells/ tissues 
during oogenesis, embryogenesis and selected third instar larval imaginal discs. The 
amino-terminal DmCBP80R fragment used for the northern analysis was also used to 
generate DIG-labelled anti-sense RNA that specifically detects mRNA and sense 
RNA, which serves as a negative control. RNA probes were subsequently hybridised 
to fixed ovarioles, staged embryos and third instar eye-antenna, haltere, brain, leg 
and wing imaginal discs. However, no specific RNA localisation was observed using 
DIG-labelled anti-sense DmCBP80R suggesting that DmCBP80R mRNA was not 
expressed during these stages (data not shown). Again this contrasts with RNA in 
situ analysis of DrnCBP80 described in Chapter 3, where DmCBP80 mRNA is found 
to be ubiquitously expressed in all tissues throughout oogenesis, embryogenesis and 
third instar imaginal stages. 
To investigate whether the weak signal observed in adult males from the northern 
blotting was due to DmCBP80R mRNA expression, a more sensitive assay was 
employed. RT-PCR was used to firstly examine whether unspliced or spliced 
DmCBP80R RNA was expressed throughout the various Drosophila developmental 
stages and secondly, to determine if the splicing of DmCBP80R occurred at the 
predicted splice sites. 
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Figure 5.4, A illustrates schematically the primer pairs designed to amplify across 
intron 1 (oligos S471 + S472) and intron 2 (oligos S473 + S474) of DmCBP80R. The 
correct splicing of intron 1 gives a product of 521 bp and the unspliced form is 609 
bp. Whilst the spliced form of intron 2 is 459 bp and the pre-mRNA is 549 bp. Total 
RNA was extracted from staged embryo collections, three larval instars, adult flies 
and analysed by RT-PCR. RNase treated RNA preparations were included as a 
negative control to ensure that the RT products were derived from RNA (data not 
shown). 
Complementing the data from the northern and RNA in situ analysis, no RT bands 
corresponding to spliced CBP80R were observed in RNA isolated from staged 
embryos, as well as first or second instar larvae (Figure 5.4, Panel B [i] and [ii] lanes 
1-7). It is important to note that the RT-PCR gels presented here had annealing 
temperatures optimised for the PCR of spliced eDNA. Therefore, when the annealing 
temperature was varied, bands corresponding to unspliced RNA were detected in the 
embryonic and first and second larval stages (for example [ii] lane 1, 3, 4 and 7 and 
data not shown). In addition, although certain lanes have high levels of non-specific 
background, repeat performances of these experiments showed no underlying cDNA 
bands were obscured (data not shown). In contrast to embryonic, first and second 
larval stages, RNA samples isolated from adult flies showed that DmCBP80R 
splicing was exclusive to adult males. Adult females showed no detectable splicing 
of either intron with only low levels of unspliced pre-mRNA being observed 
(compare lanes 10-11 from [i] and [ii]). Interestingly, splicing of DmCBP80R introns 
1 and 2 was also observed in male and female third instar larvae ([i] and [ii] lanes 8 
and 9). Generally, RNAs of proteins predominantly expressed in male testes are only 
detected in male third instar larvae (Haynes et al., 1997). One possibility is that 
DmCBP80R mRNAs were detected in both male and female third instar larvae due 
to mis-sexing. However, this is unlikely since individuals experienced in larval 
sexing (Petra zur Lage and Nicola Wrobel) confirmed separation of male and female 
larvae. 
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Figure 5.4 DmCBP80R mRNA is expressed in 3rd  instar larvae and adult 
males. RT-PCR analysis of DmCBP80R splicing during Drosophila 
development. A. Schematic diagram illustrating predicted DmCBP80R gene 
structure with positions of primer pairs used for RT-PCR. Oligos S471 + S472 
and S473 + S474 were used to perform RT-PCR across introns 1 and 2 
respectively. B. Total RNA was isolated from embryos staged 0-4 hours, 4-8 
hours, 8-12 hours, 12-16 hours and 16-22 hours. Along with first, second and 
third instar male and female larvae, adult males and females. RT-PCR was 
performed across DmCBP80R intron I and intron 2. [i] Splicing of intron 1 
gives a product of 521 bp and unspliced product is 609 bp. [ii] Spliced intron 2 
is 459 bp and unspliced form is 549 bp. [iii] RT-PCR across intron 2 of 
DmCBP80 was included as a positive control, spliced intron 2 is 423 bp and 
unspliced form is 484 bp.  
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The most likely explanation is that DmCBP80R mRNA expression is tightly 
regulated. Transcripts appear to be expressed early in pole cell development but are 
switched off later in females during pupation. 
To ensure the RNA preparations used in these experiments were intact and not 
degraded, a positive control RT-PCR that amplified across intron 2 of DmCBP80 
was also included. Splicing of DmCBP80 intron 2 gives a product of 423 bp and the 
unspliced form is 484 bp. As expected, DmCBP80 mRNA was spliced throughout 
embryogenesis ([iii] lanes 1-5), three larval instars ([iii] lanes 6-9) and adult flies 
([iii] lanes 10-11). It is important to note that comparisons of the RT gels in Figure 
5.4, B show that the RT-PCR was not quantitative. However, it is apparent that RT 
bands corresponding to DmCBP80 mRNA are detected in adult males and females, 
which suggests the RNA preparations used were intact and not degraded. This 
strongly supports the presence of spliced DmCBP80R in males and unspliced 
CBP80R in females (compare lanes 10-11 from [i]-[iii]). In order to substantiate the 
cDNA products from the RT-PCR corresponded to spliced and unspliced RNAs, the 
RT bands were gel purified and sequenced (data not shown). This confirmed that in 
third instar larvae and adult males, both introns of DmCBP80R were spliced at the 
correct splice sites and the slower migrating species corresponded to the intron-
containing fragment. 
5.2.3 DmCBP80R is predominantly expressed in the abdomen 
of adult males 
The RT-PCR experiments have shown that Din CBP8OR is a bona fide gene that is 
restrictively expressed in Drosophila development. DmCBP80R mRNA is first 
detected in male and female third instar larvae and mRNA expression is 
subsequently restricted to adult males only. The next question to address was in 
which tissues is DmCBP80R mRNA expressed. RNA in situ hybridisation 
experiments performed on selected third instar imaginal discs showed no specific 
mRNA expression in the eye-antenna, haltere, brain, leg or wing discs (data not 
shown). 
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Figure 5.5 DmCBP80R mRNA is predominantly expressed in the male 
abdomen. RT-PCR analysis of DmCBP80R splicing in adult tissues. A. 
Schematic representation of predicted DmCBP80R gene structure with 
position of primer pair used for RT-PCR. Oligo pair S471 + S474 was used to 
perform RT-PCR across introns I and 2. B. Total RNA was extracted from 50 
adult males and females cut into three body parts, shown as head (H), thorax 
(T) and abdomen (Ab). C. [i] RT-PCR across introns 1 and 2 gives a spliced 
product of 1, 021 bp and unspliced form is 1, 196 bp. [ii] RT-PCR across 
intron 2 of DmCBP80 was included as a positive control, spliced intron 2 is 
423 bp and unspliced product is 484 bp. 
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This implies that DmCBP80R mRNA must be restricted to other third instar larval 
tissues such as the fat body, salivary glands or gonads. Since adult males are easier to 
manipulate than larvae, it was decided that DmCBP80R mRNA expression would be 
further examined in adult male tissues. 
As before, RT-PCR was used to determine whether unspliced or spliced DmCBP80R 
was present in various adult body parts. A total of 50 adult females and adult males 
were cut into three body parts illustrated in Figure 5.5, B. Total RNA was extracted 
and used in RT-PCR in combination with the oligo pair S471 + S474, which 
amplifies across both introns I and 2 (Panel Q. Correct splicing of DmCBP80R 
introns 1 and 2 gives a 1, 021 bp product whilst the pre-mRNA is 1, 196 bp. In adult 
females, no detectable spliced RNA was detected in either the head, thorax or 
abdomen tissues (Panel C, [i] lanes 4-6). In contrast, spliced DmCBP80R was 
predominantly observed in the male abdomen with very low detectable levels present 
in the male thorax ([i] lanes 2 and 3). Although not clearly visible in Figure 5.5 B, 
low levels of unspliced DmCBP80R RNA were detected in the head, thorax and 
abdomen tissues ([i] lanes 1-3). Again the positive control, which used primers 
designed against DmCBP80 intron 2, demonstrated that RNA preparations used in 
these experiments were intact and not degraded. As expected, DmCBP80 mRNA is 
expressed throughout the head, thorax and abdomen tissues of adult males and 
females ([ii] lanes 1-6). The negative controls using total RNA treated with RNase 
showed that the RT products were derived from RNA (data not shown). Subsequent 
preliminary experiments have performed RT-PCR on adult male abdomens with 
testes removed and isolated testes. This determined that in the male abdomen 
CBP80R mRNA is predominantly expressed in adult testes (data not shown). 
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52.4 Production of polyclonal antibodies against DmCBP80R 
In order to proceed with immunofluorescence and biochemical investigations, it was 
necessary to raise antibodies against DmCBP80R. Since DmCBP80R was not readily 
available in a vector to express protein, it was decided to raise peptide antibodies 
against DmCBP80R. Comparison of DrnCBP80R and DmCBP80 protein sequences 
demonstrated greater sequence divergence and length heterogeneity within the 
carboxyl-regions. As a result, two rabbits were immunised with a 15 amino acid 
synthetic peptide (MSEDASDLRPEISKT) designed against the carboxyl-terminus of 
DmCBP80R. The rabbits were subjected to three bleeds before they were killed and 
purified polyclonal sera extracted (Abcam). Western blots were prepared that 
contained total protein extracted from 50 adult male and female abdomens, which 
effectively served as positive and negative controls. The conceptual translation of 
DmCBP80R gives a protein product of 85 KDa. However, western analysis of the 
bleeds and purified antibody showed no bands were recognised corresponding to the 
predicted size of DmCBP80R in male abdomens (data not shown). 
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5.3 DISCUSSION 
5.3.1 Drosophila melanogaster has two CBP80 homologues 
Searches of the completed Drosophila genome indicate DmCBP20 is a single-copy 
gene and DrnCBP80 has two homologues. Results from Chapter 3 show DmCBP80 
is mapped to 4C7-8 on the X-chromosome. In contrast, DrnCBP80R is located to the 
right arm of chromosome 3 on polytene segment 93E1-2. Comparison of the 
predicted protein sequences show DmCBP80R is highly divergent from DmCBP80. 
However, DmCBP80R does share many of the strongly conserved residues found in 
CBP80 homologues from higher eukaryotes. Indeed, the bipartite NLS and recently 
described MIF4G domain are strongly conserved in both Drosophila proteins 
(Izaurralde et al., 1995; Ponting, 2000). The functional role of the MIF4G domain is 
currently not known, however, it is thought to implicate CBP80 in NMD (Mendell et 
al., 2000; Ishigaki et at., 2001). In comparison to the amino-region, the carboxyl-
terminus of DmCBP80R is highly divergent to CBP80. This is particularly apparent 
in the last 150 amino acids of DmCBP80R, which show very low sequence identity 
to DmCBP80. In addition, a majority of the size difference between DmCBP80 and 
DmCBP80R proteins results from deletions of amino acids within this region. 
Recently, the X-ray crystal structure of HsCBP80 has been determined and shows the 
carboxyl-terminal 150 amino acids fold into two alpha helices that form a very long 
coiled-coil. This coiled-coil protrudes from CBP80 and is thought to provide a 
distinct surface for protein-protein interactions between CBP80 and RNA processing/ 
export factors (Mazza et al., 2001). Although the coiled-coil is strongly conserved in 
DmCBP80, most of the corresponding amino acids in DmCBP80R are deleted or 
share very low sequence identity to HsCBP80. This suggests that in comparison to 
DmCBP80 and HsCBP80, the carboxyl-region of DmCBP80R might mediate 
interactions with different cellular proteins. Taken together, these data suggest the 
high sequence divergence between the two Drosophila homologues might result 
from DmCBP80R acquiring new functions during evolution. 
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53.2 CBP80R is predominantly expressed in 3rd  instar larvae 
and adult testes 
Results from the northern and RT-RCR analysis show DmCBP80R is restrictively 
expressed throughout Drosophila development. Spliced DmCBP80R is initially 
detected in third instar larvae and subsequently becomes restricted to adult males 
only. In adult males, DmCBP80R mRNA is restricted to the abdomen and 
preliminary results show it appears to be predominantly expressed in the testes. 
Consequently, the RNA analysis strongly suggests that DmCBP80R plays a role in 
spermatogenesis. In contrast to DmCBP80R, DmCBP80 is ubiquitously expressed in 
development and appears to be maternally derived (Chapter 3). Although roles for 
DmCBP80 have been defined in somatic cells, it is unclear whether DmCBP80 also 
functions during spermatogenesis. Moreover, it remains to be determined whether 
DmCBP80 and DmCBP80R are functionally redundant. Future RT-PCR experiments 
will determine whether DrnCBP80 and DmCBP80R are co-expressed or mutually 
excluded in testes. In addition, RNA in situ analysis can be used to address if 
DmCBP80R is expressed ubiquitously or restricted to specific cell types in the testes. 
Chapter 4 has already described how the mobilisation of a P-element in DmCBP20 
generates a very high number of homozygous viable male sterile lines. Initial 
characterisation of these lines suggests the sterility might arise from defects in 
spermatid differentiation during the final stages of spermatogenesis. It is well 
established that CBC has a characterised role in the RNA processing events of pre-
mRNA splicing and RNA 3'-end formation that are coupled with transcription 
(Lewis and Izaurralde, 1997; Hirose and Manley, 2000). However, in 
spermatogenesis, RNAP II transcription rarely occurs after meiosis. Instead, mRNAs 
required for the later stages of spermatogenesis are transcribed early and sequestered 
in a stable form ready for translation. Therefore, defects in CBC function would be 
expected to affect the early pre-meiotic stages of spermatogenesis. Taken together, 
the DmCBP20 male sterile mutations suggest Din CBP2O might have novel functions 
outside nuclear RNA processing and this might occur with DmCBP80R. 
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During spermatogenesis the translation of certain mRNAs are delayed until the 
proteins are required in post-meiotic cells (Venables and Eperon, 1999). However, 
the strategies and mechanisms for regulating translation remain unclear. Many RNA-
binding proteins, like DrnCBP20, appear to be important for spermatogenesis but 
little is understood about their specific functions (Venables and Eperon, 1999). One 
possibility is that DmCBP20 could bind DrnCBP80R to form a male-specific CBC 
that affects the translational status of rnRNAs transcribed during early 
spermatogenesis. The male-specific CBC could mask mRNAs from the translation 
machinery until later stages of spermatogenesis when the proteins are required for 
function. In order to support this hypothesis, additional work is necessary to initially 
determine whether DmCBP80R can bind DmCBP20 to form a male-specific CBC. 
5.4 CONCLUSIONS 
A second divergent CBP80 homologue has been identified in Drosophila 
melanogaster. DmCBP80R mRNA is detected in third instar larvae and adult males 
where it is predominantly expressed in testes. 
128 
Chapter 6 Expression of wild-type and mutant CBC protein using GALA- UAS system 
CHAPTER 6 
Expression of wild-type and mutant CBC 
protein using the GAL4-UAS system 
6.1.1 INTRODUCTION 
The available evidence shows that CBC is a key player in the metabolism of RNAP 
II transcripts. CBC is found to mediate the positive effects of the cap in at least three 
major aspects of nuclear RNA processing: pre-mRNA splicing, RNA 3'-end 
formation and U snRNA export (Lewis and Izaurralde, 1997). Despite this, little is 
known about the proteins CBC interacts with or the molecular mechanisms involved. 
Genetic studies in S. cerevisiae have used synthetic lethal screens and yeast two-
hybrid systems to identify CBC-interacting genes (Gamberi et al., 1997; Fortes et al., 
1999b). However, these experiments have had limited success and current data 
strongly suggests that genetic approaches in Drosophila melanogaster might be more 
useful in identifying CBC-interacting genes. 
Characterisation of CBC's function in pre-mRNA splicing shows that it promotes the 
association of Ui snRNP with the cap-proximal splice site. Furthermore, the role of 
CBC in cap-dependent splicing is found to be conserved from yeast to humans (Colot 
et al., 1996; Lewis et al., 1996). Although the molecular mechanism by which CBC 
functions during splicing has not been elucidated, recent genetic studies in S. 
cerevisiae show that CBC appears to mediate the positive effect of the cap through 
direct interactions with Ui snRNP (Fortes et al., 1999a and 1999b). This contrasts 
with the mammalian system, where there is no evidence of a direct interaction 
between CBC and Ui snRNP. Instead, the available data suggests that in higher 
eukaryotes, CBC function is facilitated through yet unidentified adaptor proteins 
(Lewis et al., 1996). As a result, the mechanism of CBC action appears to be 
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different between higher and lower eukaryotes. Given that Drosophila is closer to 
humans than yeast, genetic studies in fruit-flies might be more successful in 
identifying candidate adaptor molecules that facilitate the function of CBC and the 
cap in RNAP II transcript metabolism. 
Further support for using fruit-flies as a tool for identifying CBC-interacting genes 
comes from the characterisation of DmCBC. Although mutations in the constituents 
of S. cerevisiae CBC only impair vegetative growth, in Drosophila, at least CBP20 is 
an essential gene (Chapter 4). This suggests that the requirement for CBC in RNAP 
II transcript metabolism is greater in higher eukaryotes. In addition, both human and 
Drosophila cap-binding proteins share a very high degree of conservation (Chapter 
3). This strongly supports that CBC function might also be conserved between these 
species. Finally, the recent sequencing of the Drosophila genome has revealed 
extensive conservation between the components of the spliceosome in vertebrate and 
Drosophila systems (Adams et al., 2000; Mount and Salz, 2000). This suggests the 
complexity of mechanisms such as splicing, which contribute to RNAP II transcript 
processing are similar in both Drosophila and humans. Therefore, the identification 
of CBC-interacting genes in fruit-flies might lead to a greater understanding of the 
biology of CBC. Taken together, these data provide a strong case for using genetic 
approaches in Drosophila melanogaster to elucidate the mechanisms by which CBC 
and the cap facilitate multiple aspects of RNAP II transcript metabolism. 
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6.1.2 GAL4-UAS system 
In order to identify interacting genes in Drosophila, one genetic approach is to use 
flies with a sensitized genetic background in genetic modifier screens. These flies 
can be generated by creating mutants in the endogenous gene of interest, or 
alternatively, using the GAL4-UAS system to produce transgenic flies with dominant 
phenotypes. The GAL4-UAS system is a powerful tool that allows the biology of 
genes to be studied in vivo (Brand and Perrimon, 1993). Classically, GAL4-UAS has 
been used to investigate the effects of over-expressing wild-type or mutated proteins 
that cause dominant phenotypes (Kraus and Lis, 1994; Pan and Rubin, 1997; Elefant 
and Palter, 1999). Targeted gene expression studies have been useful in examining 
the roles of regulatory proteins such as wingless and EGFR in specifying cell fates 
(Freeman, 1996; Johnston and Schubiger, 1996). However, GAL4-UAS generated 
dominant phenotypes have also been successfully used in genetic modifier screens to 
identify interacting gene products or to establish epistatic relationships (Rorth et at., 
1998; Helms et at., 1999; Wan et al., 2000). 
GAL4-UAS gene expression is a binary system where the target gene is separated 
from its transcriptional activator in the form of two distinct transgenic strains, the 
GAL4 driver and the UAS line (Figure 6.1). The GAL4 driver contains the S. 
cerevisiae GAL4 gene that has been randomly inserted into the fly genome and is 
under the control of a tissue-specific promoter. The UAS-transgenic line is generated 
by cloning the gene of interest into pUAST, the vector that directs Ga14 dependent 
transcription. In pUAST, the cloned gene is situated downstream of five Ga14 
upstream activation sites (UAS) and upstream of a SV40 transcriptional terminator 
and polyadenylation site. Consequently, gene transcription is only activated within 
cells that express Ga14 protein. P-element mediated transformation is used to 
integrate the UAS-gene into the fly genome and the resultant transgenic lines contain 
the UAS-gene that is transcriptionally silent. 
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Figure 6.1 The GAL4-UAS system. Targeted gene expression using the 
GAL4-UAS system. FO. GAL4 driver is crossed to the UAS-transgenic tine. 
GAL4 driver contains the yeast GAL4 gene that has been randomly inserted 
into the fly genome and is under the control of a tissue-specific promoter. 
UAS-transgenic line contains the gene of interest, which is cloned behind five 
Ga14 upstream activating sites (UAS). In the absence of Ga14, the target gene 
is transcriptionally silent. Fl. Resultant progeny can activate UAS-transgene 
transcription in the tissues where Ga14 protein is expressed. 
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UAS-gene transcription is only activated when a GAL4 driver is crossed with a 
UAS-transgenic line. Subsequently, the Fl progeny can only activate UAS-gene 
transcription in specific tissues allowing the phenotypic consequences of targeted 
expression to be studied. 
Complementary to the P-element induced mutagenesis described in Chapter 4, the 
GAL4-UAS system was used to over-express wild-type and mutant CBP20 and 
CBP80 proteins in non-essential adult tissues. These transgenic flies were screened 
for dominant phenotypes, which were subsequently used in genetic modifier screens 
to identify CBC-interacting genes. This Chapter describes the identification and 
characterisation of dominant phenotypes in both CBP20 and CBP80. 
6.2 RESULTS 
6.2.1 GAL4-UAS Crosses 
In order to generate dominant adult phenotypes in CBC, the GAL4-UAS system was 
used to employ two different strategies. Firstly, the system was used to over-express 
wild-type Drosophila and human CBP20 and CBP80 proteins. Secondly, one of the 
cap-binding proteins in the CBC heterodimer was mutated and over-expressed with 
the aim of generating putative dominant negative forms of CBC. Full-length 
Drosophila UAS-CBP20 and UAS-CBP80 were cloned into pUAST along with the 
human transgenes. Despite being highly homologous to DmCBC, the human cap-
binding proteins contain notable amino acid changes at conserved regions that might 
represent different protein-protein interactions. It was therefore reasoned that over-
expression of either HsCBP20 or HsCBP80 might generate a hybrid CBC that would 
also produce dominant phenotypes in adult tissues. 
The strategy employed in creating a dominant negative form of CBC involved 
making C-terminal truncations in DmCBP20 and DmCBP80 by PCR and cloning 
these constructs into pUAST. The predicted amino acid sequence of DmCBP80 
contains a conserved putative bipartite NLS at the amino-terminus. The NLS has 
been demonstrated to be functional in humans since mutation of this sequence 
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inhibits the nuclear import of HsCBP80 (Mattaj, 1993; Izaurralde et al., 1994). As a 
result, four C-terminal truncations were made outside this domain, at regions 
believed to be conserved boundaries from amino acid sequence alignments (Figure 
6.2, A). Interestingly, the recently described MIF4G domain that represents 
significant sequence similarities between the middle portion of eIF4G, domains in 
NMD2/Upf2 and CBP80 homologues was also left intact in all four truncations 
(Ponting, 2000; Mazza et al., 2001). As mentioned earlier, the MIF4G motif 
implicates CBC in NMD. Although the functional significance of this domain is 
currently unknown, it is thought to mediate protein-protein interactions (Ishigaki et 
al., 2001). 
In contrast to DmCBP80, the amino acid structure of DmCBP20 consists essentially 
of a RBD comprised of two RNP motifs, followed by a C-terminal tail rich in 
arginine and glycine residues (Makkerh 1996; Izaurralde et al., 1995). The RBD of 
CBP20 is thought to have a phylogenetically conserved functional role in binding 
capped RNA (Mazza et al., 2001). Since the RBD appears to be essential for RNA or 
cap-binding activity, it was left intact. Instead truncations were made in the auxiliary 
RGG tail, whose function in CBC is currently unknown, but probably serves to 
stabilise the interaction between CBC and capped RNA (Birney et al., 1993; Burd 
and Dreyfuss, 1994). As a result, two truncations were made in DmCBP20, the first 
in the middle of the RGG domain and the second deleted this domain altogether 
(Figure 6.2, B). 
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Figure 6.2 UAS-CBP20 and UAS-CBP8O constructs transformed into 
flies. Schematic diagram representing A. UAS-CBP80 and B. UAS-CBP20 
constructs. Full-length human and Drosophila ORFs together with C-terminal 
truncations were cloned into pUAST. UAS-transgenic lines were then 
generated by P-element mediated transformation. 
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Both full-length and truncated Drosophila and human CBP20 and CBP80 constructs 
were cloned into pUAST and sequenced. P-element mediated transformation was 
then used to generate UAS-transgenic lines, which were characterised according to 
the eye colour of female adults and the mapping of transgene insertions. Each UAS-
construct generated lines with independent insertions as demonstrated by the range of 
white marker expression, which might suggest varying strengths of transgene 
expression and the transgenes mapping to different chromosomes (Appendix B). In 
order to check that the UAS-transgenic lines were transcriptionally silent, adult flies 
were examined under a dissecting light microscope. This determined that in the 
absence of Ga14, UAS-transgenic flies did not exhibit any visible phenotypes. 
6.22 Screen for CBP20 and CBP80 dominant adult 
phenotypes 
To test whether CBP20 and CBP80 UAS-transgenic strains generated dominant 
phenotypes once transcriptionally activated, a screen was performed crossing five 
independent lines from each UAS-transgene to six different GAL4 drivers. The 
UAS-transgenic lines were selected on account of varying eye colour and transgene 
insertion on different chromosomes. The GAL4 drivers chosen for the screen 
included patched, decapentaplegic, scabrous, S31, vestigal, scalloped, GMR, eyeless 
and OK-384, which collectively express Ga14 in the larval eye, wing and leg 
imaginal discs. Since Ga14 activity is temperature dependent, crosses were set up at 
29°C, 25°C and 18°C and the Fl progeny were screened for dominant adult 
phenotypes. As a control, GAL4 lines were crossed to w"8 flies to observe the effects 
of expressing Ga14 alone. The results from these mass GAL4-UAS crosses are 
presented in Appendix C. In summary, over-expression of full-length Drosophila and 
human CBP20 and CBP80 proteins did not produce any obvious defects in adult 
tissues. However, the targeted expression of the smallest truncations in both 
DmCBP20 and DmCBP80, which remove 29 and 152 amino acids from the C-
terminus respectively, did generate dominant adult phenotypes. 
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6.2.3 Identification of the dominant truncation UAS-
DmCBP20AC 1-125 
A total of two C-terminal truncations were generated in Din CBP2O, the first was 
made in the middle of the RGG domain and the second deleted this domain all 
together. Only the truncation in the middle of the RGG domain, UAS-DmCBP20AC 
1-125 (20/tC jj)  generated visible phenotypes when crossed with patched (plc) GAL4 
alone (Appendix Q. Although the function of the RGG domain in CBP20 is 
currently not known, it is thought to stabilise the interaction between CBC and 
capped RNA (Birney ci al., 1993; Burd and Dreyfuss, 1994; Izaurralde et al,, 1995). 
The transcriptional activation of 20zW 1425  with ptc-GAL4 produced dominant 
phenotypes in the eye, wing and thoracic tissues of adult flies. This is consistent with 
ptc being a segment polarity gene and directing Ga14 expression in the stripes 
between the anterior-posterior boundary of larval imaginal discs (Speicher et al., 
1994). Although, a total of three independent transgenic lines were generated 
containing the 20AC 1125 transgene, only line #1 produced notable phenotypes in 
combination with plc-GAL (Figure 6.3, A). As a result, the dominant phenotypes 
observed in 20AC 1125  #1/ ptc-GAL4 adult eye, wing and thoracic tissues are 
described below. 
The thorax of an adult fly can be broadly divided into two regions, the upper notum 
and the lower scutellum. In a wild-type fly, the scutellum is characterised by four 
long bristles termed macrochaetae and these are highlighted in the control fly that 
expresses Ga14 alone (Figure 6.4, Panel A[i]  and  B[iii]).  The transcriptional 
activation of 20AC 1125  #1 in combination with ptc-GAL4 caused the scutellar 
macrochaetae located proximally on the thorax to over-produce. As can be observed 
from Figure 6.4, at 25°C the two proximal scutellar macrochaetae were multiplied 
nearly 5 fold. The macrochaetae increased from the wild-type number of two, to 9 
macrochaetae in the 20zC 1175 #1/ptc-GAL4 mutant (compare Panel B [iii] with [iv]). 
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Figure 6.3 Identification of dominant truncations UAS-DmCBP20AC 1425 
and UAS-DmCBP80C 	Summary of UAS-transgenic lines and GAL4 
drivers that generate dominant phenotypes. A. Out of three transgenic lines 
containing UAS-DmCBP20EC 1425  transgene, line #1 in combination with 
patched-GAL4 (ptc) produced observable phenotypes in eye, wing and 
thoracic tissues. B. Eight transgenic lines contained the UAS-DmCBP80LC 1 
648 transgene of which, four lines generated visible phenotypes when crossed 
with scabrous (sca), decapentaplegic (dpp), eyeless (ey), ptc or OK-384 
GAL4 drivers. UAS-lines are listed in order of relative strength, where line #6 
is the strongest and line #7 is the weakest. 
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Figure 6.4 UAS-DmCBP20AC 1-125  #1/ptc-GAL4 
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Figure 6.4 UAS-DmCBP20AC 1425  #1/ ptc-GAL4 dominant bristle 
phenotype. At 25°C, over-expression of UAS-DmCBP20zsC 1425  #1 under 
ptc-GAL4 control leads to over-production of the two proximal scutellar 
macrochaetae. Scutellum of ptc-GAL4/+ control flies is characterised by four 
macrochaetae at A. [i] 18°C and B. [iii] 25°C. In UAS-DmCBP20AC 1425  #1/ 
ptc-GAL4 adults, proximal set of scutellar macrochaetae are B. [iv] multiplied 
at 25°C and A. [ii] wild-type at 18°C. C. Graph illustrating frequency of 
proximal scutellar macrochaetae within population of UAS-DmCBP20EC 1425 
#11ptc-GAL4 and control flies at 25°C. 
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However, this increase in proximal scutellar macrochaetae was not consistent within 
the Fl population. The graph in Panel C illustrates the range in the number of 
proximal scutellar macrochaetae in 20AC 1125 #1/ptc-GAL4 and GAL4 controls. In 
20AC 1425  #1/ptc-GAL4 adults, the macrochaetae ranged from 3 to 11 bristles, where 
34% of the population exhibited 9 bristles. In contrast, 94% of GAL4 control flies 
had the wild-type number of 2 bristles and the remaining 6% of control flies had 3 
proximal scutellar macrochaetae. Since the GAL4-UAS system is temperature 
dependent, repeating the cross at a lower temperature would be expected to decrease 
the severity of the dominant phenotype. Indeed, this was observed at 18°C where the 
proximal scutellar macrochaetae reverted to the wild-type number of two (compare 
Panels A [i] with [ii]). Conversely, increasing the Ga14 activity by raising the 
temperature to 29°C resulted in the more severe phenotype of pupal lethality (data 
not shown). Taken together, these observations suggest that the dominant 
macrochaetae phenotype is due to 20AC 425#1  transgene expression. 
In addition to the over-production of scutellar macrochaetae, the transcriptional 
activation of 20AC 1/25#1  under the control of ptc-GAL4 generated dominant eye and 
wing phenotypes at 25°C. Similar to the macrochaetae phenotype, the aberrant eye 
phenotype was not fully penetrant within the Fl population. As can be observed from 
Figure 6.5, eyes from the control fly that expressed Ga14 alone were wild-type (Panel 
A [i]). In comparison, 20/tC 1125 #1/ptc-GAL4 eyes ranged from mildly rough and 
reduced to wild-type in appearance (Panels A compare [ii and iii] with [iv and v]). 
This dominant eye phenotype also had a low penetrance within the Fl population 
with only 25% of adults exhibiting aberrant eyes (Panels A [ii] to [iv]). Whilst the 
remaining 20AC 1175 #1/ptc-GAL4 flies had eyes that were wild-type (Panel A [v]). 
Decreasing the Ga14 activity by reducing the temperature to 18°C produced 20AC 
125 #1/ptc-GAL4 eyes that were wild-type in appearance. Conversely, increasing the 
temperature to 29°C resulted in pupal lethality (data not shown). Taken together, 
these observations suggest that the dominant eye phenotypes generated at 25°C are 
due to the over-expression of 20AC J475 #1 truncation. 
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Figure 6.5 UAS-DmCBP20EC 125  #1/ ptc-GAL4 dominant wing and eye 
phenotype. At 25°C, over-expression of UAS-DmCBP20AC 1425  #1 directed 
by ptc-GAL4 generates aberrant phenotypes in adult eye and wing tissues. A. 
[i] Eye from ptc-GAL4I + control is wild-type. [ii-v] Eyes from UAS-
DmCBP20z\C 1125 #1/ptc-GAL4 range from mildly rough and reduced to wild-
type B. [i] Wing from ptc-GAL4/ + control is wild-type. [ii] Wing from 
DmCBP20AC 1125  #1/ptc-GAL4 has additional short veins indicated as A-D. 
D. [i] ptc-GAL4I+ control [ii] Additional short veins result from over-production 
of wing bristles. 
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Over-expression of 20AC ]475 #1 under the ptc promoter also elicited mild growth 
defects in the developing wing. At 25°C, additional veins were found in 20AC 1125 
#1/ptc-GAL4 wings that were not present in the control flies that expressed GAL4 
alone (Figure 6.5, Panels B compare [i] with [ii]). In 20AC 1125 #1/ptc-GAL4 flies, 
the wing bristles were over-produced at specific regions and this generated additional 
short veins (Panel B compare [i] D with [ii] D). In comparison to the dominant eye 
phenotype, the wing phenotype was more penetrant within the Fl population. 
Interestingly, extra short veins were consistently found in the first posterior cell and 
distal tip of the wing in 75% and 49% of 20AC 1125 #1/ptc-GAL4 adults respectively 
(Panel B [ii], A and D). Whilst two other short veins were also present in 62% of 
mutant flies but these were randomly located on the adult wing (for example, Panel B 
[ii], B and Q. 
Although, 20AC 1175 #1/ptc-GAL4 flies exhibited dominant phenotypes in the eye, 
wing and thoracic tissues, only the scutellar macrochaetae phenotype was considered 
suitable to facilitate a genetic screen. The macrochaetae phenotype was easily 
detected under a dissecting light microscope and in addition, was consistent within a 
population at 21°C and 25°C (data not shown). To proceed with the genetic analysis, 
it was necessary to recombine ptc-GAL4 and 20AC 1/25  #1 transgenes onto the same 
chromosome. Consequently, large scale recombination crosses were performed at 
21°C and 25°C. In over 1000 crosses, no viable recombination events were found at 
either temperature that included both UAS and GAL4 transgenes. This suggests that 
recombining 20AC 1125  #1 and ptc-GAL4 might be lethal or alternatively, both 
transgenes are inserted too close to allow recombination. As a result, work in the 
following sections concentrate on the DmCBP80 dominant truncation, UAS-
DmCBP80AC164 . 
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6.2.4 Identification of the dominant truncation UAS-
Dm CBP80AC1648 
A total of four C-terminal truncations were generated in DmBP80 at regions 
believed to be conserved domain boundaries from multiple sequence alignments. As 
before, transgenic lines containing these truncations were transcriptionally activated 
by crossing with several GAL4 drivers. Out of the four truncations, only UAS-
DmCBP80AC J48  (80AC 1-648)  transgene induced significant phenotypic effects when 
over-expressed with ptc, decapentaplegic, scabrous, eyeless and OK-384 GAL4 
drivers (Appendix Q. 80AC 	is the shortest truncation in DmCBP80 that removes 
152 amino acids from the C-terminus. However, the functional significance of this 
deletion is currently unknown. A total of eight independent lines were generated 
containing the 80AC /648  transgene, of which four lines produced dominant 
phenotypes. Figure 6.3, B presents these four lines placed in order of their relative 
strengths of expression, as judged by the range of phenotypes observed with various 
GAL4 drivers at different temperatures. The dominant phenotypes observed in 
combination with eyeless, OK-384 and scabrous GAL4 drivers are described below. 
Transgenic line UAS-DmCBP80L\C 1648#4 (80AC 1648  #4), which was mapped to the 
second chromosome and the second strongest transgene, produced dominant adult 
phenotypes under the control of scabrous, decapentaplegic, OK-384, ptc and eyeless 
GAL4 drivers (Figure 6.3, B). Transcriptional activation of 80zlC 1648  #4 in 
combination with eyeless (ey)-GAL4 generated dominant phenotypes in the adult 
eye. This is consistent with eye directing Ga14 expression to cells anterior of the 
morphogenetic furrow in larval and late pupal eye discs (Eggert et al., 1998b). At 
25°C, over-expression of 80AC 1648  #4 generated smaller eyes compared to the 
control that expressed GAL4 alone (Figure 6.6, B). Examination of the adult eyes by 
scanning electron microscopy (SEM) clearly showed that the basic unit of the eye, 
the ommatidia clusters, were reduced in number over gross regions (Panels B, 
compare [i] with [ii-iv]). There was no consistent pattern of ommatidia loss with 
approximately 15% to 80% of ommatidia being absent in adult eyes. 
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Figure 6.6 UAS-DmCBP80AC i648#4; ey-GAL4 
Dominant Eye Phenotype 
Figure 6.6 UAS-DmCBP80EC 1-648  #4; ey-GAL4 dominant eye phenotype. 
Over-expression of UAS-DmCBP80tC 1-648  #4 under control of ey-GAL4, 
which expresses in the head and eye,results in loss of eye tissue at 25°C and 
smaller head at 29°C. A. At 29°C, eyes from [i] ey-GAL4/+ control pharate at 
late pupal stage are wild-type. [ii] In SOAC 1646  #4; ey-GAL4 pharate of same 
stage, both eyes are absent and the head is smaller. Scanning electron 
micrographs of adult eyes. B. [i] At 25°C, eye from ey-GAL4/ + control flies is 
wild-type. [ii-iv] 80LC 1-648  #4; ey-GAL4 eyes are reduced to varying degrees. 
Measurements based on images suggest approximately 15% to 80% of the 
eye is absent. C. [i] and [ii] At 18°C, ey-GAL4/ + and 80AC 1648  #4; ey-GAL4 
eyes are wild-type. 
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This suggests that the dominant phenotype is caused by growth defects in ommatidial 
assembly. Since the GAL4-UAS system is temperature dependent, increasing the 
Gal4 activity by raising the temperature to 29°C generated the more severe 
phenotype of pupal lethality. On closer examination, eyes from 80AC 1-648  #4; ey-
GAL4 pharates were found to be completely absent (Panels A, compare [i] and [ii]). 
This significantly reduced the size of the head, which suggests the lethality might 
result from the inability of pharates to push through the pupal case and eclose. 
Conversely, decreasing the temperature to 18°C produced 80/tC 1648  #4; ey-GAL4 
adults with eyes that were wild-type in comparison to the GAL4 control (Panels C, 
compare [i] and [ii]). Taken together, these observations suggest that the dominant 
eye phenotypes produced at higher temperatures are specifically due to 80/tC 1648  #4 
transgene expression. 
Although the dominant phenotype observed in 80AC 1648  #4; ey-GAL4 flies 
obviously arises from defects in eye development, it is unclear which stages of 
development are being affected. Ommatidial assembly is an ordered process of cell 
recruitment where the photoreceptor cells form a cluster along with cone cells, 
pigment cells and bristle cells respectively (Chang et al., 1994). Eyes from 80AC 1648 
#4; ey-GAL4 adults clearly show that the ommatidia are reduced in number. This 
suggests that the dominant eye phenotype might arise from defects in cell growth. 
Disruptions in cell proliferation, cell death or cell fate decisions would affect 
ommatidial assembly and decrease the number of ommatidial clusters. Interestingly, 
GMR-GAL4 failed to generate aberrant eye phenotypes when crossed with 80AC 1648 
transgene at 18°C, 25°C or 29°C. GMR-GAL4 expresses Ga14 during the later stages 
of eye development, in cells posterior to the morphogenetic furrow. Collectively, this 
suggests that the dominant eye phenotype might arise due to defects in cell growth 
during the earliest stages of eye development. This is consistent with the time cells 
undergo rapid cell proliferation. 
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In contrast to the restricted expression of ey-GAL4, OK-384-GAL4 drives Ga14 
expression in most adult tissues including the wing, eye, leg and thorax (Connolly et 
al., 1996). It is therefore not surprising that over-expression of 80AC 1-648  under the 
control of OK-384 resulted in lethality. The transgenic line UAS-DmCBP80AC 1648 
#7 (80AC 1-648  #7), which was mapped to the third chromosome and the weakest 
transgene, produced dominant phenotypes under the control of ey, ptc and OK-384 
GAL4 drivers (Figure 6.3, B). The transcriptional activation of 80AC 1648  #7 in 
combination with OK-384-GAL4 resulted in pupal lethality at 29°C. Whilst the 
control flies that expressed Ga14 alone were viable and wild-type in appearance at 
this temperature. Decreasing the temperature and consequently Ga14 activity to 25°C 
or 18°C produced viable 80AC j64  #7; OK-384-GAL4 adults that did not exhibit any 
visible phenotype (data not shown). Taken together, these data suggest that the pupal 
lethality at 29°C is specifically due to the over-expression of 80/tC 1648  truncation. 
The transgenic line UAS-DmCBPSOAC 1648#6 (80AC 1648  #6), which was mapped to 
the second chromosome and the strongest transgene, produced dominant phenotypes 
under the control of decapentaplegic, ey, ptc, OK-384 and sca GAL4 drivers (Figure 
6.3, B). Scabrous (sca) specifically directs Ga14 expression in a subset of cells called 
the proneural cluster and sensory organ precursor (SOP), which are involved in the 
development of the external sense organs (Hinz et al., 1994). Defects in this 
developmental pathway are easily visualised in adults as aberrant bristles on the 
head, thorax and wing tissues. When 80AC 1648  #6 was crossed with sca-GAL4 at 
25°C, 80/tC 1643  #6/ sca-GAL4 progeny exhibited a severe loss of macrochaetae. To 
illustrate this point, the phenotype observed in the thoracic tissues will be described 
in comparison to the control fly that expressed Ga14 alone. Both the dorso-central 
region of the notum and scutellum are defined by four macrochaetae that are 
indicated in Figure 6.7, Panel A [i]. At 25°C, activation of 80zillC 1 648  #6 transcription 








Figure 6.7 UAS-DmCBP80AC 1-648  #6, sca-GAL4 
Dominant Bristle Phenotype 




Figure 6.7 UAS-DmCBP80AC 1-648  #6, sca-GAL4 dominant bristle 
phenotype. Over-expression of UAS-DmCBP80AC 1-648  #6 under control of 
sca-GAL4 produces aberrant macrochaetae on thorax. A. [i] Central region of 
notum and scutellum are each defined by four macrochaetae, depicted 1-4 in 
blue and green respectively. [i]-[iii] In sca-GAL4I + adults, macrochaetae on 
thorax are wild-type at 18°C, 21°C and 25°C. B. [i] In 80AC 1648#6,  sca-GAL4 
adults, macrochaetae on notum and scutellum are absent at 25°C. [ii] At 
21°C, two distal scutellar macrochaetae are present, whilst macrochaetae on 
notum are still absent. Measurements based on images suggest scutellar 
macrochaetae are 45% shorter and thinner than GAL4 controls. [iii] At 18°C, 
80AC 1648  #6, sca-GAL4 adults have wild-type number of macrochaetae on 
both notum and scutellum. These macrochaetae are approximately 35% 
shorter and thinner than GAL4 controls. 
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In addition, there was a loss of smaller bristles or microchaetae on the notum 
compared with the Ga14 control (compare Panels A [i] with B [i]). In 80AC 1648  #6/ 
sca-GAL4 adults, this 'bald' phenotype was reduced in severity at lower 
temperatures, which is consistent with a decrease in Ga14 activity. At 21°C, two out 
of four scutellar macrochaetae were present within 65% of the Fl population. The 
remaining 35% of 80AC 1648  #6/ sca-GAL4 adults had an additional macrochaeta 
found on the central region of the notum. These macrochaetae were approximately 
45% shorter and thinner than the GAL4 controls. Also associated with the reduced 
temperature was an increase in microchaetae towards the wild-type number (compare 
Panels A [ii] with B [ii]). At the lowest temperature, the wild-type number of both 
macrochaetae and microchaetae were present. However, the macrochaetae were 
approximately 35% shorter in length and thinner than the GAL4 controls (compare 
Panels A [iii] with B [iii]). Conversely, increasing the temperature to 29°C resulted 
in the more severe phenotype of pupal lethality (data not shown). 
Taken together, these observations show that 80AC ]648  dominant phenotypes 
described in the eye and thorax are independent of the chromosomal integration site 
and reproducible with different GAL4 drivers. As a result, the dominant adult 
phenotypes are specifically due to the over-expression of 80AC 1648  truncation. 
Out of the four transgenic lines containing 804C 1648 transgene, 80LtC /648  #6/ sca-
GAL4 dominant bristle phenotype was considered the best suited for genetic modifier 
screens. This macrochaetae phenotype was easily detected under a dissecting light 
microscope at either 25°C or 21'C. Furthermore, the dominant bristle phenotype was 
highly penetrant within the Fl population at 25°C and 21°C, with little variation 
within the population (Figure 6.7 and data not shown). To further facilitate the 
genetic analysis, it was necessary to recombine sca-GAL4 and 80AC 1643  #6 
transgenes onto the same chromosome. Consequently, mass recombination crosses 
were performed at 25°C and 21°C. This generated 80AC 1643  #6, sca-GAL4 
recombinants on the second chromosome at both temperatures. Unfortunately, 80AC 
1648 #6, sca-GAL4 adults were sterile at 25°C. However, at 21°C, 80AC 1648  #6, sca-
GAL4 adults were fertile and the macrochaetae phenotype was tested for 
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reproducibility. This confirmed that the recombinant chromosome produced a 
dominant macrochaetae phenotype indistinguishable from when the transgenes 
resided on homologous chromosomes (data not shown). 
The primary aim of this Chapter was to generate a dominant adult phenotype in 
either CBP20 or CBP80 that could be used in a screen for genetic interactors. 
Therefore, time was not spent examining the developmental defects that underlie the 
80AC 1-648  dominant phenotypes. Like 80z\C 	#4; ey-GAL4, it remains to be 
determined which specific stages of sense organ development are being disrupted in 
sca-GAL4, 80AC /648  #6 adults. In brief, sense organ development involves the 
selection of the SOP precursor from the proneural cluster. The SOP then divides to 
form four components of the external sense organ that are the macrochaeta, socket, 
neuron and sheath (Jan and Jan, 1993). In sca-GAL4, 80LiC 1648  #6 adults, the 
macrochaetae were strikingly thinner and shorter than GAL4 controls at 21°C and 
18°C. Whilst at 25°C, the macrochaetae were absent with very few sockets being 
observed. This suggests that similar to 80AC 1648  #4; ey-GAL4 eyes, the 
macrochaetae phenotype might arise from defects in cell growth. The same factors 
are probably responsible for generating the range of dominant phenotypes observed 
in all four 80AC 1648  transgenic lines. It has not been investigated whether the neuron 
and sheath components of the external sense organ are also formed in 80AC 1648  #6, 
sca-GAL4 adults at 25°C. As a result, defects in cell proliferation or cell fate 
decisions are possible candidates for inducing 80/C 1648  dominant phenotypes during 
eye and sense organ development. 
In comparison to the developmental defects that underlie 80AC 1648  dominant 
phenotypes, it was considered more important to investigate the molecular defects 
generated by 80/tC 	truncation. This would reveal the significance of the deleted 
domain in 80z%C 1648  mutants and its contribution to CBC function. Out of the four 
transgenic lines, 80LC 1648  #6 had the strongest relative strength of expression. As a 
result, the next section describes how 80zC 1648  #6 mutants were analysed 
biochemically for defects in RNAP II transcript processing. 
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6.2.5 Analysis of RNA processing in UAS-DmCBP80AC 1.648#6  
mutants 
Characterisation of CBC has shown that it mediates the positive effects of the cap in 
pre-mRNA splicing, RNA 3'-end formation and U snRNA export (Lewis and 
Izaurralde, 1997). To test whether 80zlC 1-648  #6 mutants exhibit a splicing defect, the 
same northern blotting assay described in the characterisation of DmCBP20MFS in 
Chapter 4 was used. Whilst ovaries from DmCBP20IF  adults were easily dissected 
for analysis, 80/tC 1648  #6 also needed to be ubiquitously expressed in tissues that 
were easily isolated and collected. Consequently, the GAL4 driver C22 was chosen 
to direct 80/tC 	#6 expression in embryos. In order to characterise C22-GAL4 
expression, it was used to transcriptionally activate UAS-GFP and the resultant UAS-
GFP/ C22-GAL4 embryos were examined by fluorescence microscopy (data not 
shown). This determined that UAS-GFP was expressed ubiquitously throughout 
embryogenesis. As a result, 80AC 1648  #6 was over-expressed in combination with 
C22-GAL4 and this generated 80AC 1648  #6/ C22-GAL4 embryos that were lethal at 
25°C and viable at 18°C. Closer examination of 80AC 1-648  #6/ C22-GAL4 embryos 
staged the lethality towards the end of embryogenesis, around stage 14. In contrast, 
C22/ + control embryos that expressed Ga14 alone were viable at both 25°C and 
18°C (data not shown). This confirmed that the embryonic lethality observed was 
specifically due to the effects of 80AC 1648  #6 transgene expression and not Ga14 
alone. 
To determine whether the lethality of 80AC -648#61  C22-GAL4 embryos resulted 
from defects in pre-mRNA splicing, northern analysis was used to examine the 
splicing of endogenous ribosomal protein mRNAs during embryogenesis. Ribosomal 
proteins RpL19, RpS3 and RpA1 were specifically selected for analysis since they 
are ubiquitously expressed throughout embryogenesis and have pre-mRNAs that 
contain two introns, one intron and no introns respectively. Characterisation of CBC 
has shown that it mediates the stimulatory effects of the cap in the splicing of the 
cap-proximal intron alone (Izaurralde et al., 1994; Lewis et al., 1996). Therefore, if 
80AC 1648  #6 truncation generates a splicing defect, increased steady state pre-mRNA 
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to mRNA ratios would be observed in RpS3 pre-mRNAs that contain one intron. In 
contrast, over-expression of 80AC 1-648  #6 would be predicted to have no influence on 
the splicing of RpL19 that contains two introns and RpA1, which contains no introns 
and effectively serves as a negative control. 
Embryos were collected and matured from 80/iC 1648  #6/ C22-GAL4 and C22-GAL4/ 
+ at 18°C and 25°C for the following time points: 0-4, 4-8, 8-12, 12-16 and 16-22 
hours. Total RNA was then isolated from staged embryos and equivalent amounts of 
RNA were analysed by northern blotting. The nitrocellulose filters were 
subsequently probed with full-length RpL19, RpS3 and RpAJ cDNAs and the steady 
state ratios of pre-mRNA to mRNA were quantitated using Storm 860 
Phosphorlmager together with ImageQuant software (data not shown). However, no 
significant increase was observed in the steady state pre-mRNA to mRNA ratio of 
RpS3 ribosomal protein pre-mRNA5 throughout embryogenesis (data not shown). 
This suggested that the northern analysis might not be sensitive enough to detect a 
splicing defect in 80/iC 1648  #6/ C22-GAL4 embryos. Alternatively, embryonic 
lethality might be induced by defects in other functions of CBC such as RNA 3'-end 
formation (Flaherty et al., 1997). It was therefore reasoned that a more sensitive 
assay, such as RNase protection, would be better suited to address whether over-
expression of 80/iC J648  #6 generates aberrant pre-mRNA splicing. RNase protection 
assay would also address whether 80/iC 1648  #6/ C22-GAL4 embryos had defects in 
poly(A) tail formation. Unfortunately, the RNase experiments were not completed 
due to lack of time. 
6.2.6 UAS-DmCBP80AC 1-648 #6, sca-GAL4 is not a true 
dominant negative 
Before 80/iC 1648  #6, sca-GAL4 macrochaetae phenotype can be used in a genetic 
modifier screen, it needs to be characterised genetically. The original aim of this 
Chapter was to truncate either DmCBP20 or DmCBP80 and identify a dominant 
negative form of CBC, which gives a visible phenotype in adult tissues. To 
determine whether 80/iC 1-648  #6, sca-GAL4 macrochaetae phenotype was due to a 
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dominant negative effect, specific test crosses were performed at 21°C. If a 
truncation acts as a dominant negative, simultaneous removal of one wild-type copy 
of the gene would be predicted to increase the severity of the dominant phenotype. 
Conversely, flies that over-express full-length transgenes, as well as the truncation, 
would be predicted to suppress the dominant phenotype. As a result, flies were 
generated that in addition to over-expressing 80zC 1-648  #6, sca-GAL4, also contained 
Df(J) bi-D3 that uncovers the DmCBP80 locus. This determined that the 
macrochaetae phenotype was not enhanced by removing one wild-type copy of 
DmCBP80 (data not shown). However, the dominant phenotype was partially 
suppressed by introducing transgenes that over-expressed full-length UAS-DmCBP80 
#1. As can be observed from Figure 6.8, all four macrochaetae were present on the 
central notum and scutellum of 80AC 1648  #6, sca-GAL4; UAS-DmCBP80 #1 adults. 
However, these macrochaetae were approximately 35% shorter and thinner than 
GAL4 controls (compare [i], [ii] and [iii]). It was reasoned that the suppression 
observed might not be caused by UAS-DmCBP80 but by a lack of Ga14 available to 
activate both UAS-DinCBP80 and 80z%C 1648  #6 transgenes. To test this, full-length 
UAS-DmCBP20 and truncated UAS-DmCBP80 constructs were crossed into the 
80/tC 1648  #6, sca-GAL4 background. These constructs did not modify the dominant 
macrochaetae phenotype, which suggests that the partial suppression observed was 
specific to over-expressing full-length UAS-DmCBP80. Taken together, this data 
shows that 80AC 1648  #6 truncation is not a true dominant negative. Instead, 80AC 
648 #6 appears to be a gain-of function mutant. 
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Figure 6.8 UAS-DmCBP80AC 1-648  #6, sca-GAL4 
Dominant Bristle Phenotype is Partially 
Suppressed by UAS-DmCBP80 #1 and 
Df(3R) P14 sr' that uncovers DmCBP20 
21 °C 	sca-GAL4/ + 	80AC 1-648  #6, sca-GAL4 
80LC 1-648  #6, sca-GAL4; 80AC 1-648  #6, sca-GAL4; 
UAS-DmCBP80 #1 	Df(3R)P14sr1 
Figure 6.8 UAS-DmCBP80AC 1-648  #6, sca-GAL4 bristle phenotype is 
partially suppressed by UAS-DmCBP80 #1 and Df(3R) P14 Sr1 that 
uncovers DmCBP20. [i] At 21°C, sca-GAL41 + control has four wild-type 
macrochaetae on central region of notum and scutellum. [ii] In 80tC 1-648  #6, 
sca-GAL4 adults, two distal scutellar macrochaetae are present, whilst 
macrochaetae on notum are absent. [iii] Over-expression of UAS-DmCBP80 
#1 in 80AC 1648#6,  sca-GAL4 background. All four macrochaetae are present 
on central notum and scutellum. Measurements based on images suggest 
macrochaetae are 35% shorter and thinner than control. [iv] Dominant 
phenotype is also partially suppressed by crossing Df(3R) P14 S11 into 80AC 
648 #6, sca-GAL4 background. All four macrochaetae are present on central 
notum and scutellum and are approximately 55% shorter and thinner than 
control. 
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6.2.7 UAS-DmCBP80AC 1-648 #61  sca-GAL4 interacts with 
DmCBP20 deficiency 
Considering DmCBP20 and DmCBP80 must heterodimerise to form a functional 
CBC (Izaurralde et al., 1994), it was reasoned that the dominant macrochaetae 
phenotype might be modified by alleles of DmCBP20. In order to test this, various 
DmCBP20 alleles were crossed into 80/tC 	#6, sca-GAL4 background at 21°C. 
These alleles included transgenes ubiquitously expressing DmCBP20 genomic region 
and ORF; Df(3R) P14 sr' that uncovers the DmCBP20 locus; together with 
DmCBP20' and DniCBP2 OMFs  alleles generated from the P-hop described in 
Chapter 4. This determined that the macrochaetae phenotype was not modified by 
transgenes that over-expressed DmCBP20. However, the dominant phenotype was 
partially suppressed by crossing in Df(3R) P14 sr' and DmCBP20 deletion alleles #1 
and #2. As can be observed from Figure 6.8, all four macrochaetae were present on 
central notum and scutellum of 80zlC 1-648  #6, sca-GAL4; Df(3R) P14 sr' adults. 
However, these macrochaetae were approximately 55% shorter and thinner than 
GAL4 controls (compare [i], [ii] and [iv]). Collectively, this genetic data suggests 
that increasing the level of DmCBP20 protein appears to have no effect on 80AC 1-648 
#6 activity. Whereas reducing endogenous DrnCBP20, by the introduction of a 
deficiency or DmCBP20 deletion alleles, does partially suppress the dominant 
macrochaetae phenotype. 
6.2.8 UAS-DmCBP80AC 1-64,8#6, sca-GAL4 does not interact 
with DmCBP80R deficiency 
Since Drosophila has a second DmCBP80 homologue, an obvious question to 
address was whether mutant alleles in DinCBP80R could modify 80AC -641#6,  sca-
GAL4 dominant phenotype. To date, no known mutant alleles have been described 
for DmCBP80R. However, a BDGP search identified Df(3R) e-N19 that uncovers 
DmCBP80R locus on polytene segment 93E1-2. Df(3R) e-N19 was crossed into 
80AC 1648  #6, sca-GAL4 background at 21'C. This determined that Df(3R) c-NJ 9 did 
not modify the macrochaetae phenotype (data not shown). Characterisation of 
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DmCBP80R from Chapter 5 shows that DmCBP80R mRNA is restricted to third 
instar larvae and adult males, where it is predominantly expressed in the testes. 
Therefore, a deficiency uncovering DmCBP80R would not be predicted to interact 
with 80AC 1643  #6 truncation that is over-expressed in somatic tissues. Indeed, this is 
consistent with the result observed here. 
6.3 DISCUSSION 
6.3.1 Identification of the dominant truncation UAS-
DmCBP20A1125  
Results from the GAL4-UAS crosses show that over-expression of full-length 
Drosophila and human UAS-CBP20 and UAS-CBP80 do not produce visible 
phenotypes in adult flies. However, the targeted over-expression of the shortest 
truncations in both DmCBP20 and DmCBP80, which remove 29 and 152 amino 
acids from the C-terminus respectively, do generate dominant adult phenotypes. A 
total of three transgenic lines contained the 20/tC 1-125  transgene, of which line #1 
generated phenotypes in combination with ptc-GAL4 alone. Aberrant phenotypes 
were observed in the eye, wing and thoracic regions of adult flies, which is consistent 
with ptc expression. However, since only one 20AC 1175 transgenic line produces 
dominant phenotypes, it cannot be assumed that the phenotypes observed were 
independent of the chromosomal integration site and specific to 20AC 1125 transgene 
expression. 
The 20iC 1125 transgene is predicted to encode a protein that is truncated in the 
middle of the C-terminal RGG tail. The function of the RGG domain in DmCBP20 is 
currently unknown, however, RGG tails often serve as an auxiliary domain in RNA-
binding (Birney et al., 1993; Burd and Dreyfuss, 1994). It is therefore thought that 
the RGG domain in DmCBP20 might act to stabilise the interaction between CBC 
and capped RNA. 
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In contrast to 20z.%C J425, the transgene 20AC 	does not produce visible adult 
phenotypes when crossed with the range of GAL4 drivers used in this study. The 
conceptual protein product of 20ztC 	deletes the RGG domain altogether. One 
possibility is that flies over-expressing 20LIC 	might form mutant CBC that does 
not stably bind capped RNA. Instead, endogenous CBC preferentially binds and 
consequently 20AC J95 expression does not generate aberrant phenotypes. In 
comparison, over-expression of 20AC 1125  would form mutant CBC containing a 
partially deleted RGG domain. This mutant CBC might be relatively more stable in 
binding capped RNA. However, the mutant CBC might dissociate prematurely 
during RNAP II transcript processing. This would destabilise protein-protein 
interactions and induce molecular defects in cap-dependent RNA metabolism and the 
dominant phenotypes observed in adult tissues. 
6.3.2 Identification of the dominant truncation UAS-
Dm CBP80AC1648  
Four truncations were made in DmCBP80, however, only the over-expression of 
80z%C 1648  generated dominant phenotypes in adult tissues. A total of eight transgenic 
lines contained 80AC ]648  transgene. Out of these, four independent lines generate 
dominant adult phenotypes in combination with several GAL4 drivers. Over-
expression of 80z\C 1648  creates a number of adult phenotypes ranging from visible 
tissue defects to lethality. This demonstrates that the phenotypic effects are 
independent of the chromosome integration site and reproducible with different 
GAL4 drivers. Taken together, these data support that the dominant adult phenotypes 
observed are specifically due to 80AC 1648  transgene over-expression. 
Site-directed mutagenesis of HsCBP80 has identified a number of key residues that 
interact with HsCBP20. Since only CBP20 binds the cap, CBP80 must 
heterodimerise with CBP20 to form a functional CBC (Mazza et al., 2001). 
Interestingly, the key residues in CBP80 that interact with CBP20 are extensively 
conserved and reside within the middle and carboxyl-regions of CBP80. The three 
longest UAS-truncations in Din CBP8O delete these conserved residues. Therefore, 
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these UAS-DmCBP80 truncations would not be predicted to form a stable 
heterodimer with endogenous DmCBP20. As a result, no mutant CBC is formed and 
no dominant phenotypes are observed in combination with various GAL4 drivers. 
80/tC 1648 's the shortest truncation made in DmCBP80 and removes 152 amino acids 
from the C-terminus. This truncation was made at a region believed to be a 
conserved boundary from amino acid alignments. Recently, the crystal structure of 
HsCBC has been determined (Mazza et al., 2001). A distinct feature of HsCBP80 
carboxyl-terminus is a very long coiled-coil that is comprised of two alpha helices. 
The coiled-coil protrudes from HsCBP80 and might provide a distinct surface for 
protein-protein interactions. Interestingly, this coiled-coil is highly conserved in 
DmCBP80. Furthermore, 80C 	is predicted to encode a protein where the coiled- 
coil is nearly deleted altogether. Although the functional significance of this domain 
is currently not known, truncation of HsCBP80 coiled-coil does not appear to affect 
HsCBP20 or cap-binding activities (Mazza et al., 2001). This suggests that the 
coiled-coil might mediate interactions between CBP80 and RNAP II processing/ 
export factors. Therefore, over-expression of 80AC 1648 might generate mutant CBC 
that is defective in mRNA processing. It is possible that mutant CBC containing 
80AC 1648  truncation generates disruptions in a number of cap-dependent mRNA 
processing events. A culmination of molecular defects in pre-mRNA splicing, RNA 
3'-end formation and U snRNA export might ultimately disrupt RNAP II transcript 
metabolism and produce the dominant adult phenotypes observed here. Northern 
analysis did not detect a defect in the splicing of RpS3 RNAs in embryos that over-
expressed 80/iC 1648  transgene. However, further biochemical analysis of 80/iC 1648 
mutants using more sensitive assays such as RNase protection or alternatively, 
microarray analysis might be more successful in determining the functional 
significance of the deleted domain. 
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6.3.3 CBC dominant phenotypes might arise from defects in 
cell growth 
Over-expression of 204C 1425  and 80AC j48  generate a range of aberrant adult 
phenotypes in the wing, eye and thoracic tissues. Since no evidence suggests CBC 
has specific functions in either wing, eye or sense organ development, the defects 
that underlie these dominant phenotypes have not been investigated. Interestingly, 
recent work has suggested that the cap-binding activity of CBC is subject to 
regulation by extracellular stimuli (Wilson et al., 1999 and 2000). This raises the 
question of whether CBC might be the nuclear end-point for multiple signalling 
pathways required to regulate RNAP II transcript metabolism and ultimately cell 
growth. It can therefore be reasoned that defects in CBC activity and subsequently 
cap-dependent RNA metabolism might in turn deregulate cell growth control. As a 
result, the molecular defects induced by 80LiC 1-648  and 20AC ,-95  transgene over-
expression might ultimately affect cell growth control and account for the dominant 
phenotypes observed. 
Disruptions in cell growth can encompass a range of possible defects in processes 
such as cell proliferation, cell death or cell fate decisions. However, the dominant 
adult phenotypes arising from the transcriptional activation of 80zi\C 1648  probably 
result from a common defect. In UAS-DmCBP80AC 	#6, sca-GAL4 flies, the 
macrochaetae on the central notum and scutellum are absent with very few sockets 
present at 25°C. Whilst at 21°C and 18°C, the macrochaetae on the thorax are 
notably shorter and thinner than the GAL4 controls. This suggests that disruptions in 
cell proliferation or cell differentiation might be responsible for these phenotypes. 
Similarly, in UAS-DmCBP80AC 1648  #4; ey-GAL4 adults, the ommatidia are 
strikingly reduced in number. No dominant eye phenotypes are observed when 80AC 
1-648 is transcriptionally activated with GMR-GAL4 that expresses later in eye 
development. This suggests that CBC-related defects occur early in eye 
development, at times consistent with cell proliferation. Alternatively, it is possible 
that checkpoint mechanisms exist during eye and sense organ development that 
detect general defects in cell growth. As a result, disruptions in cell growth might 
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induce cell death by apoptosis and generate the dominant phenotypes observed. 
However, in the absence of any experimental data, this is purely hypothetical. 
6.3.4 UAS-DmCBP80AC 1-648  #6, sca-GAL4 is a gain-of function 
mutant 
UAS-DmCBP80AC 1648  #6, sca-GAL4 dominant phenotype is not enhanced by a 
deficiency that uncovers DmCBP80 locus. However, macrochaetae are partially 
suppressed by simultaneously over-expressing UAS-DmCBP80 in U A S - 
DmCBP80AC 1648  #6, sca-GAL4 background. This partial suppression is not due to a 
lack of Ga14 to activate both 80AC 1648 and UAS-DmCBP80 transgenes. Interestingly, 
over-expression of full-length UAS-DmCBP80 in combination with the GAL4 
drivers used in this study does not generate dominant adult phenotypes. This suggests 
UAS-DmCBP80AC ]648  #6, sca-GAL4 macrochaetae phenotype observed here is 
specific to the over-expression of 80/\C 1643  truncation. Therefore, UAS-
DmCBP80AC 1648  #6, sca-GAL4 is not a true dominant negative but rather a gain-of 
function mutant. 
The data suggests the partial suppression observed from over-expressing both full-
length UAS-DmCBP80 and truncated 80AC /648 in  the same tissues might increase the 
competition for endogenous DmCBP20. As a result, the activity of mutant CBC 
containing 80AC 1-648  truncation would decrease and cause the macrochaetae 
phenotype to be partially suppressed. However, reducing the endogenous levels of 
DinCBP80 in UAS-DmCBP80AC 1648  #6, sca-GAL4 background does not affect the 
activity of 80/tC 1-64.. Therefore, the dominant macrochaetae phenotype is not 
modified. 
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6.3.5 UAS-DmCBP80AC 1-648  #6, sca-GAL4 interacts with 
DmCBP20 deficiency 
UAS-DmCBP80itC 1648  #6, sca-GAL4 dominant phenotype was not modified by 
D,nCBP20l mutants or transgenes that ubiquitously express DmCBP20 genomic 
region and ORF. However, macrochaetae are partially suppressed by a deficiency 
that uncovers DinCBP20 locus and DmCBP20 deletion alleles # 1 and #2 described 
in Chapter 4. An interaction between UAS-DmCBP80LIC 1648  #6, sca-GAL4 and 
DinCBP20 mutants is not surprising, since DmCBP20 and DmCBP80 are only 
functional as constituents of a heterodimeric CBC. This data provides further support 
that the macrochaetae phenotype observed in UAS-DmCBP80zi\C /648  #6, sca-GAL4 
adults is specific to 80t%C 1648 transgene over-expression. It appears that reducing the 
endogenous DmCBP20 protein available decreases the activity of 80AC 1-648  and 
partially suppresses the macrochaetae phenotype. 
6.3.6 UAS-DmCBP80AC 1-648#6,  sca-GAL4 does not interact 
with DmCBP80R deficiency 
UAS-DmCBP80AC 1648  #6, sca-GAL4 dominant phenotype is not modified by a 
deficiency that uncovers DmCBP80R locus. This negative result is not surprising 
since decreasing the endogenous amounts of DmCBP80R would have no effect on 
somatic tissues that over-express 80AC 1648•  Instead, this deficiency would be 
predicted to reduce the endogenous levels of DmCBP80R present in adult testes. 
However, an interesting question to address is whether DmCBP80 and DmCBP80R 
are functionally redundant. Therefore, to determine if over-expressing DmCBP80R in 
somatic tissues could rescue mutants in DmCBP80. Unfortunately, the genetic tools 
required to test such a hypothesis are currently not available. 
Although DmCBP80 and DmCBP80R share high conservation, much of the 
sequence divergence lies within the carboxyl-terminal 200 amino acids. In HsCBP80 
and DmCBP80, this region is predicted to encode a prominent coiled-coil that may 
mediate protein-protein interactions between CBP80 and rnRNA processing! export 
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factors. The carboxyl-terminal 200 amino acids of DmCBP80R shares very low 
sequence identity to either DmCBP80 or HsCBP80. This suggests that in 
DmCBP80R, the carboxyl-region might mediate different protein-protein 
interactions. Intriguingly, since the coiled-coil region is deleted in 80LtC 	both 
DmCBP80R and 80z1tC 	are predicted to be structurally similar. One possibility is 
that the dominant phenotypes observed in UAS-DinCBP80AC 	#6, sca-GAL4 
adults is caused by 80AC 1648 behaving in a manner analogous to DmCBP80R in 
somatic cells. One might predict that the misexpression of DmCBP80R in somatic 
cells would give the same phenotypes as the over-expression of the 80/C /648 
truncation. 
6.4 CONCLUSIONS 
The targeted over-expression of UAS-DmCBP20AC 1/25  and UAS-DmCBP80AC 
using the GAL4-UAS system generated dominant adult phenotypes. Characterisation 
of UAS-DmCBP80AC 	#6, sca-GAL4 shows it is a gain-of function mutant whose 
dominant adult macrochaetae phenotype is suitable for genetic modifier screens. 
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CHAPTER 7 
Screen for CBC-Interacting Genes 
7.1 INTRODUCTION 
Characterisation of the cap and CBC show they act as a molecular tag to define 
RNAP II transcripts for nuclear processing. Key roles for CBC have been described 
in pre-mRNA splicing, RNA 3'-end formation and U snRNA export (Lewis and 
Izaurralde, 1997). Despite this, little is currently known about the proteins that CBC 
interacts with or the molecular mechanisms involved. In metazoans, both cap-
binding proteins appear to be evolutionarily conserved. Indeed, results from Chapter 
3 have shown that DmCBP20 and DmCBP80 are highly homologous to the 
corresponding human proteins. This suggests that CBC function might also be 
conserved between Drosophila inelanogaster and human species. 
The completed Drosophila melanogaster genome shows that components of the 
RNAP II transcript processing machinery are highly conserved (Adams et al., 2000). 
In general, Drosophila proteins are more closely related to their vertebrate 
counterparts than S. cerevisiae. This implies the complexity of mechanisms that 
contribute to RNAP II transcript processing are similar between Drosophila and 
vertebrates. Therefore, genetic studies in fruit-flies rather than yeast might be more 
successful in identifying candidate adaptor molecules that facilitate the function of 
CBC and the cap. 
The overall aim of the GAL4-UAS study was to generate a dominant adult 
phenotype in either Din CBP2O or DmCBP80 that could be used in genetic modifier 
screens to identify CBC-interacting genes. Chapter 6 has described the identification 
and initial characterisation of UAS-DrnCBP80LC 1648  #6, sca-GAL4 dominant 
macrochaetae phenotype. However, before a dominant adult phenotype can be used 
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in a genetic modifier screen, it needs to fulfil three main criteria. Firstly, the 
dominant phenotype must be easily detected under a dissecting microscope. Indeed, 
the previous Chapter has already shown that UAS-DmCBP80L\C 1648#6,  sca-GAL4 
recombinants exhibit a macrochaetae phenotype that is clearly observed at 210C. At 
this temperature, adults have no macrochaetae on the central notum and only two out 
of four scutellar macrochaetae. This produces an intermediate phenotype that allows 
both enhancers and suppressers to be readily scored. Secondly, the dominant adult 
phenotype needs to be consistent within a population. As mentioned earlier, UAS-
DrnCBP80AC 1.648  #6, sca-GAL4 macrochaetae phenotype is highly penetrant within 
a population at 2 1°C. Approximately 65% of UAS-DmCBP80L\C J64,#6,  sca-GAL4 
recombinants exhibit the phenotype described above. The remaining 35% of adults 
have an additional macrochaeta on the central region of the notum. Finally, the 
dominant adult phenotype must be sensitive to modification. 
In order to address the last criteria, Chapter 7 describes how UAS-DinCBP80AC 1648 
#6, sca-GAL4 adults were crossed to a collection of deficiencies and candidate CBC-
interacting genes. This determined whether UAS-DmCBP80L%C 1648  #6, sca-GAL4 
dominant macrochaetae phenotype would be a useful tool that could be used in future 
large-scale genetic modifier screens. 
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7.2 RESULTS 
7.2.1 Deficiency screen using UAS-DmCBP80AC 1-648 #6, sca-
GAL4 
To test whether 80AC 1648  #6, sca-GAL4 dominant phenotype could be modified and 
useful for identifying CBP80 interactors, a screen was performed using chromosomal 
deficiencies. 80AC 1648#6,  sca-GAL4 adults were crossed to a deficiency collection, 
which uncovered approximately 65% of the second chromosome and 50% of the 
third chromosome. Crosses were set up at 21°C and the Fl progeny were screened 
for modification of 80z%C 1648  #6, sca-GAL4 macrochaetae phenotype. To confirm 
the genetic interaction was specific to 80AC 1648  truncation, the modifying 
deficiencies were subjected to three control crosses. Firstly, the interacting 
deficiency was crossed to sca-GAL4 alone at 21'C. This ensured that the 
modification observed did not result from an interaction between the deficiency and 
Ga14 protein. Secondly, the deficiency was crossed with an unrelated UAS-GAL4 
transgenic line and the Fl progeny screened for modification. The selected line was 
UAS-atonal, S31-GAL4 that exhibits a dominant scutellar macrochaetae phenotype at 
25°C. In contrast to CBC, atonal is a RNAP II transcription factor with specified 
roles in sense organ development. 531-GAL4 driver expresses Ga14 in the same 
tissues as sca-GAL4. Similar to 80AC 1648  #6, sca-GAL4 dominant phenotype, UAS-
atonal, S31-GAL4 adults lack the two distal macrochaetae present on the scutellum at 
25°C (Jarman et al., 1998). This determined whether the enhancement or suppression 
was specific to CBC. The final control involved further mapping the interacting 
genetic regions using smaller overlapping deficiencies. This eliminated the 
possibility of second site modifiers causing the modification of 80AC 1648  #6, sca-
GAL4 macrochaetae. Once the minimal interacting breakpoints had been defined, the 
polytene regions were analysed for candidate CBC-interacting genes using the 
cytosearch tool in Flybase. Since CBC facilitates the positive effects of the cap in 
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splicing, RNA 3'-end formation and U snRNA export, genes involved in these 
processes and other aspects of RNAP II transcript metabolism were investigated. 
The results from the deficiency screen are presented in Figure 7.1. In summary, 
80AC 1648  #6, sca-GAL4 dominant phenotype was both enhanced and suppressed by 
deficiencies on the second and third chromosome. Out of 100 deficiencies screened, 
5 independent deficiencies were found to modify the macrochaetae phenotype at 
21'C. A total of 70 deficiencies were tested on the second chromosome, of which 
four deficiencies interacted. Whilst one interacting deficiency was identified from 30 
deficiencies residing on the third chromosome. The following sections describe these 
interacting genetic regions in more detail along with the candidate CBC-interacting 
genes uncovered. 
Figure 7.1 Summary of Deficiencies Modifying UAS- 
DmCBP80AC 1-648  #6, sca-GAL4 Macrochaetae Phenotype 
Interacting Deficiency Mapped Region Modification 
I)j(2L)Dii'ec-c/cI1 iS 27C 1-27E Suppessor 
Df(2R)ST] 42133-42C Enhancer 
Df(2R)knSA3 51C1-51D8 Enhancer 
Df(2R)Pu-D17 57D12-58D1 Enhancer 
Df(3L)thl02 71F-72D1 Suppressor 
Figure 7.1 Summary of deficiencies modifying UAS-DmCBP80zXC 1648#6, sca-GAL4 
macrochaetae phenotype. 80AC 1-648  #6, sca-GAL4 recombinants were crossed to 70 
deficiencies on the second chromosome and 30 deficiencies on the third chromosome. 
Crosses were set up at 21°C and the Fl progeny were scored for suppression or 
enhancement compared to 80AC 1-648  #6, sca-GAL4 macrochaetae phenotype and sca-
GAL4 adults alone. 
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7.2.2 Genetic region 27C1-27E suppresses UAS-DmCBP80AC 
1-648 #6, sca-GAL4 macrochaetae phenotype 
DJ(2L)Dwee-de1ta5 was initially found to strongly suppress 80LC 1648#6,  sca-GAL4 
macrochaetae phenotype at 2 1°C. Introducing Df(2L)Dwee-de1ta5 into 80z\C 1648  #61 
sca-GAL4 background restored the macrochaetae to the wild-type number and this 
was fully penetrant within the Fl population. As can be observed from Figure 7.2, A, 
Df(2L)Dwee-delta5/ 80AC /648  #6, sca-GAL4 adults have all four macrochaetae 
present on the central notum and scutellum (compare [i] and [iii]). However, the 
distal pair of macrochaetae on the notum and scutellum were approximately 10% 
shorter and thinner than the GAL4 control (compare [ii] and [iii]). 
Df(2L)Dwee-de1ta5 uncovers polytene segments 27A; 28A on the second 
chromosome. To determine whether this interacting region could be further defined, 
smaller overlapping deficiencies listed in Appendix D were tested for interaction 
with 80/tC 1.648  #6, sca-GAL4 at 21'C. This demonstrated that like Df(2L)Dwee-
delta5, Df(2L)J-H and Df(2L)spd'2 also suppressed the dominant macrochaetae 
phenotype. As a result, the interacting genetic region was further mapped to 27C1-
27E (Figure 7.2, B). These deficiencies did not enhance or suppress sca-GAL4 at 
21'C. In addition, the deficiencies did not modify UAS-atonal, S31-GAL4 dominant 
scutellar macrochaetae phenotype at 25°C (data not shown). This suggests that the 
modification observed was due to a specific interaction between the genetic 
interacting region 27C1-27E and 80AC J648 
At the time, cytosearches in Flybase revealed a number of genes that resided within 
the interacting region 27C1-27E. To determine whether the suppression could be 
reproduced and the putative CBC-interacting gene identified, all the Bloomington 
stocks available of known genes along with randomly selected P-insertions in 
unknown genes were crossed with 80/tC 1648#6,  sca-GAL4 at 21°C (Appendix E). 
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Figure 7.2 Genetic region 27C1-27E suppresses UAS-DmCBP80AC 1.648 
#6, sca-GAL4 macrochaetae phenotype. A. [i] At 21°C, 80AC 1-648  #6, sca-
GAL4 adult has two out of four distal scutellar macrochaetae whilst three out 
of four macrochaetae on central notum are absent. [ii] In sca-GAL4/ + control, 
four macrochaetae on central notum and scutellum are present. For ease of 
comparison the same control images [i] and [ii] are used in Figures 7.2 to 7.7. 
[iii] Crossing Df(2L)Dwee-delta5 into 80LC 18  #6, sca-GAL4 background 
restores all four macrochaetae on central notum and scutellum. B. 80zC 
#6, sca-GAL4 interacting region was further mapped to 27C1-27E. Red 
rectangles indicate deficiencies that suppressed 80AC 1-648  #6, sca-GAL4 
phenotype. White rectangles depict deficiencies that did not modify 80AC 1-648 
#6, sca-GAL4 macrochaetae. Black lines indicate possible deficiency 
breakpoints. 
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The genetic region 27C1-27E uncovered 5 genes with roles implicated in RNAP II 
transcript metabolism; snRNP70K, Hrb27C, x16, nop5 and CC1.3. snRNP70K 
encodes a Ui-specific protein, Hrb27C is a hnRNP whilst x16 and CC1.3 are 
predicted splicing factors. Characterisation of CBC has shown it facilitates the 
interaction between Ul snRNP and the cap-proximal 5' splice site (Lewis et al., 
1996). In higher eukaryotes, the molecules that mediate CBC function during 
splicing are currently unknown. Therefore, snRNP70K, Hrb27C, x16 or CC1.3 might 
be possible adaptor proteins that facilitate the effects of CBC and the cap in 
spliceosomal assembly. Nop5 encodes a snoRNA involved in rRNA processing. 
Although the cap contributes to the export of RNAP II transcribed snoRNAs, the 
cap-binding activity that mediates the cap's effect has not been identified (Jacobson 
and Pederson, 1998). It is therefore possible that this effect is mediated by CBC. As a 
result, mutant alleles were obtained for each of these gene except CC1.3 and tested 
for interaction with 80C 1648  #6, sca-GAL4 at 21°C. However, none of these alleles 
were found to modify 80AC 1648  #6, sca-GAL4 macrochaetae phenotype (Appendix 
E and data not shown). 
7.2.3 Genetic region 42B3-42C enhances UAS-DmCBP80AC 1- .. 
648 #6, sca-GAL4 macrochaetae phenotype 
In contrast to 27C1-27E , Df(2R)STJ was identified as enhancing 80/tC 1648  #6, sca-
GAL4 macrochaetae phenotype at 21°C. Furthermore, the enhancement was fully 
penetrant within the Fl population. Figure 7.3, A shows that adults containing 
Df(2R)STJ in combination with 80AC 1648  #6, sca-GAL4 have severely reduced 
distal macrochaetae on the scutellum (compare [i], [ii] and [iii]). Df(2R)STJ uncovers 
polytene segments 42133-5; 42E15-18 on chromosome 2. Further mapping of this 
genetic region using the deficiencies listed in Appendix D narrowed the interacting 
region to 42B3-42C (Figure 7.3, B). Df(2R)ST] did not modify sca-GAL4 alone at 
21°C, nor UAS-atonal, S31-GAL4 dominant scutellar macrochaetae phenotype at 
25°C (data not shown). 
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Figure 7.3 Genetic region 42133-42C enhances UAS-DmCBP80AC 1-648  #6, 
sca-GAL4 macrochaetae phenotype. A. [i] At 21°C, 80EC 1-648  #6, sca-
GAL4 adult has two out of four distal scutellar macrochaetae whilst three out 
of four macrochaetae on central riotum are absent. [ii] In sca-GAL4/ + control, 
four macrochaetae on central notum and scutellum are present. For ease of 
comparison the same control images [I] and [ii] are used in Figures 7.2 to 7.7. 
[iii] Crossing Df(2R)ST1 into 80EC 1848  #6, sca-GAL4 background severely 
reduced the two distal scutellar macrochaetae. B. 80AC 1648  #6, sca-GAL4 
interacting region was further mapped to 42133-42C. Red rectangles indicate 
deficiencies that suppressed 80AC 1648  #6, sca-GAL4 phenotype. White 
rectangles depict deficiencies that did not modify 80EC 1-648  #6, sca-GAL4 
macrochaetae. Black lines indicate possible deficiency breakpoints. 
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This suggests that the enhancement of 80AC 1-648  #6, sca-GAL4 macrochaetae 
phenotype resulted from a specific interaction between 80AC -64,, and the genetic 
region 42133-42C. 
Cytosearches of the genetic region 42133-42C showed no obvious putative CBC-
interacting genes with functions in RNAP II transcript processing. Two Bloomington 
P-insertion stocks were available for the genes jing and Adfl that are predicted to 
encode RNAP II transcription factors. As a result, these alleles along with 3 
randomly selected Bloomington P-insertions in yet uncharacterised genes were 
obtained and tested for interaction with 80AC 1648  #6, sca-GAL4 at 21°C (Appendix 
E). However, no genetic interaction was observed (data not shown). 
7.2.4 Genetic region 51C1-51D8 enhances UAS-DmCBP80AC 
1648#6, sca-GAL4 macrochaetae phenotype 
Df(2R)knSA3 was found to strongly enhance 80zC 1-648  #6, sca-GAL4 dominant 
macrochaetae at 21°C. As can be observed from Figure 7.4, A, crossing 
Df(2R)knSA3 into 80AC 1648  #6, sca-GAL4 background increased the severity of the 
dominant phenotype. In Df(2R)knSA3/ 80zW 1648  #6, sca-GAL4 adults, both the 
distal scutellar macrochaetae and sockets were notably absent at 21°C (compare [i], 
[ii] and [iii]). Df(2R)knSA3 uncovers polytene segments 51135-11; 51D7-E2 on the 
second chromosome. The interacting genetic region was further mapped to 51C1-
51D8 using surrounding deficiencies listed in Appendix D (Figure 7.4, B). 
Df(2R)knSA3 did not modify sca-GAL4 alone at 21°C, nor UAS-atonal, 531-GAL4 
dominant scutellar macrochaetae phenotype at 25°C (data not shown). This suggests 
that the enhancement of 80AC 1648  #6, sca-GAL4 macrochaetae resulted from a 
specific interaction between 80AC 1648  and the genetic region 51C1-51D8. 
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Figure 7.4 Genetic region 51C1-51D8 enhances UAS-DmCBP80AC 1-8 
#6, sca-GAL4 macrochaetae phenotype. A. [i] At 21°C, 80AC 1-648  #6, sca-
GAL4 adult has two out of four distal scutellar macrochaetae whilst three out 
of four macrochaetae on central notum are absent. [ii] In sca-GAL4/+ control, 
four macrochaetae on central notum and scutellum are present. For ease of 
comparison the same control images [I] and [ii] are used in Figures 7.2 to 7.7. 
[ju] Crossing Df(2R)knSA3 into BOAC 1648  #6, sca-GAL4 background results in 
the absence of the two distal scutellar macrochaetae. B. 80AC 1648  #6, sca-
GAL4 interacting region was further mapped to 51C1-51D8. Red rectangles 
indicate deficiencies that suppressed 80EC 1-648  #6, sca-GAL4 phenotype. 
White rectangles depict deficiencies that did not modify 80AC 1-648  #6, sca-
GAL4 macrochaetae. Black lines indicate possible deficiency breakpoints. 
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Cytosearches in Flybase revealed a number of genes that resided within 51C1-51D8. 
The most interesting candidate CBC-interacting gene was cleavage factor IA that is 
predicted to function in the cleavage step of RNA 3'-end formation. Given the role of 
CBC in RNA 3'-end processing, CBC might interact with cleavage factor IA to 
facilitate RNA cleavage (Flaherty et al., 1997). However, no mutant alleles were 
available in cleavage factor IA. As a result, the available alleles of genes that mapped 
to 51C1-51D8 were crossed with 804C -648#6,  sca-GAL4 at 21°C and the Fl 
progeny screened for modification (Appendix E). These included RNAP II 
transcription factor Kn, endopeptidase regulator Rpn6, sf and boc that do not 
currently have predicted functions. However, no genetic interaction with 80AC 1648 
#6, sca-GAL4 was observed (data not shown). 
7.2.5 Genetic region 57D12-58D1 enhances UAS-DmCBP80zXC 
1-648 #6, sca-GAL4 macrochaetae phenotype 
Df(2R)Pu-D]7 was also identified as enhancing 80AC 1648  #6, sca-GAL4 
macrochaetae phenotype at 21°C. Figure 7.5, A shows that adults containing 
Df(2R)Pu-D17 in combination with 80AC 1648  #6, sca-GAL4 lack the two distal 
scutellar macrochaetae and sockets at 21°C (compare [i], [j] and [iii]). Df(2R)Pu-
D17 uncovers polytene segments 57134; 58B on chromosome 2. To determine 
whether this interacting region could be further defined, smaller overlapping 
deficiencies listed in Appendix D were tested for interaction with 80AC 1648#6,  sca-
GAL4 at 21°C. This demonstrated that like Df(2R)Pu-D17, Df(2R)PKJ and 
Df(2R)Egfr5 also enhanced the dominant macrochaetae phenotype (Figure 7.5, B and 
data not shown). As a result, the interacting genetic region was mapped to 57D12-
58D1. These deficiencies did not enhance or suppress sca-GAL4 at 21'C. In addition, 
the deficiencies did not modify UAS-atonal, S31-GAL4 dominant scutellar 
macrochaetae phenotype at 25°C (data not shown). This suggests that the 
modification observed was due to a specific interaction between the genetic region 
57D12-58D1 and 80AC 1-648- 
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Figure 7.5 Genetic region 571312-58D1 enhances UAS-DmCBP80AC 1-648 
#6, sca-GAL4 macrochaetae phenotype. A. [i] At 21°C, 80AC 	#6, sca- 
GAL4 adult has two out of four distal scutellar macrochaetae whilst three out 
of four macrochaetae on central notum are absent. [ii] In sca-GAL4I + control, 
four macrochaetae on central notum and scutetlum are present. For ease of 
comparison the same control images [i] and [ii] are used in Figures 7.2 to 7.7. 
[iii] Crossing Df(2R)Pu-D1 7 into 80EcC 1-648  #6, sca-GAL4 background results 
in the absence of the two distal scutellar macrochaetae. B. 80AC 1648  #6, sca-
GAL4 interacting region was further mapped to 57D12-58D1. Red rectangles 
indicate deficiencies that suppressed 80EC 1-648  #6, sca-GAL4 phenotype. 
White rectangles depict deficiencies that did not modify 80AC 	#6, sca- 
GAL4 macrochaetae. Black lines indicate possible deficiency breakpoints. 
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The interacting genetic region 57D12-58D1 was used in cytosearches and this 
revealed no genes with predicted roles in RNAP II transcript processing. However, 
the transcription factor dye along with four P-insertions in yet uncharacterised genes 
did reside within 57D12-58D1 and were crossed into 80AC /648  #6, sca-GAL4 
background at 21°C (Appendix E). This showed that none of these alleles reproduced 
the enhancement of 80AC 1648  #6, sca-GAL4 macrochaetae observed with Df(2R)Pu-
D17. 
7.26 Genetic region 71F-72D1 suppresses UAS-DmCBP80AC 
1-648#6, sca-GAL4 macrochaetae phenotype 
Df(3L)thl02 was the only deficiency on the third chromosome that modified 80AC 
648 #6, sca-GAL4 phenotype at 21°C. Introducing Df(3L)thl02 into 80AC 1648#6, 
sca-GAL4 restored the macrochatae to the wild-type number and this was fully 
penetrant within the Fl population. As can be observed from Figure 7.6, A, 
Df(3L)thJ02/ 80AC 1648  #6, sca-GAL4 adults have all four macrochaetae present on 
the central notum and scutellum (compare [i] and [iii]). However, the distal pair of 
macrochaetae on the notum and scutellum were approximately 20% shorter and 
thinner than the GAL4 control (compare [ii] and [iii]). Df(3L)thl02 uncovers 
polytene segments 71F3-5; 72D12. To determine whether this interacting region 
could be further defined, overlapping deficiencies listed in Appendix D were tested 
for interaction with 80AC 1648#6,  sca-GAL4 at 21°C. This demonstrated that like 
Df(3L)th 102, Df(3L)brmll also suppressed the dominant macrochaetae phenotype 
(Figure 7.6, B and data not shown). As a result, the interacting genetic region was 
further mapped to 71F-72D1. Df(3L)thl02 and Df(3L)brmll did not modify sca-
GAL4 alone at 21'C, nor UAS-atonal, S31-GAL4 dominant scutellar macrochaetae 
phenotype at 25°C (data not shown). This suggests that the suppression of 80zC 1-648 
#6, sca-GAL4 macrochaetae phenotype resulted from a specific interaction between 
80AC 1648  and the genetic region 71F-72D1. 
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Figure 7.6 Genetic Region 71F-72D1 Suppresses 
UAS-DmCBP80AC 1-648  #6, sca Phenotype 
A 
80AC 1-648  #6, sca-GAL4; 
80AC 1-648  #6. sca-GAL4 sca-GAL4I + 	Df(3L)th 102 
III 
Lr: 
70 	71 79 71 7A 
71F 	72D1 
Figure 7.6 Genetic region 71F-72D1 suppresses UAS-DmCBP80AC 1-8 
#6, sca-GAL4 macrochaetae phenotype. A. [i] At 21°C, 80AC 1-648  #6, sca-
GAL4 adult has two out of four distal scutellar macrochaetae whilst three out 
of four macrochaetae on central notum are absent. [ii] In sca-GAL4/+ control, 
four macrochaetae on central notum and scutellum are present. For ease of 
comparison the same control images [i] and [ii] are used in Figures 7.2 to 7.7. 
[iii] Crossing Df(3L)th 102 into 80AC 1-648  #6, sca-GAL4 background restores 
all four macrochaetae on central notum and scutellum. B. 80AC 1-648  #6, sca-
GAL4 interacting region was further mapped to 71F-72D1. Red rectangles 
indicate deficiencies that suppressed 80tC 1648  #6, sca-GAL4 phenotype. 
White rectangles depict deficiencies that did not modify 80AC 1648  #6, sca-
GAL4 macrochaetae. Black lines indicate possible deficiency breakpoints. 
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Analysis of genetic region 71F-72D1 by cytosearch revealed no obvious candidate 
CBC-interacting genes. Stocks were available for the RNAP II transcription factor 
ArJ72A and P-insertions in yet uncharacterised genes located in 71F-72D1. As a 
result, these alleles were tested for interaction with 80/tC 1648#6,  sca-GAL4 at 21°C 
(Appendix E). However, no modification of the macrochaetae phenotype was 
observed (data not shown). 
In summary, the CBC-interacting genes residing in the five interacting deficiencies 
remain to be determined. However, the results from the deficiency screen do show 
that 80AC 1648  #6, sca-GAL4 provides a sensitised genetic background for genetic 
modifier screens. 
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7.2.7 Targeted genetic modifier screen using UAS-
DmCBP80AC 1-648  #6, sca-GAL4 
In parallel to the deficiency screen, genes that might interact with CBC were 
screened for interaction with 80AC 1648#6,  sca-GAL4. Together, the cap and CBC 
act as a molecular beacon to facilitate the recognition of capped RNA by various 
components of RNAP II transcript processing machinery. In particular, CBC 
mediates the stimulatory effects of the cap in pre-mRNA splicing, RNA 3'-end 
formation and U snRNA export (Lewis and Izaurralde, 1997). As a result, genes 
involved in these processes, as well as other aspects of RNA metabolism such as 
transcription and cap-dependent translation, were screened for interaction with 80AC 
1648 #6, sca-GAL4 (Figure 7.7 and Appendix F). 
Although the completed Drosophila genome allows the identification of fruit-fly 
homologues, the availability of mutant alleles in the targeted genes was limited. 
Consequently, most of the mutant alleles used in the genetic modifier screen 
constituted deficiencies and P-element insertions. Alleles of selected genes were 
crossed into 80/tC 1648 #6, sca-GAL4 background at 21°C. The resultant Fl progeny 
were then scored for suppression or enhancement compared to 80AC 1643  #6, sca-
GAL4 and sca-GAL4 adults alone. The following sections describes the genes tested 
for interaction with 80AC -648 #6, sca-GAL4 and the reasons why they were targeted. 
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Figure 7.7 Summary of Proteins Targeted for Interaction with 
UAS-DmCBP80AC 1-648 #6, sca-GAL4 
Protein Function 
RNAP 11 215 Transcription, largest subunit of RNAP II. 
RNAP 11140 Transcription, 2" largest subunit of RNAP II. 
CTD-binding proteins Facilitate the coupling of transcription with nuclear RNA processing? 
eIF4E Cap-binding protein of eIF4F translation initiation complex. 
eIF4E-binding protein Translation, regulate eIF4E activity. 
eIF4E-related proteins Translation? 
eIF4G Component of eIF4F cap-dependent translation initiation complex. 
eIF4A RNA helicase component of eIF4F cap-dependent translation initiation 
complex. 
CPSF RNA 3' -end formation, heterotetrameric complex comprised of 160, 100, 73 
and 30 kDa subunits. Participates in cleavage and polyadenylation reactions. 
CstF RNA 3'-end formation, heterotrimeric complex comprised of 79, 50 and 64 
kDa subunits. Participates in cleavage reaction. 
Ui snRNAs Splicing, Ui snRNA non-coding proteins. 
SmD3 Splicing factor, U snRNA core Sm protein. 
Sans fille Splicing factor, homologue of both U1 snRNP-U1A and U2 snRNP-U2B". 
Luc7-like Splicing factor, homologue of yeast Ui 	snRNP-specific protein Luc7. 
Participates in commitment complex assembly. 
Luc7-related Splicing factor, homologue of yeast Ui snRNP-specific protein Luc7. 
Participates in commitment complex assembly. 
U2AF 50 Splicing factor, homologue of human U2AF65. Binds polypyrimidine tract 
to recruit U2 snRNP during A complex. 
U2AF 38 Splicing factor, homologue of human U2AF35. Binds polypyrimidine tract 
to recruit U2 snRNP during A complex. 
Noisette Splicing factor, homologue of human 60 kDa subunit of heterotrimeric 
SF3a. 
B52 Splicing factor, homologue of human SRp55. 
Hrb 87F hnRNP RNA-binding protein. 
Pendulin Nuclear protein transport, importin a homologue of yeast srpl. 
Karyopherin cii Nuclear protein transport, importin cx homologue of yeast srpl. 
Crm I U snRNA export receptor, homologue of human Xpo 1. 
Diminished-7 Ran-binding protein. 
Bx34 Nucleoporin, homologue of human TPR. 
Figure 7.7 Summary of proteins targeted for interaction with UAS-DmCBP80zC 	#6, 
sca-GAL4. Proteins involved in RNAP II transcript metabolism were selected for the genetic 
modifier screen using 80z\C 1-648  #6, sca-GAL4. These included proteins with functions in 
transcription, pre-mRNA splicing, RNA 3'-end formation, RNA export and cap-dependent 
translation. See text for more detail. Crosses where set up at 21°C and the Fl progeny were 
scored for for suppression or enhancement compared to 80AC 1-648  #6, sca-GAL4 and sca-GAL4 
adults alone. 
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CBC's function in pre-mRNA splicing has been shown to be evolutionarily 
conserved between humans and yeast. CBC increases the efficiency of Ui snRNP 
binding to the cap-proximal 5' splice site. This enhances the recognition of the 5' 
splice site and subsequent commitment or E complex assembly. As a result, CBC 
facilitates efficient pre-mRNA splicing (Colot ci' at., 1996; Lewis et al., 1996). In 
vertebrates, little is currently known about the mechanism of CBC action. However, 
genetic studies in S. cerevisiae have identified a number of splicing factors, most of 
which are components of U  snRNP, that interact with CBC (Fortes et al., 1999a and 
1999b). Therefore, Drosophila homologues of both Ui snRNAs and Ui snRNP- 
specific proteins were targeted for interaction with SOAC /648  #6, sca-GAL4 at 210C. 
The Drosophila genome contains five genes that encode Ui snRNAs. No mutant 
alleles were available for these genes. Consequently, small deficiencies that uncover 
the predicted gene loci of the five U] snRNAs were crossed with 80AC 1648  #6, sca-
GAL4 at 21'C. Fl progeny that carried both alleles were then scored for suppression 
or enhancement compared to 80z%C 1648  #6, sca-GAL4 and sca-GAL4 adults alone. 
This showed that 80AC /648  #6, sca-GAL4 macrochaetae phenotype was not 
modified by deficiencies that uncovered U] snRNA genes (Appendix F and data not 
shown). 
Each U snRNP contains a set of Sm core proteins shared with other snRNPs and a set 
of U snRNP-specific proteins. Genetic studies in S. cerevisiae have demonstrated 
synthetic lethal interactions between CBC and the Sm core protein SmD3, the Ui 
snRNP-specific proteins Luc7, Mudi, Snu56, Snu71 and Nam8. Moreover, Snu56 
has been shown to interact directly with CBC in yeast (Fortes et al., 1999a and 
1999b). Drosophila homologues have been identified for SrnD3, Luc7 and Mudi! 
U1A proteins. Interestingly, Luc7 appears to have two homologues in fruit-flies, 
Luc7 and Luc7-related. Whilst the Drosophila protein sans fille corresponds to both 
vertebrate Ui snRNP-U1A and U2 snRNP-U2B" proteins (Polycarpou-Schwarz et 
al., 1996). In contrast, 5nu56, Snu71 and Narn8 Ui snRNP-specific proteins do not 
appear to have clear counterparts in the Drosophila database. As a result, 
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deficiencies that uncovered SmD3, Luc7, Luc7-related and mutant alleles in sans fille 
were crossed with 80AC 1648  #6, sca-GAL4 at 21°C. Fl progeny were then scored for 
modification compared to 80AC 1648  #6, sca-GAL4 and sca-GAL4 adults alone. This 
determined that 80AC 1-648  #6, sca-GAL4 dominant phenotype was not modified by 
the Ui snRNP-specific mutants tested (Appendix F and data not shown). 
During commitment or E complex assembly, U  snRNP associates with the 5' splice 
site and Mud2/U2AF65-35 binds to the polypyrimidine tract. In S. cerevisiae, a 
genetic and physical interaction has been identified between CBC and Mud2 (Fortes 
et al., 1999a and 1999b). The Drosophila homologue of Mud2 is U2AF50, which 
forms a heterodimer with U2AF38. P-insertion and deletion alleles were obtained for 
the components of U2AF heterodimer and tested for interaction with 80AC 1648  716, 
sca-GAL4 at 21'C. However, none of these alleles modified the dominant 
macrochaetae phenotype in comparison to 80AC 1648  #6, sca-GAL4 and sca-GAL4 
controls alone (Appendix F and data not shown). 
Interestingly, Mud2 is not required for facilitating the interaction between Ui snRNP 
and 5' splice site but promotes the binding of U2 snRNP for A complex assembly. 
This suggests that the role of CBC in splicing might extend beyond the Ui snRNP 
function and CBC might participate at later stages in the splicing cycle (O'Mullane 
and Eperon, 1998). Therefore, the U2 snRNP-specific protein, noisette and splicing 
factor, B52 both of which function during the early stages of spliceosome assembly 
were also tested for interaction with 80AC 1648#6,  sca-GAL4 at 21°C. This showed 
the dominant macrochaetae phenotype was not enhanced or suppressed by mutants in 
noisette or B52 (Appendix F and data not shown). 
A role for CBC has also been described in RNA 3'-end formation. During 3'-end 
processing, CBC facilitates the positive effect of the cap in RNA cleavage (Flaherty 
et al., 1997). However, the molecular mechanism by which CBC mediates this effect 
has not been elucidated. To determine whether CBC interacts with components of the 
cleavage complex, 80AC 1-648  #6, sca-GAL4 was crossed with various alleles of 
CPSF and CStF at 21°C (Appendix F). In vertebrates, CPSF is a heterotetrameric 
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complex that binds the cleavage and polyadenylation sequence and functions in both 
RNA cleavage and polyadenylation reactions. Whilst CStF is a heterotrimer that 
associates with the GU-rich motif and participates in RNA cleavage only. P-insertion 
and deletion mutants were available for the largest subunits of both CPSF and CstF 
complexes (CPSP-160 and CStF-77), along with deficiencies that uncovered the 
predicted genetic loci of the remaining subunits. However, none of the mutants in 
CPSF or CstF modified the macrochaetae phenotype in comparison to 80AC 1648  #61 
sca-GAL4 and sca-GAL4 controls (Appendix F and data not shown). 
Characterisation of CBC has shown that it also mediates the cap's effect in U snRNA 
export. CBC and the adaptor molecule PHAX are both necessary and sufficient for 
Xpol mediated U snRNA export (Fornerod et al., 1997; Ohno et al., 2000). CBC is 
then thought to be recycled back to the nucleus via the importin pathway. The NLS 
in CBP80 appears to bind the adaptor srpl/ importin a, which in combination with 
importin 0, transports cytoplasmic CBC to the nucleus (Gorlich et al., 1996). The 
Drosophila homologue of Xpol is Crml and homologues of the importin a family 
include karyopherin al and pendulin. Since no mutant alleles were available for 
these genes, small deficiencies that uncovered the predicted loci were crossed to 
80/iC 1648  #6, sca-GAL4 at 2 1°C. Fl progeny that carried both alleles were then 
scored for suppression or enhancement compared to 80/iC /648  #6, sca-GAL4 and 
sca-GAL4 adults alone. This showed the macrochaetae phenotype was not modified 
by deficiencies that uncovered Crm], karyopherin a] or pendulin genes (Appendix F 
and data not shown). 
After RNAP II transcripts have been processed in the nucleus, they are exported to 
the cytoplasm for translation. In order to initiate cap-dependent translation, CBC 
must exchange with the cytoplasmic cap-binding protein eIF4E. This allows the 
heterotrimeric translation initiation complex, eIF4F, to form at the cap. Although the 
mechanism for the exchange of cap-binding proteins is unknown, it is thought to be 
mediated through eIF4G (Fortes et al., 2000; McKendrick et al., 2001). As a result, 
the components of eIF4F were screened for genetic modification with 80/iC 1648  #6, 
sca-GAL4. In addition, proteins that regulate cap-dependent translation such as 
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eIF4E-binding protein were targeted. eIF4E-binding proteins specifically control the 
initiation of cap-dependent translation through binding to eIF4E. Although there is a 
family of eIF4E-binding proteins in vertebrates, the Drosophila genome appears to 
only contain a single gene encoding one eIF4E-binding protein homologue. P-
insertion and deletion mutants were obtained for these translation factors and crossed 
with 80AC 1648#6,  sca-GAL4 at 21'C. Fl progeny were then scored for modification 
compared to 80AC 1648  #6, sca-GAL4 and sca-GAL4 adults alone. This determined 
that 80LIC 1648  #6, sca-GAL4 dominant phenotype was not modified by the 
translation mutants tested (Appendix F and data not shown). 
Taken together, the results show that none of the mutants in pre-mRNA splicing, 
RNA 3'-end formation, RNA export or cap-dependent translation factors modified 
80/iC 1648  #6, sca-GAL4 dominant phenotype at 21'C. However, the following 
sections describe how the macrochaetae phenotype was suppressed by an allele of 
the largest subunit of RNAP II and a deficiency that uncovered the CTD-binding 
protein, cleavage factor 1A. 
7.28 RNAP II 215w8 suppresses UAS-DmCBP8OzXC 1-648  #6, 
sca-GAL4 macrochaetae phenotype 
Many lines of evidence have shown that RNAP II transcription is intimately coupled 
in vivo to nuclear mRNA processing events such as capping, pre-mRNA splicing and 
RNA 3'-end formation (Hirose and Manley, 2000). Given the role CBC plays in pre-
mRNA splicing and RNA 3'-end formation, it was reasoned that CBC might also 
interact with the CTD to facilitate these processes (see Chapter 1). Therefore, genes 
tested for interaction with 80/iC 1648  #6, sca-GAL4 included RNAP 11215 and RNAP 
11 140 that encode the two largest subunits of RNAP II. In particular, RNAP II 215 
was targeted since its CTD specifically couples transcription with RNA processing. 
A number of mutants were available in RNAP 11 215 and RNAP 11 140 that included 
deletion and EMS-induced alleles. These alleles were crossed with 80/iC 1-648  #6, 
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sca-GAL4 and the Fl progeny screened for genetic modification at 21°C (Appendix 
F). 
Surprisingly, one allele of the largest RNAP II subunit, RNAP 11 215 W8  was found to 
strongly suppress 80AC 1648  #6, sca-GAL4 phenotype at 210C. RNAP 11215 
W8  is a 
recessive lethal caused by a 631 bp insertion of residual P-element sequences into 
CTD heptad repeat #20. This generates a RNAP 11 215 subunit with a premature stop 
codon. As a result, the RNAP 11 215 subunit contains a partially truncated CTD with 
only 19 of the normal 42 CTD heptad repeats (Brickey and Greenleaf, 1995). 
Crossing RNAP 11 215 W8  into 80AC 1-648  #6, sca-GAL4 background strongly 
suppressed the macrochaetae phenotype to wild-type. As can be observed from 
Figure 7.8, A, all four macrochaetae on the central notum and scutellum were 
restored. However, these marcrochaetae appeared to be approximately 16% shorter 
and thinner than the GAL4 control (compare panels [i]-[iii]). In contrast, introducing 
other RNAP II 215 alleles only resulted in a mild suppression of the dominant 
phenotype. This is illustrated in Figure 7.8, A where crossing a null allele of RNAP 11 
215 (RNAP 215 NULL)  restored one of the four macrochaetae on the central notum 
along with three out of four scutellar macrochaetae. However these macrochaetae 
were approximately 55% shorter than the GAL4 control (compare panels [i]-[iv]). 
To determine whether the suppression observed was specific to 80AC 1648  #6, sca-
GAL4, RNAP 11215 alleles were crossed with an UAS-GAL4 control. It was decided 
that UAS-atonal, 531-GAL4 would not be an ideal control since atonal is a RNAP II 
transcription factor. Therefore, RNAP 11 215 alleles might modify UAS-atonal, S31-
GAL4 dominant macrochaetae phenotype for legitimate reasons. As expected, 
crossing the RNAP 11 215 alleles into UAS-atonal, S31-GAL4 background mildly 
suppressed the scutellar macrochaetae phenotype at 25°C (Appendix F and data not 
shown). Instead, UAS-importin /3, GMR-GAL4 was selected as an alternative UAS-
GAL4 control. Importin /3 encodes a protein import receptor that binds cargo 
carrying a classical NLS through the adaptor, importin a.. Unlike atonal, importin 








Figure 7.8 RNAP H 215w8 suppresses UAS-
DmCBP80AC 1-648  #6, sca phenotype 
Figure 7.8 RNAP II 215w8 suppresses UAS-DmCBP80iC 1-648  #6, sca-
GAL4 macrochaetae phenotype. A. [i] At 210C, 80AC 1-648  #6, sca-GAL4 
adult has two out of four distal scutellar macrochaetae whilst four 
macrochaetae on central notum are absent. [ii] In sca-GAL4/ + control, four 
macrochaetae on central notum and scutellum are present. [iii] Crossing 
RNAP j/ 215w8 into 80AC 1648  #6, sca-GAL4 background restores all four 
macrochaetae on central notum and scutellum. [iv] Crossing RNAP II 215 NULL 
into 80AC 1648  #6, sca-GAL4 background partially suppresses 80EC 1648  #6, 
sca-GAL4 macrochaetae. B. [i] At 25°C, importin P , GMR-GAL4 eye is rough 
and blistered. [ii] GMR-GAL4I + eye. Crossing [iii] RNAP II 215W8  or [iv] 
RNAP II 215 NULL  into importin f3, GMR-GAL4 background results in mild 
suppression. 
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Figure 7.8, B illustrates the dominant eye phenotype observed in UAS-importin /3, 
GMR-GAL4 adults at 25°C. Typically, UAS-importin /3, GMR-GAL4 eye appears to 
be severely rough and blistered at 25°C (compare [i] with [ii]). Introducing various 
alleles of RNAP II 215 into UAS-importin /3, GMR-GAL4 background mildly 
suppressed the dominant eye phenotype at 25°C. As can be observed in Figure 7.8, B 
RNAP 215 W8;  UAS-importin /3, GMR-GAL4 eye appears to be rough in comparison 
to the GAL4 control. Likewise, crossing RNAP 215 NULL  into UAS-importin /3, GMR-
GAL4 background also generated a mildly rough eye. Both RNAP II 215 NULL  and 
RNAP 11 215 W8  affect transcription, therefore the observed mild suppression might 
not be surprising. One possibility is that the RNAP II 215 mutants might have 
reduced transcription and consequently produce lower levels of Ga14 protein. The 
reduction in Ga14 availability might in turn mildly suppress both UAS-atonal, 531-
GAL4 and UAS-importin /3, GMR-GAL4 dominant phenotypes. Similarly, the mild 
suppression observed in RNAP 215 NULL;  80/iC 1648  #6, sca-GAL4 macrochaetae was 
also deemed non-specific. In comparison, the strong suppression observed in RNAP 
215 w8,  80/iC /648  #6, sca-GAL4 adults was considered significant. Collectively, 
these data suggest 80/iC 1648  #6, sca-GAL4 macrochaetae phenotype is modified by 
RNAP 215 W8  Moreover, this genetic interaction is specific to the CTD of RNAP 11 
215. 
To test whether CBC interacts (directly or indirectly) with RNAP II biochemically, 
immunoprecipitation experiments were performed on Drosophila and HeLa nuclear 
extracts. RNAP II complexes from both extracts were immunoprecipitated with the 
monoclonal antibody 8WG16, which recognises non-phosphorylated epitopes on the 
CTD (Yuryev et al., 1996). RNAP II immunoprecipitates were separated by SDS-
PAGE and then analysed by western blotting. The presence of CBC was detected 
using anti-1426 antibody that is directed against HsCBP20 but also cross-reacts with 
DmCBP20 (Izaurralde et al., 1994 and Chapter 4). As a positive control, the western 
blot was probed with monoclonal antibody Y12 that recognises epitopes on the Sm 
protein family (Brahms et al., 2000). However, CBC was not found to co-
immunoprecipitate with RNAP II complexes in Drosophila nuclear extracts (data not 
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shown). In contrast, immunoprecipitation experiments using larger quantities 
(approximately 2 mgs) of HeLa nuclear extracts showed CBC was enriched in RNAP 
II immunoprecipitates (E. Thompson, unpublished data). This suggests a weak 
association between CBC and the CTD of RNAP II that might be indirect and 
mediated by adaptor proteins. Alternatively, the interaction between CBC and RNAP 
II might be direct and enhanced by CTD phosphorylatiori. Therefore, further work 
using alternative antibodies directed against different phospho-epitopes on the CTD, 
such as H5 and H14 that detect serine-2 and serine-5 respectively, might prove more 
successful in determining a biochemical interaction between CBC and RNAP II 
CTD. 
7.2.9 Deficiency uncovering CTD-interacting protein, 
cleavage factor I suppresses UAS-DmCBP80AC 1-648#6,  sca-
GAL4 macrochaetae phenotype 
Although the CTD of RNAP II couples transcription with mRNA processing, very 
little is currently known about the molecules that facilitate the effects of the CTD or 
the mechanisms involved. Yeast two-hybrid screens have identified a family of 
proteins that specifically interact with the CTD (Yuryev et al., 1996; Bourquin et al., 
1997; Tanner et al., 1997). These proteins resemble the SR splicing factors and have 
been designated SR-like CTD associated factors (SCAFs). SCAFs interact with the 
CTD through a distinct CTD-interacting domain (CID). To date, two types of CID 
have been characterised. Type 1 CID is comprised of approximately 80 conserved 
amino acids located at the carboxyl-terminus. In comparison, type 2 CID has around 
120 amino acid conserved region at the amino-terminus. Although both sets of CID 
are unrelated in amino acid sequence, they are probably related structurally. 
In order to identify Drosophila proteins that contain a CID, the peptide sequences of 
type 1 and type 2 CID were used in BLASTP searches of the BDGP database (Joe 
Lewis). This identified five putative CID genes that are listed in Appendix F. No 
mutant alleles were available for any of the CID genes. As a result, small 
deficiencies that uncovered these genes were crossed into 80AC I648#6,  sca-GAL4 
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background at 21°C. Interestingly, Df(2)knSA3 that uncovers the CID gene 
CG10228, was already identified as a 80AC /648  #6, sca-GAL4 interacting 
deficiency. Df(2)knSA3 was found to strongly suppress 80AC ]648  #6, sca-GAL4 
macrochaetae phenotype at 21°C and the genetic interacting region was mapped to 
51C1-51D8 (Figure 7.4). CG10228 is predicted to encode cleavage factor 1A, which 
is the homologue of S. cerevisiae pcf 11. Cleavage factor JA is located to 51D1-2 and 
like CBC, is predicted to function in the cleavage step of RNA 3'-end formation 
(Barilla et al., 2001; Flaherty et.al., 1997; Gross and Moore, 2001). Taken together, 
these data suggest that cleavage factor JA is a strong candidate CBC-interacting gene 
that resides in genetic interacting region 51C1-51D8. 
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73 DISCUSSION 
7.31 UAS-DmCBP80AC 1.648 #6, sca-GAL4 is a useful tool for 
genetic modifier screens 
The deficiency screen showed that 80AC 1648  #6, sca-GAL4 dominant phenotype is 
sensitive to modification. The macrochaetae phenotype is both enhanced or 
suppressed by a total of five deficiencies from the second and third chromosomes. 
Consequently, 80AC 1643  #6, sca-GAL4 dominant phenotype provides a sensitised 
genetic background for performing genetic modifier screens. Together with being 
consistent within a population and easily detected at 21°C, the macrochaetae 
phenotype fulfils all three criteria required for use in genetic modifier screens. This 
suggests 80AC 1643  #6, sca-GAL4 is an useful tool by which to identify CBC-
interacting genes and could be applied to large-scale genetic screens using P-element 
collections. 
Although Flybase cytosearches identified candidate genes with predicted functions in 
RNA processing within the interacting deficiencies, very few mutant alleles were 
available. It was therefore not possible to directly test these putative CBC-interacting 
genes for interaction with 80AC ]648  #6, sca-GAL4. For example, genetic interacting 
region 51C1-51D8 uncovers cleavage factor 1A, which is the Drosophila homologue 
of S. cerevisiae pcf 11. Characterisation of pcf 11 has shown it participates in the 
cleavage step of RNA 3'-end formation. Since CBC also participates in RNA 3'-end 
cleavage, it can be reasoned that CBC might facilitate the stimulatory effect of the 
cap through interactions with cleavage factor 1A. However, in the absence of any 
direct genetic data this is purely hypothetical. As a result, the identity of the 80/tC I - 
648 #6, sca-GAL4 interacting genes that reside within the five deficiency mapped 
regions remains to be determined. 
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7.3.2 RNAPII 215 W8suppresses  UAS-DmCBP80zXC 1-648#6, 
sca-GAL4 macrochaetae phenotype 
Chapter 6 has already discussed how 80AC 1-648  truncation removes a significant 
portion of a prominent carboxyl-terminal coiled-coil that protrudes from CBP80. In 
CBC-cap bound mRNA, CBP80 is thought to serve as a platform for the assembly of 
various components of the RNAP II transcript processing/ export machinery (Mazza 
et al., 2001). Key roles for CBC have been characterised in cap-dependent splicing, 
RNA 3'-end formation and U snRNA export (Lewis and Izaurralde, 1997). In 
addition, recent work in mammalian cells has also suggested that CBC functions 
during a pioneer round of cap-dependent translation where newly synthesised 
proteins are scanned for premature stop codons and therefore subject to NMD (Fortes 
et al., 2000; Ishigaki et al., 2001). One possibility is that the over-expression of 
80AC 1648  truncation removes the distinct coiled-coil surface required for 
interactions with different RNA processing/ export/ pioneer round of cap-dependent 
translation factors. As a result, RNAP II transcripts are not subject to efficient cap-
dependent splicing, RNA 3'-end formation or NMD. RNAs are inefficiently 
processed and translated, which generates the dominant macrochaetae phenotype 
observed in 80/tC I64s#6,  sca-GAL4 adults. 
Results from the targeted genetic modifier screen show 80AC 1-648  #6, sca-GAL4 
macrochaetae phenotype is strongly suppressed by an allele of RNAP 11 215 subunit. 
RNAP II 215 is a recessive embryonic lethal of the largest subunit of RNAP II. 
RNAP II 215 W8  contains a partially truncated CTD caused by a 631 bp insertion of 
residual P-element sequences into CTD heptad repeat #20, which generates a 
premature stop codon. As a result, RNAP 11 215 subunit has only 19 of the normal 42 
CTD heptad repeats (Brickey and Greenleaf, 1995). Interestingly, 80AC ]648#6,  sca-
GAL4 macrochaetae phenotype is not significantly modified by RNAP 11215 EMS or 
deletion alleles that mutate regions upstream of the CTD. Nor is the dominant 
phenotype modified by a null allele in the second largest RNAP II subunit, 140. 
Collectively, these data suggest a genetic interaction exists between CBC and the 
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largest subunit of RNAP II. Furthermore, this interaction appears to be specific to the 
CTD of RNAP 11 215. 
Characterisation of RNAP 11 215 w8l + adults show the mRNA steady state levels 
from the RNAP 11 215 W8  allele are much lower than wild-type. As a result, RNAP 11 
215 W8 protein subunit is under-represented and the majority of RNAP II in RNAP II 
215 W8/  + adults contain a wild-type CTD (Brickey and Greenleaf, 1995). RNAP 11 
215 W8  contains a premature stop codon approximately 500 nucleotides upstream of 
the normal termination site. This strongly suggests that the low steady state levels of 
RNAP II 215 W8  mRNA result from transcript degradation by NMD (Brickey and 
Greenleaf, 1995). One possibility is that in 80AC 1648#6,  sca-GAL4 adults, mRNAs 
might undergo defective pioneer translation initiation and therefore are not subjected 
to efficient NMD. As a result, in RNAP 11 215 W8•  80AC 1648  #6, sca-GAL4 adults, 
there is inefficient detection and degradation of the premature stop codon in RNAP II 
215 w8transcripts.  This leads to increased steady state levels of RNAP II 215 
W8  
mRNAs that are translated and incorporated into RNAP II holoenzymes. Therefore, 
RNAP 11215 	80z1\C 1648#6,  sca-GAL4 flies might have catalytically active RNAP 
II that contains a truncated CTD. Although purely speculative, this hypothesis could 
be initially tested by using northern analysis to compare the steady state levels of 
RNAP 11 215 w8transcripts  in RNAP 11215 w8f + and RNAP 11215 
W8;  80/tC 1648#6, 
sca-GAL4 mutants. 
The CTD of RNAP II has been shown to couple transcription with capping, pre-
mRNA splicing and RNA 3'-end formation in vivo. Not only does the CTD 
independently stimulate each of these RNA processing events but different regions of 
the CTD appear to perform distinct functions in mRNA processing (Hirose and 
Manley, 2000; Fong and Bentley, 2001). Recent work has shown the carboxyl-region 
of mammalian CTD can support capping, splicing and 3'-end processing. However, 
the amino-region of the CTD can only support capping (Fong and Bentley, 2001). 
RNAP 11 215 '4'8  is predicted to encode a carboxyl-truncated CTD with 19 out of the 
42 normal heptad repeats (Brickey and Greenleaf, 1995). One possibility is that 
RNAP 11 215 ; 80/tC 1648  #6, sca-GAL4 adults express RNAP II whose truncated 
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CTD supports capping but does not carry out efficient transcription coupled splicing 
and/ or RNA 3'-end formation. 
It can therefore be reasoned that in RNAP 11 215 W8;  80AC 1648  #6, sca-GAL4 
mutants, mRNAs undergo a compounded effect. Firstly, RNAP II transcripts are 
predicted to undergo inefficient transcription coupled splicing! RNA 3'-end 
formation due to the activity of RNAP II with a truncated CTD. Secondly, mRNAs 
might also undergo aberrant CBC-cap-dependent splicing and 3'-end formation 
resulting from the over-expression of 80zXC 1648 truncation. In addition, CBC might 
co-operate with the CTD of RNAP II to facilitate these mRNA processing events. 
Before mRNAs are released from transcription sites, they are monitored for correct 
splicing and 3'-end formation by checkpoints such as the nuclear exosome 
(Bousquet-Antonelli et al., 2000; Hilleren et al., 2001). Aberrantly processed 
mRNAs that undergo this compounded effect in RNAP 11215 w8•  80/iC 1648#6,  sca-
GAL4 mutants might not escape such quality control systems and be retained in the 
nucleus and degraded. As a result, the inefficiently processed mRNAs in 80/iC 1648 
#6, sca-GAL4 adults are not translated and the dominant macrochaetae phenotype is 
suppressed. 
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7.3.3 Cleavage factor IA is a CTD-interacting protein 
uncovered by UAS-DmCBP80AC 1-648 #6, sca-GAL4 interacting 
region 5ICI-5ID8 
BLASTP searches of the BDGP database identified five Drosophila proteins that 
contained CIDs. Apart from deficiencies, no mutant alleles are available for any of 
these putative CTD-interacting genes. Interestingly, Df(2R)knSA3 that uncovers 
putative CTD-interacting gene CG10228, was already identified as a 80ztC 1-648 #6, 
sca-GAL4 interacting deficiency. Df(2R)knSA3 strongly suppresses 80AC 1648  #6, 
sca-GAL4 macrochaetae phenotype at 21°C. CG10228 is located to 51D1-2 and 
resides within the genetic interacting region 51C1-51D8. CG10228 contains a type 2 
amino-terminal CID and is predicted to encode cleavage factor 1A, the Drosophila 
homologue of S. cerevisiae pcf 11. Characterisation of pcf 1 1 shows it is a subunit of 
the heterotetrameric CF1A, which functions in RNA 3'-end formation and 
transcription termination. Moreover, recent work has confirmed that pcf 1 1 directly 
interacts with the CTD of RNAP II and this interaction is stimulated by CTD 
phosphorylation (Barilla et al., 2001; Gross and Moore 2001). This suggests that 
pcf 11 is an adaptor molecule that couples transcription with RNA 3'-end formation 
by facilitating the stimulatory effects of the CTD during 3'-end processing. 
Taken together, these data suggest that cleavage factor JA is a strong candidate for 
the CBC-interacting gene that resides within 51C1-51D8. However, until mutant 
alleles of cleavage factor JA become available to cross with 80AC 1-648  #6, sca-
GAL4, this remains purely speculative. Alternatively, biochemical approaches such 
as immunoprecipitations could be used to explore a possible interaction between 
CBC and cleavage factor JA. 
Roles in the cleavage step of RNA 3'-end formation have been described for 
Drosophila cleavage factor 1A, CBC and the CTD of RNAP II. One possibility is 
that during RNA 3'-end formation, the CTD might facilitate the coupling of 
transcription with RNA 3'-end formation by recruiting 3'-end processing factors to 
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the cleavage complex. As a result, CTD-interacting adaptor molecules such as 
cleavage factor 1A might interact with CBC in the cleavage complex to facilitate the 
positive effects of the cap in RNA 3'-end formation. 
7.4 CONCLUSION 
Genetic modifier screens using deficiencies and targeted genes have shown UAS-
DrnCBP80AC 1648  #6, sca-GAL4 is a useful tool by which to identify CBC-
interacting genes. An allele of the largest subunit of RNAP II that has a carboxyl-
truncated CTD suppresses UAS-DinCBP80AC 1648  #6, sca-GAL4 macrochaetae 
phenotype. This suggests an indirect/ direct interaction between CBC and RNAP II 
that is mediated through the CTD. 
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CHAPTER 8 
Final Summary 
The original objectives of this thesis were to firstly, determine whether CBC has 
novel functions during fruit-fly development. And secondly, identify CBC-
interacting genes to further understand the mechanisms by which CBC and the cap 
facilitate multiple aspects of RNAP II transcript metabolism. Indeed, the research in 
this thesis presents three main findings. Firstly, novel function(s) are implicated for 
DmCBP20 outside RNA processing during spermatogenesis. Next, a second CBP80 
homologue has been identified in Drosophila melanogaster that is predominantly 
expressed in third instar larvae and adult testes. Finally, a genetic interaction is 
identified between CBC and the CTD of RNAP II. The following sections summarise 
these results and the working hypotheses that can be tested in the future. 
Initial characterisation of CBC in Drosophila shows that both cap-binding proteins 
are highly homologous to the corresponding human proteins. DmCBC behaves in a 
manner analogous to HsCBC and both subunits are required to heterodimerise to 
form a functional cap-binding complex (Chapter 3). Taken together, these findings 
suggest that CBC function is conserved between Drosophila and human species. 
This presents a strong argument for using Drosophila as a model system to dissect 
the biology of CBC in vivo. 
As a first step to characterising CBC function in Drosophila, an existing P-insertion 
in DinCBP20 was mobilised to generate a battery of DrnCBP20 mutants. Results 
from the P-hop determined DinCBP20 is an essential gene that is required for both 
somatogenesis and gametogenesis (Chapter 4). CBC RNA is expressed throughout 
Drosophila development and appears to be maternally derived (Chapter 3). This 
profile is typical for a key player in RNAP II transcript metabolism that is important 
for the viability of all cells in Drosophila development. 
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Surprisingly, DmCBP20 makes a greater contribution to male fertility than female 
fertility. Analysis of the testes from DmCBP20 male sterile lines indicate that the 
early pre-meiotic stages, which correlate to times of active RNAP II transcription 
coupled RNA processing, appear to be wild-type. Instead, preliminary observations 
suggest the defects underlying the male sterility might arise during the final stages of 
spermatogenesis, at times consistent with tight post-transcriptional regulation 
(Chapter 4). One possibility is that DmCBP20 plays novel roles during 
spermatogenesis in post-transcriptional regulation. Additional work will have to be 
done to determine the exact stage and cause of sterility during spermatogenesis. 
Although CBP20 is present as a single-copy gene in Drosophila, humans have two 
CBP20 homologues. Initial characterisation of HsCBP20R has shown that it is 
predominantly expressed in the adult testes (E. Thompson). This suggests a role for 
CBP20 in spermatogenesis is conserved amongst higher eukaryotes. Intriguingly, 
Drosophila has two CBP80 homologues whilst humans only have one. Similar to 
HsCBP20R, DmCBP80R is predominantly expressed in the adult testes with little 
expression in the somatic tissues (Chapter 5). The functional significance of 
HsCBP20R or DmCBP80R is currently unknown. One possibility is that 
DmCBP80R, together with DmCBP20, might have acquired novel functions in 
spermatogenesis during evolution. DmCBP80R might bind DniCBP20 to form a 
male-specific CBC that functions in translation regulation. The male-specific CBC 
might mask mRNAs transcribed early from the translation machinery until the 
proteins are required during the later stages of spermatogenesis. Future experiments 
will be directed to whether DmCBP80R can bind DmCBP20 to form a male-specific 
CBC. In addition, it remains to be determined whether DmCBP80 and DmCBP80R 
are expressed in the same cell types or if the expression is mutually exclusive. 
Finally, over-expression of the UAS-DmCBP80AC 1-648  truncation using the GAL4-
UAS system generates dominant adult phenotypes in various non-essential tissues. 
Characterisation of the UAS-DmCBP80AC 1648 #6, sca-GAL4 dominant 
macrochaetae phenotype shows it is suitable for large-scale genetic modifier screens 
to identify CBP80-interacting genes (Chapter 6 and 7). Interestingly, the dominant 
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macrochaetae phenotype was suppressed by an allele of the largest subunit of RNAP 
II that has a truncated CTD (Chapter 7). This result suggests CBC interacts with the 
largest subunit of RNAP II and this interaction is facilitated through the CTD. 
CBC and the cap act as a molecular tag to define RNAP II transcripts during 
processing. It is well established that transcription is coupled with RNA processing 
and this is facilitated through the CTD of the largest subunit of RNAP II. However, 
very little is known about the molecules that mediate the interaction between the 
CTD and various RNA processing factors. The strong suppression of UAS- 
DinCBP80AC /648  #6, sca-GAL4 suggests a connection between the CTD of RNAP 
II and CBC. One hypothesis is that the cap-CBC might interact with the CTD of 
RNAP II to facilitate efficient coupling of transcription with processing. Such an 
interaction would help target transcripts to the CTD for pre-mRNA splicing and 
RNA 3'-end formation. Alternatively, CBC might play a novel role in RNAP II 
transcription, for example during transcription initiation. Future efforts will be 
directed to elucidating whether CBC functions in the early steps of transcription 
initiation and/ or the coupling of splicing and 3'-end processing to this process. 
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Appendices 
Appendix A: Summary of DmCBP201  PCR Screen 
DmCBP2d/ TM3  
Line Mutation Line Mutation 
1 -20() bp deletion 42 Putative deletion 
2 -200 bp deletion 43 Putative deletion 
3 -200 bp deletion 44 Putative deletion 
4 Putative deletion 45 Putative deletion 
5 Putative deletion 46 Putative deletion 
6 -25 bp residual P-element 47 -50 bp residual P-element 
7 Putative deletion 48 Putative deletion 
8 Putative deletion 49 Putative deletion 
9 -40 bp residual P-element 50 Putative deletion 
10 -100 bp residual P-element 51 -600 bp residual P-element 
11 Putative deletion 52 -400 bp residual P-element 
12 Putative deletion 53 Putative deletion 
13 Putative deletion 54 Putative deletion 
14 Putative deletion 55 -1, 700 bp residual P-element 
15 Putative deletion 56 -1, 200 bp residual P-element 
16 -400 bp residual P-element 57 Putative deletion 
17 Putative deletion 58 -800 bp residual P-element 
18 -1, 200 bp residual P-element 59 Putative deletion 
19 Putative deletion 60 -25 bp residual P-element 
20 Putative deletion 61 Putative deletion 
21 Putative deletion 62 Putative deletion 
22 -900 bp residual P-element 63 -100 bp residual P-element 
23 Putative deletion 64 Putative deletion 
24 Putative deletion 65 -1, 700 bp residual P-element 
25 Putative deletion 66 Putative deletion 
26 Putative deletion 67 Putative deletion 
27 -60 bp residual P-element 68 Putative deletion 
28 Putative deletion 69 Putative deletion 
29 Putative deletion 70 Putative deletion 
30 -50 bp residual P-element 71 Putative deletion 
31 Putative deletion 72 -40 bp residual P-element 
32 Putative deletion 73 Putative deletion 
33 Putative deletion 74 Putative deletion 
34 Putative deletion 75 Putative deletion 
35 Putative deletion 76 -25 bp residual P-element 
36 Putative deletion 77 -600 bp residual P-element 
37 -300 bp residual P-element 78 Putative deletion 
38 -100 bp residual P-element 79 Putative deletion 
39 Putative deletion 80 Putative deletion 
40 Putative deletion 81 Putative deletion 
41 Putative deletion 82 Putative deletion 
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DmCBP2/ TM3  
Line Mutation Line Mutation 
83 Putative deletion 124 Putative deletion 
84 -40 bp residual P-element 125 Putative deletion 
85 -1, 000 bp residual P-element 126 Putative deletion 
86 600 bp residual P-element 127 30 bp residual P-element 
87 800 bp residual P-element 128 Putative deletion 
88 30 bp residual P-element 129 -2(() bp residual P-element 
89 Putative deletion 130 Putative deletion 
90 Putative deletion 131 Putative deletion 
91 Putative deletion 132 Putative deletion 
92 Putative deletion 133 Putative deletion 
93 Putative deletion 134 Putative deletion 
94 '-500 bp residual P-element 135 1, 500 bp residual P-element 
95 Putative deletion 136 40 bp residual P-element 
96 Putative deletion 137 Putative deletion 
97 200 bp residual P-element 138 Putative deletion 
98 -25 bp residual P-element 139 Putative deletion 
99 Putative deletion 140 Putative deletion 
100 Putative deletion 141 -100 bp residual P-element 
101 -400 bp residual P-element 142 Putative deletion 
102 Putative deletion 143 Putative deletion 
103 -10() bp residual P-element 144 -40 bp residual P-element 
104 Putative deletion 145 -60 bp residual P-element 
105 Putative deletion 146 Putative deletion 
106 -100 bp residual P-element 147 Putative deletion 
107 Putative deletion 148 Putative deletion 
108 Putative deletion 149 -500 bp residual P-element 
109 Putative deletion 150 -40 bp residual P-element 
110 -200 bp residual P-element 151 Putative deletion 
111 Putative deletion 152 Putative deletion 
112 Putative deletion 153 --30 bp residual P-element 
113 Putative deletion 154 Putative deletion 
114 Putative deletion 155 Putative deletion 
115 '-1, 100 bp residual P-element 156 Putative deletion 
116 -50 bp residual P-element 157 -30 bp residual P-element 
117 Putative deletion 158 Putative deletion 
118 -60 bp residual P-element 159 Putative deletion 
119 Putative deletion 160 Putative deletion 
120 Putative deletion 161 Putative deletion 
121 --100 bp residual P-element 162 Putative deletion 
122 -500 bp residual P-element 163 Putative deletion 
123 -200 bp residual P-element  
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Appendix B: UAS-Transgenic Lines 
UAS-HsCBP20  
Line Eye Colour Chromosome Homozygous Viable? 
1 Yellow 2 Yes 
2 Orange 3 Yes 
3 Light Orange 3 Yes 
4 Dark Orange X Yes 
5 Orange 3 No 
6 Red 3 No 
7 Yellow 3 Yes 
8 Light Orange 3 Yes 
9 Dark Orange 2 Yes 
10 Dark Orange X Yes 
11 Light Orange 2 No 
12 Red 3 Yes 
13 Orange 3 Yes 
14 Orange 3 Yes 
15 Dark Orange 2 Yes 
16 Dark Orange 2 Yes 
17 Yellow 2 Yes 
18 Red 2 Yes 
UAS-DmCBP20  
Line Eye Colour Chromosome Homozygous Viable? 
Light Orange 3 Yes 
2 Dark Orange 2 Yes 
3 Red X Yes 
4 Orange 3 Yes 
5 Dark Orange X Yes 
6 Orange 2 No 
UAS-DmCBP20AC1  
Line Eye Colour Chromosome Homozygous Viable? 
Light Orange 2 No 
2 Orange X Yes 
3 Red 2 No 
4 Orange 3 Yes 
5 Red 3 Yes 
6 Yellow 3 Yes 
7 Orange 3 Yes 
8 Light Orange 2 No 
9 Orange X Yes 
10 Light Orange 3 Yes 
11 Orange 3 Yes 
12 Orange 2 No 
13 Orange 3 No 
14 Red 2 No 
15 Red 3 Yes 
16 Orange X Yes 
17 Dark Orange 2 No 
18 Orange 3 No 
19 Red 3 Yes 
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20 Dark Orange 2 Yes 
21 Yellow 3 Yes 
22 Orange 2 No 
UAS-DmCBP20AC1125  
Line Eye Colour Chromosome Homozygous Viable? 
Red 2 Yes 
2 Orange 3 Yes 
3 Orange 3 Yes 
UAS-HsCBP80  
Line Eye Colour Chromosome Homozygous Viable? 
Orange 2 Yes 
2 Dark Orange 2 Yes 
3 Orange 3 Yes 
4 Light Orange 2 Yes 
5 Yellow 2 Yes 
6 Orange X T 	Yes 
UAS-DmCBP80  
Line Eye Colour Chromosome Homozygous Viable? 
1 Red 2 Yes 
2 Orange 3 Yes 
3 Yellow 3 No 
UAS-DmCBP80AC1.178  
Line Eye Colour Chromosome Homozygous Viable? 
I Orange X Yes 
2 Dark Orange 3 Yes 
3 Orange 2 Yes 
4 Dark Orange 3 Yes 
5 Orange X Yes 
6 Orange X Yes 
7 Orange 3 No 
8 Dark Orange 3 Yes 
9 Red 3 Yes 
10 Light Orange 2 No 
11 Red 3 Yes 
12 Orange 3 No 
13 Light Orange X Yes 
14 Orange X Yes 
15 Yellow 2 Yes 
UAS-DmCBP80AC1424  
Line Eye Colour Chromosome Homozygous Viable? 
1 Orange 3 Yes 
2 Yellow 2 Yes 
3 Light Orange 3 Yes 
4 Orange X Yes 
5 Orange 3 Yes 
6 Light Orange 3 Yes 
7 Orange 3 No 
8 Dark Orange 2 Yes 
9 Orange 2 Yes 
10 Dark Orange X No 
11 Orange 3 Yes 
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12 Yellow 2 Yes 
13 Red 2 Yes 
14 Dark Orange 2 Yes 
UAS-DmCBP80AC1410  
Line Eye Colour Chromosome Homozygous Viable? 
Red 3 Yes 
2 Orange 3 Yes 
3 Dark Orange 2 Yes 
4 Orange 2 Yes 
5 Dark Orange 3 Yes 
6 Orange X Yes 
7 Orange 3 No 
UAS-DmCBP80AC148  
Line Eye Colour Chromosome Homozygous Viable? 
1 Light Orange 2 No 
2 Orange X Yes 
3 Yellow 3 Yes 
4 Red 2 Yes 
5 Orange 3 Yes 
6 Dark Red 2 Yes 
7 Orange 3 Yes 
8 Dark Orange 3 No 
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Appendix C: GAL4-UAS Crosses 
Transgenic Line L GAL4 Driver 
Line Number I Chromosome Eye Colour GMR I sca I 	vg ptc 384 
UAS-HsCBP20  
1 2 Yellow X X X X X 
2 3 Orange X X X X X 
3 3 Light Orange X X X X X 
4 X Dark Orange X X X X X 
7 3 Yellow X X X X X 
12 3 Red X X X X X 
UAS-DmCBP20  
1 3 Light Orange X X X X X 
2 2 Dark Orange X X X X X 
3 X Red X X X X X 
4 3 Orange X X X X X 
5 X Dark Orange X X X X X 
6 2 Orange X X X X X 
UAS-DmCBP204C195  
2 X Orange X X X X X 
4 3 Orange X X X X X 
14 2 Red X X X X X 
15 3 Red X X X X X 
16 X Orange X X X X X 
19 3 Red X X X X X 
UAS-DmCBP204C1.125  
1 2 Red X X X • X 
2 3 Orange X X X X X 
3 3 Orange X X X X X 
UAS-DmCBP80  
1 2 Orange X X X X X 
2 2 Dark Orange X X X X X 
3 3 Orange X X X X X 
4 2 Light Orange X X X X X 
5 2 Yellow X X X X X 
6 X Orange X X X X X 
X 	= No dominant phenotype observed in Fl progeny at 18°C, 25°C or 29°C. 
= Dominant phenotype observed in Fl progeny at 25°C and 29°C. 
i)1 
Chapter 9 Appendices 
Transgenic Line GAL4 
T:C,MR  
Driver 
Line Number I Chromosome I 	Eye Colour sca vg ptc 384 
UAS-DmCBP80  
1 2 Red X X X X X 
2 3 Orange X X X X X 
3 2 Yellow X X X X X 
UAS-DmCBP804 C1.178  
1 X Orange X X X X X 
3 2 Orange X X X X X 
8 3 Dark Orange X X X X X 
9 3 Red X X X X X 
13 X Light Orange X X X X X 
15 2 Yellow X X X X X 
UAS-DmCBP80AC1  
1 3 Orange X X X X X 
2 2 Yellow X X X X X 
4 X Orange X X X X X 
6 3 Light Orange X X X X X 
7 3 Orange X X X X X 
13 2 Red X X X X X 
UAS-DmCBP80AC1.510  
1 3 Red X X X X X 
2 3 Orange X X X X X 
3 2 Dark Orange X X X X X 
4 2 Orange X X X X X 
5 3 Dark Orange X X X X X 
6 X Orange X X X X X 
UAS-DmCBP804C1. 
1 2 Light Orange X X X X X 
2 X Orange X X X • • 
3 3 Yellow X X X X X 
4 2 Red X X X • • 
5 3 Orange X X X X X 
6 2 Dark Red X X X • • 
7 3 Orange X X X 0 • 
8 3 Dark Orange I 	X X X X X 
X 	= No dominant phenotype observed in Fl progeny at 18°C, 25°C or 29°C. 
= Dominant phenotype observed in Fl progeny at 25°C and 29°C. 
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Appendix D: Deficiencies used for Mapping UAS-DmCBP80AC 
1-648 #6, sca-GAL4 Interacting Regions 
Deficiency 	 Breakpoints 	Source 
Interacting region 27C1-27E  
Df(2L)spd, al' dp' 27D-E; 28C Bloomington 
Df(2L)XE-2 750 28B2; 28D3 Bloomington 
Jn(/)w'4; Df(2L)E110 25F3;26A1; 26D3-1 1 Bloomington 
Df(2L)Dwee-delta5 27A; 28A Bloomington 
Dft2L)J-H 27C2-9; 28B3-4 Bloomington 
W; Df(2L)spd'2, w9" 12 27C 1-2; 28A Bloomington 
Interacting region 42B3-42C  
Df(2R)171, cn' 41F3-4;42A3-9 Bloomington 
Dft2R)cn88b, cn 42C; 42E Bloomington 
Df(2R)STJ, Ad/f 5 pr' cn* 42B3-5; 43E15-18 Bloomington 
Df(2R)pk78k, Tp(2;2)CA30, sp' 42E3; 43C3 Bloomington 
Dft2R)pk78s 42F; 43F8 Bloomington 
Dft2R)Dr1' 3, bw' 42E1-4; 43C3 Bloomington 
Interacting region 51C1-51D3  
Df(2R)03072 51A5; 51C1 Bloomington 
Df(2R)trix 51 A 1-2; 51 B6 Bloomington 
w' 	Df(2R)JpI 51D3-8; 52F5-9 Bloomington 
yl wJ/Dp(1 Y)y+; Df(2R)XTE- 18 51 E3; 52C9-D 1 Bloomington 
w'/Dp( 1; Y)y; Df(2R)knSA3, 
Tp( I ;2)TE2 1F22A  
51 B5-1 1; 51 D7-E2 
Interacting region 57D12-58D1  
Df(2R)AA2J, c' px' sp' 56F9-17; 57D1 1-12 Bloomington 
Df(2R)PKI, c' px' sp' 57C5; 57F5-6 Bloomington 
Df(2R)Pu-D17, cn' bw' sp' 57B4; 58B Bloomington 
DJ(2R)Egfr5, b' pr' cn' sca' 57D2-8; 58D1 Bloomington 
Dp( 1; Y)vVy'; D/2R)X58- 12 58D 1-2; 59A Bloomington 
Interacting region 71F-72D1  
Dft3L)BKI0, ru' Ly' red' cv-c' Sbth 	Sr' e1  70C; 71F Bloomington 
Df(3L)brin]1 71F1-4; 72D1-10 Bloomington 
Df(3L)th102, h' knini  e 71F3-5; 72D12 Bloomington 
Df(3L)st7 f13, Ki' roe' p" 72C1-D1; 73A3-4 Bloomington 
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Appendix E: Genes Tested in UAS-DmCBP80AC 1-648  #6, sca-
GAL4 Interacting Regions 
Interacting region 27C1-27E 
Allele I 	Comments Reference! Source 
snRNP 70K 27C7-8 
P(rv'72 1acZ)snRNP70K 217cn' P-insertion in snRNP 70K 5' IJTR Cline et al., 1999 
Nop5 27C3-4 
y' 	
67,23 P(w diacW)nop5kO 23O P-insertion Vorbruggen et al., 2000 
x16 27C3-4 
y'  w672 ; P(w C1acW)x16k 230 P-insertion I 	Vorbruggen et al., 2000 
Hrb27C 27C3-4 
P (0i"72 1acZ)Hrb27C°27 Lethal 	P-insertion 3.3 	Kb from 
Hrb 27C coding sequence 
Hammond et al., 1997 
y'w67' 23; P(w+('iacW)Hrb27Ck 28 I 4 Lethal P-insertion in Hrb 27C Bloomington 
ee 25A3-27F2 
Dp(1;Y)y; ee'b'pr' P-insertion ? Bloomington 
ee'b'pr' Recessive viable Bloomington 
cup 26F3-6 
cup'cn'bw'sp' Female sterile Bloomington 
P(ry"72 1acZ)cup°' 5cn' P-insertion Bloomington 
Rcal 27B4-27C1 
iacZ)Rca 1°33 cn' FP-insertion Bloomington 
ms(2) 
P(ry'72 1acZ),ns(2)27CD°9'cn' P-insertion I 	Bloomington 
milton 27D5-6 
P(w4id lac  W)rni1tonAO 7O4 P-insertion Bloomington 
1(2)k09923 26D1-2 
P(lacW)i(2)k09923 109923 P-insertion Bloomington 
I(2)k14206 26F3-5 
P(lacW)1(2)k/4206 114206 P-insertion Bloomington 
Interacting region 42133-42C 
Allele Comments Reference! Source 
Adfl 42B3-4 
P(ry'72 1acZ)AdfF 349cn' P-insertion Bloomington 
jing 42B2 
P(rv t72  iacZ)jjng°1°94cn' EP-insertion Bloomington 
y' w6723; P(w*ClacW)jing O3  P-insertion Bloomington 
1(2)k09848 42A8-12 
y1w67c23; P(w+md1acW)i(2)k09848ko98 P-insertion Bloomington 
I(2)k03204 42B1-3 
v1w6723; P(w*f1acW)1(2)k03204k1104  P-insertion 	 I Bloomington 
1(2)04535b 42C1-2 
P(lacZ)1(2)04535b 135hcnJ P-insertion 	 I Bloomington 
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Interacting region 51C1-51D3 
Allele I 	Comments I 	Reference! Source 
sf 51C1-E2 
Recessive viable Bloomington 
b's! Recessive viable Bloomington 
Rpn6 51C2 
y' w672 ; P-insertion Bloomington 
Kn 51C2-5 
kn' Recessive viable Bloomington 
boc 51D1-12 
en' P(ry*172  la(-Z)boc' P-insertion Bloomington 
I(2)k08015 51D3-5 
y' w6721; P(w"1acW)1(2)kO8OI5'<°8015 P-insertion I 	Bloomington 
Interacting region 571312-58131 
Allele 	 Comments 	 Reference! Source 
dye 	 58D1-2 
yI w7c2?:  p(,*( I lac Wdve'°5  P-insertion Bloomington 
en' P(rv 172 lacZdve01738 P-insertion Bloomington 
1(2)10608 	 57E1-2 
P(lacZ)1(2) JO6O8108 	 P-insertion 	 I 	Bloomington 
1(2)03605 	 57F8-10 
P(iacZ)1(2)03605035  P-insertion Bloomington 
I(2)k10317 57E6-7 
y'w6723; P(w'1acW)1(2)k1O31 7k0317 P-insertion Bloomington 
1(2)07837 	 58A3-4 
P(ry 72 lacZ)1(2)07837 7"37cn' 	P-insertion 	 I 	Bloomington 
Interacting region 71F-72D1 
Allele Comments I 	Reference! Source 
Art72A 72C1 
ArI72AN6  P(w)71F P-insertion I Bloomington 
I(3)72Ab 72A3; 72C1 
1(3)72AbI24 P(w')71F P-insertion Bloomington 
1(3) 72CD 72C1-72D2 
I(3)72CDaJI2 P(w')71F P-insertion Bloomington 
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Appendix F: Genes Targeted for Interaction with UAS-
DmCBP80AC 1-648  #6, sca-GAL.4 
Transcription 
Allele 	 Comments 	 Reference! Source 
RNAP 11140  
RNAPII /40A5  Null in 140 Mark Mortin 
Df(3R)red' 140 located to 88A10-12, deficiency 
breakpoints 88A2; 88C1-D1  
Bloomington 
RNAPII 215  
RNAPII 215 NULL Null in 215 Mark Mortin 
RNAPJI 215 K) 215 ts allele Mark Mortin 
RNA PJI2I5 W8  215 with truncated CTD, contains 19 out of 42 
heptad repeats 
Brickey and Greenleaf, 
1995 
v'RNAPII 215 8  EMS-induced ts allele in 215, aa replacement L- 
878-F  
Chen et al., 1993 
v'RNAPII 215 12  EMS-induced ts allele in 215, aa replacement 
A-377-T  
Chen et al., 1993 
v'RNAPIJ 215 4 EMS-induced ts allele in 215, aa replacement R- 
741-H  
Chen et al., 1993 
y2ras1 v'RNAPII 215 
shi' 
Deletion in 5' upstream coding region of 215 Bloomington 
- v'RNAPII 215 3 EMS-induced ts allele in 215 Bloomington 
Df(1)GAII2 215 located to 10C2, deficiency breakpoints 
IOB1-2; 1OCI-2  
Bloomington 
Df(1)N71 215 located to 10C2, deficiency breakpoints 
lOBS; 10D4 
Biggs et al., 1985; 
Bloomington 
Putative CTD-binding proteins  
Df(2L)VAJ6 CG15160 	located 	to 	37A2, 	deficiency 
breakpoints 36F7-9; 37D1-2  
Bloomington 
Df(3L)R-G7 CG9018 	located 	to 	62D3, 	deficiency 
breakpoints 62B9; 62E7  
Bloomington 
Df(2L)J39 CG6521 	located 	to 	32B4, 	deficiency 
breakpoints 31C; 32D1-E5  
Bloomington 
Df(2R)knSA3 CG10228 	located 	to 	51D2, 	deficiency 
breakpoints 51B5-1 1; 51D7-E2  
Bloomington 
Df(2R)Pu-D1 7 CG9346 	located 	to 	57B 16, 	deficiency 
breakpoints 57B4; 58B  
Bloomington 
Df(2R)AA2I CG4266 	located 	to 	57C4-5, 	deficiency 
breakpoints 56F9-17; 57D1 1-12  
Bloomington 
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pre-mRNA splicing 
Allele 	I 	 Comments 	 I 	Reference! Source 
UI snRNA  
DJ(2L)S2 U I a-21 D located to 21 E, deficiency breakpoints 
2106-D1; 24D3-4 
Mount and Saltz, 2000; 
Bloomington 
DJ(3R)110 Ula-82Eb 	and 	Ula-82Ec 	located 	to 	82E, 
deficiency breakpoints 82C4; 82F3  
Bloomington 
Df(3R)mbc-R1 Ula-95Ca, Ula-95Cb and Ula-95Cc located to 
95C, deficiency breakpoints 95A5-7; 95D6-11  
Bloomington 
Sans flue  
yw snj'210 Null in snf Flickinger and Salz, 
1994 
Df(i)JC70 snf located to 4F1-2, deficiency breakpoints 
4C15-16; 5A1-2  
Salz et al., 1994 
snfv24 aa replacement H-49-R in amino terminal RRM 
of snf 
Salz and Flickinger, 
1996 
SmD3 
Df(2R)CB2J S,nD3 located to 48F3, deficiency breakpoints 
48E; 49A 
Mount and Salz, 2000; 
Bloomington 
Luc7-Iike 
Df(3L)81K19 Luc7-like (CG7564) located to 74C1, deficiency 
breakpoints 73A3; 74F 
Mount and Salz, 2000; 
Bloomington 
Related to Luc7 
Tp(1;3)sn13"' Related to Luc7 (CG3198) located to 6C8, 
deficiency breakpoints 6C; 7C9-7D I 
Mount and Salz, 2000; 
Bloomington 
U2050  
Df(1)4b18, y cv vf car 
__________ 
U2af50 located to 14C1 , deficiency breakpoints 
14B8; 14C1  
Bloomington 
U2af5O' 5 Deletion of RS domain amino acids 1-34 that 
leaves a single RS dipeptide  
Rudner et al., 1998 
Deletion of amino-terminal acids 1-46 Rudner et al., 1998 
U2af 38  
Df(2L)PMF 
________ 
U2af 38 	located 	to 	21 B7-8 	, deficiency 
breakpoints 21A1; 21B7-8 




Lethal P-insertion 200bp upstream of U2af 38 
coding region  
Rudner et al., 1996 
y'w6723, P(w1acW) 
U2aJ38114504  
Lethal P-insertion in U2af 38 Bloomington 
Noisette  
P(A92)gor' 	 P-insertion in Noisette 	 Meyer et al., 1998 
B52  
Wa; B52R2  25 bp deletion in 1stRRM  of B52 Peng and Mount, 1995 
B527  Deletion in B52 Peng and Mount, 1995 
W118; Hrb87F2B52 1291 Lethal P-insertion in B52 John Lis 
w"8; Hrb87F2B52402 ' Lethal P-insertion in B52 John Lis 
B52'red e EMS-induced allele in B52 Susan Haynes 
B52 '7red e EMS-induced allele in B52 Susan Haynes 
Df(3R)r385  B52 located to 87F7-8, deficiency breakpoints 
87B 15-Cl; 87F15-88Al  
Bloomington 
Hrb 87F 
Df(3R)Hrb87F Null in Hrb87F and partial deletion in Tsr Bloomington 
Hrb87F7  Hrb87F deletion allele I 	Peng and Mount, 1995 
IM 
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RNA 3'-end formation 
Allele 	 Comments 	 I 	Reference! Source 
Cleavage and polyadenylation specificity factor  
y1w 723; 1(2)k16805 Pinsertion in CPSF-160 5' UTR. Salinas et al., 1998 
Df(2R)trix CPSF-160 	located 	to 	51B, 	deficiency Bloomington 
breakpoints 51A1-2; 51B6  
CPSFV 500 bp deletion in CPSF-160 Salinas et al., 1998 
CPSF IV" Deletion in CPSF-160 and Asx Salinas et al., 1998 
Df(3R)3450 CPSF-100 	located 	to 	98F, 	deficiency Bloomington 
breakpoints 98E3; 99A8  
Df(3R)ChaM7 CPSF-73 located to 91D, deficiency breakpoints Bloomington 
91 A; 91F5  
Df(2L)a1 CPSF-30 located to 21D, deficiency breakpoints Bloomington 
21B8-C1; 21C8-D1  
DJ(2L)ast2 CPSF-30 located to 21D, deficiency breakpoints Bloomington 
21D1-2; 22B2-3  
Cleavage stimulation factor  
DJ(I)X-1, DJ(J)y-ac, 150 bp deletion in CstF-77 at positions +2.2 to Bloomington 
sc'su(t)5 +4.3  
y'v'su(j)6 1 Kb deletion in CstF-77 at positions —0.3 to Bloomington 
+1.3  
y2sc1su(s) 21z'f'su(J) 8 CstF-77 ts lethal Bloomington 
Df(1)A209 CstF-77 located to 20E, deficiency breakpoints Bloomington 
20A; 20F  
Dfl3R)ChaM7 CstF-64 located to 91D, deficiency breakpoints Bloomington 
91A; 91F5  
Df(3R)faf-BP CstF-50 	located 	to 	IOOD, 	deficiency Bloomington 
breakpoints 100D; 100F5  
RNA transport 
Allele 	I 	 Comments 	 I 	Reference! Source 
Pendulin 
P(w+ClacW)Penk44W Lethal P-insertion in 5'UTR of Pendulin Torok et al., 1995 








Df(3L)pbl-XI Diminished-7 located to 66B8-B10, deficiency 
breakpoints 65F3; 66B10 
Bloomington 
Bx34 




Df(2L)J39 Nap 154 	located 	to 	32D1-2, 	deficiency 
breakpoints 31C-D; 32D-E 
Bloomington 
Karyopherin al 
Df(3L)VW3 Karvopherin al located to 76A-F, deficiency 
breakpoints 76A3; 76B2 
Bloomington 
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Translation 
Allele 	I 	 Comments 	 —F —Reference/ Source 
eIF4E  
Df(3L)ACI eIF4E located to 67B2, deficiency breakpoints 
67A2; 67D13 
Hernandez et al., 1997; 
Bloomington 
w; eIF4E P589.11 Lethal P-insertion in V intron of eIF4E Pascal Lachance 
eIF4E-binding protein  
yw; thor Null in eIF4E-binding protein Pascal Lachance 
Df(2L)tim°2  eIF4E-binding 	protein 	located 	to 	23F3, 
deficiency breakpoints 23F2-3; 23F6-24A1 
Bernal and Kimbrell, 
2000 
eIF4E-related proteins  
Df(3L)66C-G28 CG8023 	located 	to 	66C1, 	deficiency 
breakpoints 66B8-9; 66C9-10  
Lasko, 2000 
DJ(3L)W5.4 CG10124 	located 	to 	65C1, 	deficiency 
breakpoints 65A; 65E1 
Lasko, 2000; 
Bloomington 
Df(3R)crb-F89-4 eIF4E-homologous protein located to 95D8-10, 
deficiency breakpoints 95D7-1 1; 95F15  
Bloomington 
eIF4A  
y' w6723;  
P(w C1ac W)e1F4AkO 5Ol  
Lethal P-insertion in eIF4A Bloomington 
P(ry+172PZ)e1F4A024?9 
cn'  
Lethal P-insertion in eIF4A Galloni et at., 1999 
yw; eIF4A 162- 700 bp deletion in eIF4A at positon +2 Dorn et at., 1993 
yw; eIF4AbOO9 Lethal P-insertion into Pt intron of eIF4A Galloni et at., 1999 
yw; eIF4A 1013 Lethal P-insertion into V intron of eIF4A Galloni et at., 1999 
yw, eIF4A'°° Lethal P-insertion into 2nd  intron of eIF4A Galloni et at., 1999 
Df(2L)E110 eIF4A 	located 	to 	26A9-B1, 	deficiency 
breakpoints 25173-26A I; 26D3-1 I  
Bloomington 
eIF4G  
Df(4)G eIF4G located to 102E, deficiency breakpoints 
102E2; ElO 
Hernandez ci' at., 1998; 
Bloomington 
Df(4)M1O1 -62f Deficiency breakpoints 101 E; I 02B 10-17 Bloomington 
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